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Abstract 
A collection of three newly isolated Salmonella bacteriophages, vB_SenS-Ent1, vB_SenS-Ent2 and 
vB_SenS-Ent3 was established. These bacteriophages were characterised by electron microscopy, 
host range, sensitivity to restriction enzymes and profiles of structural proteins on SDS-PAGE gels. 
The complete genome sequences of each bacteriophage were established to greater than 30x 
coverage and bioinformatics analysis identified the functions of a number of coding sequences.  
Since the last update of virus taxonomy by the ICTV a number of additional genome sequences for 
bacteriophages infecting the genus Salmonella have been reported in the literature. To date, all but 
one of the Siphoviridae comprising the Salmonella bacteriophages with fully sequenced genomes 
remain unclassified by the ICTV. Comparative genomic analysis reveals that a number of these 
phages form a coherent group within the Siphoviridae and supports the establishment of a new 
genus, the “Setp3likeviruses”. The proposed genus includes 5 bacteriophages infecting Salmonella; 
SETP3, vB_SenS-Ent1, SE2, wksl3 and SS3e, and 5 infecting Escherichia; K1G, K1H, K1ind1, K1ind2 and 
K1ind3. This group share identical virion morphology, have terminally redundant, circularly permuted 
genomes ranging between 42-45 kb in size and are characterised by high nucleotide sequence 
similarity, shared homologous proteins and conservation of gene order. 
Bioluminescent bacterial reporters, transformed to express the luxCDABE operon of Photorhabdus 
luminescens, were used to establish the activity of the vB_SenS-Ent bacteriophages in microtitre 
broth lysis assays, efficacy as biological control agents for the removal of Salmonella in contaminated 
foods and for spatial measurements of plaque expansion in agar overlays. 
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Chapter 1 Introduction 
1.1 Overview 
Members of the genus Salmonella continue to represent significant aetiological agents of disease in 
humans and animals. With the continued rise in antibiotic resistance it is imperative to identify and 
investigate alternative strategies for the development of novel antimicrobials for use as clinical 
therapeutics or for the control of bacterial pathogens in industry. The bacteriophages, obligate 
parasites of bacteria, represent one such potential source of antimicrobial agents. 
The present study was carried out to further understand the biology of phages infecting the genus 
Salmonella and the potential of such phages to act as biological control agents. To achieve this, the 
specific aims of this thesis were five-fold: 
1. To isolate, select and characterise bacteriophages specific for Salmonella. 
2. To sequence and annotate the genomes of the isolated bacteriophages 
3. To investigate the chosen phages for their ability to function as biological control agents  
4. To investigate the use of bioluminescent bacterial reporters as a sensitive and non-
destructive method to monitor bacteriophage-mediated lysis of Salmonella. 
5. To employ bioluminescent imaging as a method to follow the expansion of plaques in overlay 
agar.   
This thesis is composed of eight chapters. Chapter one provides a general introduction to the 
bacteriophages, the genus Salmonella and bacterial bioluminescence. Chapter two describes the 
methodologies employed to achieve the aims of this project. Chapter three details the isolation, 
microbiological characterisation, sequencing and annotation of three bacteriophages specific for 
Salmonella: vB_SenS-Ent1, vB_SenS-Ent2 and vB_SenS-Ent3. Chapter four summarises a comparative 
genomics study of 42 Salmonella bacteriophages whose complete genome sequences are available 
within the international nucleotide sequence database and a proposal for the formation of a novel 
genus within the family Siphoviridae. Chapter five describes the use of Salmonella serovars 
transformed to express a bioluminescent phenotype to monitor the effects of co-incubation of 
bacteria and bacteriophage in liquid media. Chapter six investigates the use of the vB_SenS-Ent 
bacteriophages as biological control agents for the reduction of Salmonella on a variety raw and 
ready to eat food matrices. Chapter seven describes the application of bioluminescence imaging to 
monitor the formation and expansion of plaques on host bacterial lawns in overlay agar plates. 
Lastly, chapter eight presents the main conclusions of the studies presented in this thesis and 
outlines recommendations for future work. 
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1.2 The Bacteriophages 
The word virus stems from the Latin meaning ‘poison’ or ‘venom’. Every domain of life is affected by 
the actions of viruses. The Bacteria are no exception to this rule, providing a nice analogy that the 
bacteria can catch colds too. Discovered independently by Frederick Twort (1915) and Felix D’Herelle 
(1917), the bacteriophages (phages) are obligate intracellular parasites of bacteria, that is, they are 
unable to reproduce without the presence of the intact molecular machinery constituting the host 
cell. Despite the independent reports and that Twort did not pursue his finding, it is d’Herelle who is 
accredited with the discovery of these viruses and who coined the name for viruses of bacteria: the 
bacteriophages. ‘Phage’ derives from the Greek ‘phagos’ literally translating as ‘to eat’, ‘devour’ or 
‘consume’, hence bacteriophages are the ‘eaters of bacteria’. It was suggested early on that the 
bacteriophages could be employed to prevent or treat bacterial infections. Many of the early phage 
therapy trials were reported to be successful and several preparations were marketed by companies 
such as Eli Lily and L’Oreal. However, the advent of antibiotics diverted interest in the United States 
and Western Europe away from the study of bacteriophages as therapeutic agents. Rather, research 
in the West focussed upon a few model phages and led to fundamental discoveries which formed the 
backbone of modern molecular biology. In contrast, the use of bacteriophages as therapeutic agents 
was continued in Eastern Europe and the former Soviet Union where several institutions were 
founded, including the Eliava Institute in Tbilisi, Georgia. Subsequently, with the current rise of 
antibiotic resistance possibly representing the advent of a new ‘pre-antibiotic’ era, the exploitation 
of bacteriophages as therapeutic and biological control agents is subject to renewed interest. 
1.2.1 Morphology forms the basis for classification 
Phage classification began in earnest with the definition of six morphotypes, based upon virion 
morphology and type of nucleic acid (Bradley, 1967). This system was revised by Ackermann and 
Eisenstark (1974) and has subsequently been reviewed and updated over time (Ackermann, 1987, 
Ackermann, 1996, Ackermann, 2001, Ackermann, 2007a, Ackermann and Prangishvili, 2012). The 
taxonomic classification of bacteriophages is coordinated by an international body, the International 
Committee for the Taxonomy of Viruses (ICTV). For bacterial viruses, in the ninth report on virus 
taxonomy the ICTV recognise one order, the Caudovirales comprising the tailed bacteriophages and 
seven other families (King et al., 2011). Bacteriophages are classified into families on the basis of up 
to 70 criteria (Ackermann, 2009a) but most consideration is given to physical characteristics including 
virion shape (tailed, polyhedral, filamentous or pleomorphic), type and structure of nucleic acid and 
genomic information, if available. In a recent update Ackermann summarised the morphological 
descriptions of nearly 6,300 bacteriophages examined under the electron microscope (Ackermann 
and Prangishvili, 2012).  Reports of bacteriophages in the literature overwhelmingly belong to the 
order Caudovirales. Polyhedral, filamentous and pleomorphic phages are reported, but represent a 
very low fraction of studied phages (Figure 1). These phages represent seven families, some of which 
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have very few members (Ackermann, 2007a). The tailed dsDNA phages, classified in the order 
Caudovirales are represented by three families (Figure 2), the Siphoviridae (non-contractile tails), 
Myoviridiae (contractile tails) and Podoviridae (very short tails). This literature review is limited 
exclusively to the Caudovirales as all the phages isolated during the course of this work belonged to 
this order (Chapter 3). 
 
Figure 1. Schematic diagram of the different morphologies of prokaryotic viruses. Each 
morphotypes is labelled with Reproduced with permission from Ackermann and Prangishvili (2012).  
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Figure 2. Representatives of the three families of the order Caudovirales, the tailed dsDNA 
bacteriophages. The capsid enclosing the virion nucleic acid is coloured purple for each family. The 
tail is composed of the major tail (MTP) and tapemeasure (TMP) proteins and extends from the 
capsid, which for Myoviridae is enclosed by the tail sheath. The tail terminates at the baseplate to 
which the apparatus (not shown) required for adsorption and infection of host cells is attached. 
Reproduced with permission from Veesler and Cambillau (2011).  
The classification of bacteriophages is subject to continuous discussion and debate, particularly with 
the increasing volume of available genomic and proteomic data. New approaches to phage taxonomy 
are complicated as no single candidate gene analogous to the 16S rRNA gene used for the 
classification of bacteria exists in all phage families. Additionally comparative genomic studies have 
demonstrated that phage genomes are mosaic, that is, are subject to horizontal transfer events at 
relatively high frequency, further complicating approaches for classification. As such, there is no 
single criterion for the demarcation of bacteriophage species and genera. Instead a polypthetic 
approach is favoured, where clades are delineated by a set of properties, some of which may be 
absent among related members. A number of alternative taxonomic approaches have been proposed 
in the literature. These include classification based upon terminase amino acid sequence similarity 
(Casjens et al., 2005), structural genes (Deveau et al., 2006) and whole proteomes (Rohwer and 
Edwards, 2002). One promising approach is described by Lavigne et al., (2008, 2009) where BLAST-
based tools were used to delineate shared orthologous proteins between different phage genomes. 
Combining these data with literature reviews, the authors were able to classify 120 Myoviridae and 
55 Podoviridae. While approaches to taxonomy are improving and under continued development, 
the system, or rather lack of one, for the naming of isolated bacteriophages follows no convention. 
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Recently a systematic method of nomenclature has been proposed (Kropinski et al., 2009). This 
system allows the rapid identification of bacteriophage family, lifestyle and host genus for a specific 
phage isolate. 
1.2.2 Bacteriophage lifecycles 
The first stage in infection of a host cell is the primary adsorption event. Adsorption refers to 
reversible and irreversible binding events between a phage receptor binding protein and a bacterial 
cell surface structure such as LPS, one or more outer membrane proteins, fimbriae or flagella. 
Primary adsorption is mediated by phage protein structures including tailspikes and tail fibres while 
irreversible binding tends to be a function of secondary binding proteins localised at the baseplate. 
Irreversible adsorption results in the transfer of the virion genome to the host cell cytoplasm, a 
unidirectional process termed ejection or injection. Quite how the phage genome travels across the 
bacterial cell wall and inner membrane remains unclear, although a conformational change is likely 
transmitted along the tail in order to open the closed phage capsid upon irreversible binding. It is 
probable that the bacteriophages have evolved a number of different methods to facilitate this 
translocation event.  
Bacteriophages possess several lifecycles; lytic (virulent), lysogenic (temperate), pseudolysogenic and 
chronic. The lytic cycle is where phages infect and rapidly replicate within a host bacteria. The lytic 
lifecycle results in the release of newly formed progeny virions and death of the host cell through 
lysis, mediated by phage-encoded proteins which enzymatically degrade the cell wall. Lytic infection 
results in clear plaques on the respective host bacterial lawns. The period encompassing phage 
adsorption to genome replication, production of progeny virions and lysis of the host cell is described 
as the latent period. The duration from adsorption to the time of formation of progeny virions, when 
intracellular virions can be detected by plaque assay after prematurely lysing the host cell, is 
described as the eclipse phase (Ellis and Delbrück, 1939). 
Temperate phages are those which possess a lytic life cycle and a lysogenic life cycle. In the lysogenic 
life cycle, the infecting phage does not directly kill the host cell but instead either integrates into the 
host bacterial chromosome by transposition or site-specific recombination or resides as a plasmid 
within the host cell cytoplasm. In the integrated state, the phage DNA is termed a prophage and 
through gene expression can confer new or additional properties to the bacterial cell when 
expressed, a process termed lysogenic conversion (Brüssow et al., 2004). The prophage can stably 
reside within the host cell for many generations until appropriate environmental or physiological 
conditions trigger the lytic lifecycle, a process termed induction. Genome sequencing has revealed 
that many bacteria contain viable or cryptic prophage sequences encoded within the chromosome 
(Canchaya et al., 2003b, Casjens, 2003). A common feature of lysogeny is that the bacterial host 
subsequently becomes resistant to infection by related phages that share the same immunity group 
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profile or repressor specificity or by alteration of the cell surface epitope used for adsorption. 
Through various mutation events, the ability of a prophage to form functional virions upon activation 
of the lytic cycle may be lost whereby such prophages are termed cryptic prophages. Temperate 
phages tend to form cloudy plaques on bacterial lawns as the probability of infection leading to 
lysogeny is greater than for lytic infection. 
A further state, pseudolysogeny, has been proposed and is defined as a non-replicative and non-
productive state following a successful adsorption and genome transfer event (Ripp and Miller, 
1997). Pseudolysogeny is thought to occur in the presence of adverse conditions which prevent 
either genome integration or replication, perhaps caused by host cell starvation. This strategy has the 
potential to enhance bacteriophage survival, as the phage genome is protected from environmental 
conditions by ‘sheltering’ within the host cell (Miller and Ripp, 2002). A final lifestyle, termed chronic 
infection, is observed for some archaeal viruses and filamentous phage. In this scenario, progeny 
virions are slowly and continuously shed or extruded from the cell surface rather than being released 
as a single burst event (Lopez and Webster, 1983).  
An infection event which results in either integration or replication of the virion genome may be 
termed a successful infection. A productive infection is one which results in the assembly and release 
of progeny virions competent for subsequent infection of host bacteria. Infection does not always 
result in the death of the host cell and survival of the bacteriophage (Figure 3). Bacteria have evolved 
a number of resistance mechanisms including preventing uptake of the phage genome, 
superinfection immunity, clustered regularly inter-spaced palindromic repeats (CRISPR) and 
restriction modification systems (Labrie et al., 2010). 
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Figure 3. Schematic representation of the possible outcomes of infection of bacteria by 
filamentous and tailed bacteriophages. The diagram depicts the interactions between phage and 
host and the survival outcome for each. Adsorption to and release from bacterial cells are shown as 
short dashed lines. Infections leading to death of the bacterial cell are shown as long dashed lines. 
Reproduced with permission from Hyman and Abedon (2010).  
1.2.3 Bacteriophage structure 
A bacteriophage virion consists of a single or double stranded DNA or RNA encapsulated within 
either a protein or lipoprotein coat. For members of the Caudovirales the nucleic acid is exclusively 
double-stranded DNA and ranges in size from 22.2 kb for Lactococcus phage c2 to 497.5 kb for 
Bacillus phage G. Irrespective of the target host organism, the virion structure is designed to contain 
and protect the viral chromosome, facilitating its safe transfer to a host cell to allow subsequent 
replication. The binary symmetry, or head to tail structure, of the Caudovirales is unique in virology 
and phages of this order are also differentiated from animal viruses in that the delivery of their 
genetic material occurs by an ejection mechanism, rather than by an un-coating process, following 
adsorption to the host cell surface. Capsid and tail assembly occur by separate pathways involving 
the sequential addition of component subunits. The process of virion assembly and morphogenesis 
has been studied in extensive detail for P22, SPP1 and T4. More recently, the application of atomic 
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force microscopy (AFM) and 3D reconstruction from cryo-electron microscopy has yielded additional 
insights into the structure and location of these proteins in situ (Guerrero-Ferreira and Wright, 2013, 
Kuznetsov et al., 2011, Parent et al., 2012). 
1.2.4 Capsid assembly 
The head or capsid forms the protective container for the condensed bacteriophage chromosome 
and the formation of this closed shell for genome packaging requires the recruitment and 
organisation of multiple copies of protein subunits. Recent studies using 3D reconstructions from 
cryo-electron microscopy have shown that DNA resides within the mature capsid as a tightly wound 
spool (Cerritelli et al., 2003, Parent et al., 2012). It is estimated that the pressure within the capsid is 
as much as 20 atmospheres (Cordova et al., 2003) and as such, the mature capsid lattice must be 
sufficiently robust to withstand the pressure of the condensed chromosome. In general, the size of 
the phage capsid is correlated to the size of the genome being packaged. 
All members of the Caudovirales have capsids with icosahedral (20 sides/12 vertices) symmetry or 
prolate derivatives thereof, providing a characteristic appearance under the electron microscope. 
The icosahedral structure forms with known triangulation numbers T=4, 7, 13, 16 and 52, assembled 
from many copies of one or two major coat proteins (MCP). The triangulation number system was 
introduced by Caspar and Klug (1962) to describe the relationship between the number of 
pentameric and hexameric subunits giving rise to the quasi-symmetry of the capsid shell. Each corner 
of the icosahedron is generally made up of pentamers of the MCP, while the rest of each side is made 
up of hexamers of the same or a similar protein. 
Three gene products are critical for capsid formation; the portal, scaffold and MCP. Several other 
factors, including accessory proteins, chaperones and proteases are also required. The first stage in 
capsid formation is the production of assembly intermediate, precursor structures called procapsids. 
The scaffold proteins co-assemble with the MCP subunits, forming a core inside the prohead. The 
scaffold is provided either by a separately encoded protein, as for P22 (Greene and King, 1994), or 
from a region of the major coat protein itself as for HK97 (Huang et al., 2011). 
The true T=7 symmetry of the capsid is broken locally at one of the five-fold vertices by the portal 
protein complex. The portal vertex is formed as a dodecameric ring of portal protein subunits and 
serves as the gateway through which DNA enters the pro-capsid during particle assembly, and exits 
during infection (Johnson and Chiu, 2007). The portal also forms part of the junction or neck 
connecting the capsid and tail. Like other phage structural proteins, the portal proteins from 
different bacteriophages vary widely in sequence and molecular mass. The terminase complex, made 
up of small and large subunits, associates with the portal vertex and facilitates DNA packaging. The 
mechanism initiating DNA packaging differs according to the replication strategy of the viral DNA.  
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With the start of DNA packaging the scaffold is removed signalling the start of maturation. Two 
mechanisms for removal of the scaffold have been identified. For phages T4, HK97 and λ scaffold 
proteins are proteolytically cleaved by a phage-encoded protease (Liu and Mushegian, 2004), while 
for P22 and ɸ29 the scaffold proteins exit the procapsid (Eppler et al., 1991). With maturation the 
procapsid undergoes a structural transition, enlarging, becoming more angular and taking on the 
characteristic isometric shape.  
Most characterised tailed dsDNA phages assemble the capsid structure from multiple copies of one 
MCP. The exceptionally well characterised myovirus T4 is an exception, encoding two capsid 
proteins: gp24, forming the pentameric vertex capsomers and gp23, forming hexameric capsomers 
(Olson et al., 2001). The MCPs of the tailed phages show extreme amino acid sequence variation. 
Despite such disparate sequences, the 3D structure of MCPs examined at high resolution by X-ray 
crystallography exhibit the presence of HK97-like fold, named after the bacteriophage in which this 
structure was first described (Wikoff et al., 2000). High resolution structures of MCPs have been 
resolved for phages T4 (Fokine et al., 2005); ɸ29 (Morais et al., 2005), ɛ15 (Jiang et al., 2006), T7 
(Agirrezabala et al., 2007), λ (Lander et al., 2008), BPP-1 (Dai et al., 2010) and P22 (Jiang et al., 2003) 
all of which possess the HK97-like fold. These data are indicative of a common, very ancient 
evolutionary ancestor; it has long been recognised that 3D structure tends to be more highly 
conserved over much greater timespans than either nucleotide or amino acid sequence (Rossmann 
et al., 1974). Moreover, Baker et al., (2005) demonstrated similarities between the HK97-like fold of 
MCPs of the Caudovirales with those of herpesviruses and suggested that the existence of related 
viruses infecting different domains of life might have arisen from a progenitor virus predating the 
separation of the different domains of life or one that arose from a later adaptation event. 
Once the capsid is packaged with DNA, the terminase complex is substituted by neck proteins, 
variously described as connector, tail terminator or head completion proteins, which together with 
the portal form successive rings with the bottom ring being termed the gatekeeper complex (Orlova 
et al., 2003). For bacteriophage SPP1 the gatekeeper has been demonstrated to prevent premature 
exit or leakage of DNA (Lhuillier et al., 2009). 
Some bacteriophages have been found to recruit additional accessory proteins to the capsid, termed 
head decoration or capsid stabilisation proteins. Studies of the Dec protein of bacteriophage L 
(Gilcrease et al., 2005) found that this protein increased tolerance to EDTA of the closely related P22 
virion. The authors suggested that a loss of divalent cations by the chelating activity of EDTA causes 
an increase in pressure upon the condensed chromosomal DNA resulting in capsid disruption or DNA 
ejection. Similarly, the soc gene product provides stabilisation to the T4 capsid when exposed to 
extremes of pH or temperature (Qin et al., 2010). 
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1.2.5 The Bacteriophage tail 
The tail functions to facilitate adsorption and attachment of the phage to the host cell surface and 
provide a conduit for genome ejection and it is this feature which distinguishes the three families of 
the Caudovirales. Analogous to genes encoding capsid assembly components, genes encoding 
elements for tail structure and assembly show great variation in sequence composition. However, 
the order of genes tends to be conserved, providing valuable information for the prediction of gene 
function. Genes tend to follow a ‘body plan’ of consecutive open reading frames beginning with the 
major tail protein (MTP) and ending with genes encoding the baseplate and adsorption apparatus 
(Veesler and Cambillau, 2011). Tail assembly occurs separately to the capsid and occurs by the 
addition of components in a strict sequential order (Aksyuk and Rossmann, 2011). 
The architecture of the long, flexible siphovirus tail is relatively simple, reflected in the use of the 
Greek siphon, meaning tube. The tail is based upon three main components: the tape measure 
protein, the major tail protein and the tail terminator protein. In contrast, the Myoviridae (Greek 
myos, muscle) are characterised by a complex rigid tail apparatus. For this family of phages the tail 
tube is enclosed by an outer contractile sheath. This added layer of complexity is reflected by the 
number of genes encoding the tail structure and assembly components; at least 22 genes are 
involved in assembly of the T4 bacteriophage tail (Miller et al., 2003). The Podoviridae (Greek podos, 
meaning foot) possess no real tail, rather the adsorption apparatus is connected directly to the neck 
region. 
The tail tube is formed by the polymerisation of multiple copies of the MTP and there is evidence for 
structural conservation of this protein in both contractile and non-contractile tails (Pell et al., 2009a). 
The length of the tail is determined by the tape measure protein (TMP), located inside the tail shaft. 
All long-tailed phages sequenced to date possess a large gene, usually greater than 2 kbp in length, 
encoding the TMP. This family of proteins is characterised by the presence of long hydrophobic α-
helices and the relationship between tail length and TMP length has been shown by insertion and 
deletion studies to be precisely correlated, with an approximate length of 0.15 nm per amino acid 
residue for phage λ (Katsura, 1990, Katsura and Hendrix, 1984). However, the position and precise 
molecular mechanism governing tail length determination by these proteins has not been 
unequivocally determined. Binding of the tail terminator protein halts polymerisation of the tail tube, 
completing the tail assembly. The tail terminator also interacts with the capsid to facilitate joining of 
the head and tail (Pell et al., 2009b, Zhao et al., 2003). In addition to the MTP and TMP, tailed phages 
encode a number of tail assembly chaperones and completion proteins. One common feature of 
these scaffold proteins is the presence of translational frameshifts which are conserved across a 
diverse range of long tailed phages. In λ gpGT is formed by a -1 translational frameshift occurring at 
the C-terminal end of gpG. The frameshift occurs at a frequency of approximately 4 % which results 
11 
 
in a fixed abundance ratio between gpG and gpGT. These proteins are thought to form a spiral 
scaffold with dimensions similar to the internal diameter of the tail tube (Xu et al., 2004). Notably, 
functional and sequence comparisons of the tail tube and head-tail connector proteins suggest that 
the tail proteins of Myoviridae and Siphoviridae arose from a single ancestral gene (Cardarelli et al., 
2010). 
The apparatus facilitating host adsorption is located at the distal end of the phage tail. Binding to the 
host cell surface occurs as a result of interactions with one or more host receptors by one or more 
phage receptor binding proteins. The recognition event is highly specific and facilitates rapid and 
efficient attachment to the host cell. Bacteriophages are capable of binding to a wide range of cell 
surface structures including proteins, LPS and components of the cell wall and this ability is reflected 
by a stunning diversity of distal tail morphologies. Phage receptor binding proteins are generally 
either described as tail fibres or tail spikes. Tail fibres refer to long, thin, flexible structures composed 
of one or more proteins, which extend from the top of the tail tip assembly in siphoviruses and to the 
baseplate of myoviruses. Tailspikes, in contrast, tend to be much shorter and appear as globular or 
tear-shaped structures. Transmission and cryo-electron microscopy have amply illustrated the 
diversity of tail-tip/baseplate complexes among the bacteriophages. Despite low levels of sequence 
identity, many of the characterised tail fibres and tailspikes of the Caudovirales form homotrimers 
rich in β structure. The N-terminal domain is exclusively associated with attachment of the RBP to the 
phage tail, either directly or through interaction with an adaptor protein, while the C-terminal 
domain is responsible for receptor binding.  
1.3 The Salmonellae 
The Salmonellae remain significant aetiological agents of zoonotic and food-borne disease world-
wide. Members of the genus are Gram-negative, facultatively anaerobic, non-sporulating bacilli that 
are the causative agents of typhoid fever, gastroenteritis and enteric fever in both humans and 
animals. With the exception of S. Gallinarum, serovars (serotypes) of Salmonella are motile, 
possessing peritrichous flagellae.  
The first successful clinical definition of typhoid fever was undertaken in 1851 by Sir William Jenner 
who differentiated the disease from Typhus, a vector borne disease caused by transmission of 
Rickettsia typhi or Rickettsia prowazekii by ticks and lice. In 1880, Karl Joseph Eberth isolated a 
bacillus suspected of causing typhoid from spleen sections and mesenteric lymph nodes, and in 1884 
Georg Gaffky confirmed Eberth’s findings. The bacillus reported by Eberth and Gaffky was first 
identified as a separate genus by Dr Theobald Smith, a researcher investigating swine cholera under 
the auspices of the USDA Bureau of Animal Industry. Despite identifying the bacteria, Salmon, as 
Smith’s administrator, took priority on the research paper and hence the new bacterium was named 
Salmonella (Salmon, 1884). 
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The nomenclature of Salmonella is complex and continues to be frequently revised. The 
differentiation of Salmonella isolates was initially performed using clinical evidence, serological and 
biochemical tests. Serological analysis of Salmonella dates back to the beginning of the 20th century 
with a study of antigenic components in motile and non-motile strains of S. Choleraesuis (Smith and 
Reagh, 1903). Phase variation of flagella was subsequently discovered in S. Typhimurium by 
Andrewes (1922). The first systematic serological analysis of Salmonella was initiated by White 
(1926) and continued and extended by Kauffmann (1961). Prior to the introduction of the 
Kauffmann-White scheme in 1946 by the World Health Organisation (W.H.O.) serovar names were 
allocated according to clinical manifestation, geographic location or source from which the serovar 
was first isolated. Subsequent DNA-DNA hybridisation analysis demonstrated that 
the Salmonella serovars form a single hybridisation group sharing between 70 % and 90 % DNA 
content, demonstrating that relatedness between different serovars existed at the species level 
(Crosa et al., 1973). That is, rather than possessing many species, the genus is constituted of a single 
species comprised of many serovars, a hypothesis subsequently supported by rRNA studies (Chang et 
al., 1997, Christensen et al., 1998) and sequence evidence from housekeeping and invasion genes (Li 
et al., 1995, Boyd et al., 1997). Further analysis by multi-locus enzyme electrophoresis (MLEE) and 
DNA hybridisation provided evidence that S. bongori should be considered a distinct species (Le 
Minor L et al., 1986).  
  
13 
 
Table 1. Differential biochemical characteristics of species and subspecies of Salmonella. 
Reproduced from Grimont and Weill (2007).  
Species S. enterica S. bongori 
Subspecies 
enterica 
(I) 
salamae 
(II) 
arizonae 
(IIIa) 
diarizonae 
(IIIb) 
houtenae 
(IV) 
indica 
(VI) 
 
Dulcitol + + - - - d + 
ONPG (2 h) - - + + - d + 
Malonate - + + + - - - 
Gelatinase - + + + + + - 
Sorbitol + + + + + - + 
Growth with KCN - - - - + - + 
L(+)-tartrate
(a) 
+ - - - - - - 
Galacturonate - + - + + + + 
γ-
glutamyltransferase 
+
(
*
)
 + - + + + + 
β-glucuronidase d d - + - d - 
Mucate + + + - (70 %) - + + 
Salicine - - - - + - - 
Lactose - - - (75 %) + (75 %) - d - 
Lysed by phage O1 + + - + - + d 
Usual habitat 
Warm-blooded 
animals 
Cold-blood animals and the environment 
(a) = d-tartrate. (*) = Typhimurium d, Dublin -. + = 90 % or more positive reactions. - = 90 % or more 
negative reactions. d = different reactions given by different serovars. 
The current consensus is that the genus Salmonella consists of two species, S. enterica and S. 
bongori. S. enterica is divided into five subspecies based upon biochemical tests (Table 1) and 
serotyping is used for the differentiation of isolates beyond the subspecies level. Serovars are 
distinguished on the basis of the somatic (O) and flagellar (H1 and H2) antigens. A capsular 
polysaccharide, the Vi antigen, is also present on a limited number of serovars including Typhi and 
Dublin. The list of designated serovars and their antigenic formulae, now known as the Le Minor-
Kauffmann White Scheme, is maintained by the WHO Collaborating Centre for Reference and 
Research on Salmonella at the Pasteur Institute in Paris (Grimont and Weill, 2007). The total number 
of reported serovars for all subspecies currently stands at 2,610 and continues to grow 
(Guibourdenche et al., 2010). Serovars belonging to subspecies I have retained their common names, 
due to their familiarity with clinical practitioners, and are formally presented as Salmonella enterica 
subspecies enterica serovar Enteritidis. Those serovars belonging to subspecies other than enterica 
are designated by antigenic formulae; (i) subspecies numeral, (ii) O antigen followed by a colon, (iii) 
Phase 1 H antigen followed by a colon and (iv) Phase 2 H antigen (e.g. S. IIIa 50:g,z51:-). In practice, 
many scientists, clinicians and physicians continue to use a simplified nomenclature omitting the 
subspecies epithet as the majority of infections in both humans and animals are caused by serovars 
belonging to subspecies enterica. 
Two principle clinical syndromes are associated with infection by Salmonella; typhoid fever and 
gastroenteritis. Typhoid fever is a protracted systemic illness that results from infection with the 
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exclusively human pathogens, S. Typhi and S. Paratyphi. Typhoid is characterised by an array of 
clinical manifestations including fever, abdominal pain and transient diarrhoea. The pathological 
features of typhoid fever are mononuclear cell infiltration and hypertrophy of the reticulo-
endothelial systems including the intestinal Peyer’s patches, mesenteric lymph nodes, spleen and 
bone marrow arising from the intracellular invasion and dissemination of the bacillus. In the absence 
of treatment, mortality ranges between 10 and 15 % (Parry et al., 2002). Non-typhoidal infections by 
Salmonella serovars other than Typhi and Paratyphi are generally self-limiting with clinical 
manifestations ranging from mild to severe gastroenteritis. Like many other infections by pathogenic 
bacteria, the susceptibility, severity and predisposition to serious complications upon infection by 
Salmonella are dependent upon a number of intrinsic host factors. Associated risk factors include 
age, immunosuppressive drugs, the presence underlying medical states (morbidities) and an altered 
endogenous bowel microflora resulting either from antibiotic therapy or from surgical procedures 
(Acheson and Hohmann, 2001). The incubation period varies depending upon these host factors, the 
causative serovar and size of the infectious dose ingested (Blaser and Newman, 1982). Patients 
typically present with headache, nausea, vomiting, fever, diarrhoea and abdominal cramps. In a small 
proportion of cases further complications arise including bacteraemia, gastrointestinal bleeding and 
focal infections (Acheson and Hohmann, 2001). The development bacteraemia, potentially leading to 
bacterial endarteritis and or endocarditis, is associated almost exclusively with the presence of 
underlying co-morbidities (Laupland et al., 2010). Focal infections may occur at virtually any 
anatomical site, arising from dissemination by intra-cellular invasion or bacteraemia. Specifically, 
focal infections may lead to osteomyelitis, polyarticular reactive joint disease, splenic abscesses, CNS 
infection, meningitis and urinary tract infection (Acheson and Hohmann, 2001). Whilst most non-
typhoidal Salmonella infections are transient and self-limiting, it has been demonstrated that the 
bacteria may be detected for a period after the cessation of symptoms. The median duration of 
faecal shedding is reported to be about one month in adults and over seven weeks in children under 
five years of age (Buchwald and Blaser, 1984). 
Transmission of Salmonella to humans is primarily associated with the ingestion of a wide variety of 
contaminated foods but may also arise by contact with animals, contaminated water and infected 
individuals (Hanning et al., 2009). Upon entry to the gastrointestinal tract, Salmonella preferentially 
invade microfold (M) cells overlying the lymphoid follicles of Peyer’s patches facilitated by the 
Salmonella pathogenicity island 1 (SPI-1) encoded type 3 secretion system (Jones et al., 1994, Wallis 
and Galyov, 2000). Type 3 secretion systems (T3SS) act as a molecular needle, facilitating the 
translocation of an array of effector proteins into the host cell cytosol. Dissemination away from the 
gastro-intestinal tract/mucosa occurs by uptake of the bacteria by CD18+ phagocytes and intestinal 
macrophages (Vazquez-Torres et al., 1999). The ability of Salmonella bacteria to promote uptake by 
CD18+ phagocytes and subsequently survive within the phagosome is dependent on a second T3SS 
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encoded within Salmonella Pathogenicity Island-2 (Hensel et al., 1998, Cirillo et al., 1998). After 
uptake by CD18+ phagocytes or macrophages, the acidic environment of the phagosome causes the 
induction of regulatory systems promoting intracellular survival including surface remodelling and 
induction of the SPI-2 T3SS. The SPI2 T3SS effectors are translocated across the phagosomal 
membrane and result in remodelling of the phagosome, cytoskeletal rearrangements, alterations to 
gene expression and mitigation of the oxidative burst. These protein allow Salmonella to survive 
within the host cell, where the phagosome is termed the Salmonella-containing vacuole (Haraga et 
al., 2008). A further action of the SPI2 T3SS effectors is the inhibition of antigen presentation by 
dendritic cells to naïve CD4+ T-cells. (Tobar et al., 2006), thereby limiting the host innate (adaptive) 
immune response (van Diepen et al., 2005). Systemic infection is characterised by dissemination and 
colonisation of Salmonella to the liver, spleen and lymph nodes. A further aspect 
of Salmonella pathogenesis is the establishment of an asymptomatic carrier state that serves as a 
reservoir of infection. Asymptomatic carriers of S. Typhi discontinuously shed the bacilli thereby 
facilitating the dissemination of this pathogen into the environment. 
Serovars of Salmonella can be coarsely differentiated as host-adapted, host-restricted or 
promiscuous based upon their ability to colonise and cause disease in related and unrelated species 
(Uzzau et al., 2000). Host-restricted serotypes typically cause systemic disease in a limited number of 
related species. Those serotypes frequently associated with a specific host and infrequently in 
unrelated hosts are termed host-adapted, whilst promiscuous serotypes are defined as those capable 
of causing disease in a wide range of unrelated host species. Over the past decade a number of 
Salmonella genomes have been sequenced and from subsequent comparisons, the underlying 
genetic and phenotypic characteristics contributing to host specificity and promiscuity are starting to 
be elucidated. Anjum et al., (2005) summarise the genus Salmonella as comprising a composite gene 
pool, within which distinctive variants (serovars) have arisen, possessing different degrees of 
specialisation by the acquisition, loss or mutation of different genes. 
Epidemiological data shows that the majority of non-typhoidal infections by Salmonella are limited to 
relatively few serovars, belonging predominantly to subspecies enterica and serogroups A, B, C1, C2, D 
and E (ECDC, 2010, Uzzau et al., 2000). In the US, the annual economic burden associated with 
medical care and lost productivity due to Salmonellosis is estimated at several billion dollars (Voetsch 
et al., 2004). In 2009 over 49,000 laboratory confirmed cases of Salmonella in humans were reported 
in the US while 109,885 confirmed cases were reported in the EU for the same period. The increased 
resistance of Salmonella isolates to antibiotics, particularly extended spectrum cephalosporins and 
fluoroquinolones, necessitates the identification and investigation of alternative strategies to 
conventional antimicrobial therapy (Velge et al., 2005). The bacteriophages, either as whole virions 
or derivatives of their genes represent one such alternative path for controlling this pathogen.   
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1.4 Bacterial Bioluminescence 
The ethereal qualities of bioluminescence has always attracted and intrigued human kind, evidenced 
by a wealth of historical records spanning some 3000 years (Lee, 2008, Newton, 1957). The light 
emitting enzymes responsible for bioluminescence, termed luciferases by the French physiologist 
Raphael Dubois, have been characterised in both eukaryotic and prokaryotic organisms. The term 
"luminescenz" was first coined by Elihard Wiedemann (Harvey, 1957) and literally, bioluminescence 
means “living light” comprising the Greek words bios for “living” and lumen for “light”. Luciferases 
from different phyla have evolved independently, made evident by markedly different tertiary and 
quaternary structures, substrate requirements, reaction kinetics and wavelength of emitted light. 
The single common requirement of all luciferase systems is oxygen (O2), a characteristic first 
demonstrated in the 17th century by Robert Boyle (1672), long before the discovery of bacteria. 
Although many luminescent species exist in nature (Widder, 2010, Wilson and Hastings, 1998), 
luciferases from six sources have been widely studied (Table 2). 
Table 2. Sources and characteristics of Luciferases in nature. 
Source Requirements Peak Emission Structure 
Bacterial 
Various 
Flavin mononucleotide 
Fatty acid aldehyde 
O2 
490 nm Heterodimer, 77 kDa 
Firefly  
Photinus pyralis 
D-Luciferin 
ATP 
O2 
562 nm Monomer, 62 kDa 
Click Beetle  
Pyrophorus 
plagiophthalamus 
D-luciferin 
ATP 
O2 
Green: 537 nm 
Red: 613 nm 
Monomer, 62 kDa 
Ostracod crustacean  
Cypridinia noctiluca 
Cypridina luciferin 465 nm Monomer, 62 kDa 
Cocepod crustacean 
Gaussia princeps 
 
Coelenterazine 
O2 
460 nm Monomer, 35 kDa 
Sea pansy  
Renilla reniformis 
 
Coelenterazine 
O2 
480 nm Monomer, 19 kDa 
 
Of the different luciferases, the bacterial system is best understood both in terms of regulation and 
biochemistry. In bacteria, luciferase enzymes are FMN-linked alkanal monooxygenases [E.C. 
1.14.14.3] and are found within eleven species comprising five genera; Aliivibrio, Vibrio, 
Photobacterium, Shewanella and Photorhabdus (Ulitzer, 2003). Light production is known only within 
the eubacteria, specifically the Gram-negative γ-proteobacteria. With the sole exception of the 
wound-colonising bacterium Photorhabdus luminescens, bioluminescent bacteria are exclusively 
marine in origin where they occupy a diverse range of ecological habitats and symbioses (Meighen, 
1991). Various functions have been proposed to explain the symbioses of luminescent bacteria with 
marine organisms. These include illumination of the surrounding environment, avoidance of 
17 
 
predation (through flashing and counter-illumination), defence (using light as a decoy), 
communication and the attraction of prey, the latter exemplified by the Photobacterium-containing 
lure of the deep sea Angler fish (Haddock et al., 2010). In many cases the bacteria colonise 
specialised light emitting organs, termed photophores. Many marine organisms possess photophores 
containing bioluminescent bacteria including members of Sepiolid and Lolliginid squid and various 
fish.  
Bioluminescence caused by free-living bacteria in the sea can encompass vast areas given 
appropriately high concentrations of bacteria, a phenomenon termed milky seas. Recently, Miller et 
al., (2005) corroborated reports from merchant ships off the east coast of Africa with satellite 
imagery, providing the first geographic identification of this phenomenon from space (Figure 4). 
 
Figure 4. Enhanced satellite image of a bioluminescent milky sea projected onto the Blue Marble 
(NASA). Reproduced with permission from Haddock et al., (2010).  
Luminescence in bacteria is conferred by a contiguous sequence of DNA, the luxCDABE operon 
(Meighen, 1991) and the order of lux genes is conserved within all characterised bacterial systems. 
The most widely studied of these luciferases originate from the species Vibrio harveyi, Aliivibrio 
fischeri (previously Vibrio fischeri), Photobacterium phosphereum, Photobacterium leiognathi and 
Photorhabdus luminescens. The luxAB genes encode the two subunits; α (40.11 kDa) and β 
(36.35 kDa), which comprise the 76 kDa hetero-dimeric luciferase enzyme (Meighen. 1990). A fatty 
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acid reductase, the multi-enzyme complex responsible for biosynthesis and turnover of the fatty acid 
aldehyde substrate is encoded by three genes, luxC, luxD and luxE. These three genes code for a 
reductase, a transferase and a synthetase of molecular weights 54 kDa, 42 kDa and 32 kDa 
respectively (Boylan et al., 1988). Nucleotide sequences of the luxA and luxB genes have been 
determined for V. harveyi, A. fischeri and P. phosphorum, P. leigionathi and P. luminescens (Cohn et 
al., 1985, Johnston et al., 1986, Miyamoto et al., 1986, Johnston et al., 1990, Xi et al., 1991). 
Bioinformatics evidence suggests that the α and β subunits arose by gene duplication within a 
common ancestral species, as approximately 30 % nucleotide sequence homology exists between the 
two subunits independent of the bacterial source (Cohn et al., 1985, Johnston et al., 1986, Szittner 
and Meighen, 1990).  The 3-D structure of A. fischeri luciferase has been determined at low (2.7 Å) 
and high (1.5 Å) resolution by x-ray crystallography (Fisher et al., 1996). These data show that the α 
and β subunits are non-covalently bound and that each folds into a single domain (β/α)8 barrel 
conformation (Figure 5).  
 
Figure 5. Ribbon cartoon of the quaternary structure of Vibrio harveyii bacterial luciferase. The 
alpha subunit is shown in blue and the beta subunit in purple. The image was rendered with Jmol 
Version 12.2.15 using Protein Databank Entry: 1LUC.  
1.4.1 Biochemical characteristics of Bacterial Luciferases 
Bacterial luciferase catalyses the oxidation of reduced flavin mononucleotide (FMNH2) using 
molecular O2 and a long chain aliphatic aldehyde, yielding FMN, carboxylic acid and a photon of blue-
green light (Equation 1). The reaction is highly exergonic with the primary energy source for light 
supplied by conversion of aldehyde to fatty acid (60 kcal Enstein-1). 
Equation 1. Bacterial luciferase reaction. 
FMNH2 + RCHO + O2  FMN + H2O + RCOOH + hν (λ 490 nm) 
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Two assays have been described for the quantification luciferase enzymatic activity which differ in 
the method of FMN reduction (Hastings et al., 1978). Due to the rapid oxidation of flavin in these 
assays  and slow decay of the EFO-A complex, the luciferase enzyme undergoes only a single turnover 
under these assay conditions, a feature which has allowed detailed investigation of the kinetics of 
these enzymes (Gibson and Hastings, 1962). The complex bioluminescence reaction (Figure 6) 
depends upon the sequential formation of enzyme-flavin intermediates (Hosseinkhani et al., 2005). 
Firstly, luciferase (E) reversibly binds FMNH2 via the alpha subunit to form the Enzyme-FMNH2 (EF) 
complex.  The enzyme-flavin complex then reacts rapidly with O2 forming a C4a-peroxy-flavin (EFO) 
(intermediate II). The EFO complex may either decompose to yield oxidized FMN and H2O2 or interact 
with an aliphatic aldehyde (A), supplied by the LuxCDE fatty acid reductase complex, to form the 
tetrahenal intermediate (EFO-A). Decay of the EFO-A complex occurs by either dissociation of the 
aldehyde followed by dark pathway decomposition or upon completion of the reaction to yield blue-
green light with an emission maximum at 490 nm, an aliphatic carboxylic acid and oxidised flavin. The 
dark- and light-side reactions possess distinct rate constants, termed kD and kL, respectively 
(Hastings and Balny, 1975). 
 
Figure 6. Simplified kinetic models of the bacterial luciferase reaction (A) in vitro and (B) in vivo. 
Blue arrows denote the conversion of substrate to product. Light emission is shown within the green 
star. Adapted from Campbell and Baldwin (2009).   
The aldehyde substrate in vivo is proposed to be the 14-carbon tetradecanal, derived from Co-Acyl 
Enzyme A, based upon analysis of lipid extracts and specificity of the fatty acid reductase system 
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(Ulitzur and Hastings, 1979, Wall et al., 1984). The net reaction involves reduction of fatty acid with 
the oxidation of NADPH and cleavage of ATP to AMP and PPi, catalysed by the luxCDE gene products. 
Biosynthesis of the long chain aldehyde is catalysed by the action of the luxCDE gene products. LuxC 
and LuxE are required for the reduction of myristic acid to myristic aldehyde while LuxD transports 
the fatty acid between the synthase and reductase complexes (Meighen, 1991). 
The second substrate require for bioluminescence is Flavin mononucleotide (FMN). FMN belongs to 
the family of flavoproteins whose members all contain a nucleic acid derivative of riboflavin. Reduced 
FMN is provided by species specific oxidoreductases; Frp in A. harveyi, Frase-I in V. fischeri and Fre in 
Escherichia coli (Campbell and Baldwin, 2009). These enzymes show broad substrate specificity but 
little sequence homology despite their functional similarities. Flavin mononucleotide plays an 
important role in electron transport since it can accept and donate one or two electrons and is 
involved in initial electron transfer with bacterial complex I leading to the oxidation of NADH with 
reduction of coenzyme Q (Friedrich et al., 1995). Two models are proposed for the mechanism of 
transfer of the flavin substrate from oxidoreductase to luciferase. The first proposes that a stable 
complex is formed between the oxidoreductase and luciferase (Lei and Tu, 1998). However, 
formation of a stable complex would necessitate the presence of specific recognition domains in the 
luciferase structure. The flavin oxidoreductase of E. coli shows little homology with that of A. fischeri 
yet luciferase activity is adequately expressed in transformed cells, apparently discounting the 
interaction model. A second model proposes that transfer of the flavin substrate occurs by free 
diffusion (Campbell and Baldwin, 2009). 
1.4.2 Luciferases of bioluminescent bacteria 
Luciferases encoded by different bacteria have been differentiated by turnover rate, thermostability 
and rates of decay over time from in vitro assays of the purified enzymes.  Luciferases from the genus 
Photobacterium are characterised as possessing a rapid decay rate whereas those from Vibrio and 
Photorhabdus exhibit slow decay rates. The structural region responsible for this trait has been 
identified through the creation of chimeric luciferases. Chimeric luciferases were prepared by 
substituting regions of luxA in one bacterium with the same region from another. Substitution of a 67 
amino acid sequence in the central region of LuxA from P. luminescens with the corresponding 
sequence from P. phosphoruem resulted in a chimera exhibiting a significantly greater decay rate 
than the wild-type enzyme (Valkova et al., 1999). Hosseinkhani et al., (2005) furthered these 
observations by demonstrating that substitution of the glutamic acid residue at position 175 of LuxA 
to glycine results in the conversion of the LuxAB of P. luminescens from a slow to rapid decay rate, 
suggesting that the Glu175 residue is involved in aldehyde binding and turnover of intermediates.  
The terrestrial bacterium Photorhabdus luminescens luciferase possesses markedly greater 
thermostability than luciferases of marine bacteria. The luciferase from V. harveyi is rapidly 
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denatured at temperatures of 45oC whereas P. luminescens luciferase has a half-life of greater than 3 
hours at this temperature (Szittner and Meighen, 1990). Thermal stability is conferred by the α 
subunit, as demonstrated by hybrid luciferases containing combinations of luxA and luxB genes from 
V. harveyi or P. luminescens (Li et al., 1993). For temperature-critical applications where the required 
growth temperature is greater than 30oC, the P. luminescens lux cassette must be considered the 
bioluminescent system of choice for the transformation of bacterial reporters.  
1.4.3 Bioluminescent bacterial reporters 
Bacterial luciferases have been used extensively for the generation of biosensors, for studies of gene 
expression and transcriptional regulation. A bioluminescent phenotype may be conferred by the 
introduction of either the luxAB genes, or the entire luxCDABE operon using a suitable vector and 
transformation method. The lux genes may be integrated into the bacterial chromosome or encoded 
on plasmids. Expression may be controlled using a promoter allowing constitutive expression or 
linked to a specific promoter for expression under conditions of transcriptional activation. As such, 
use of the lux genes presents two complementary methods by which data may be obtained for 
bacterial metabolism, stress responses or gene expression. 
Vectors encoding luxAB alone generate luminescent bacteria upon addition of a long chain aldehyde. 
Aldehyde is required because an appropriate fatty-acid reductase is not encoded by the vast majority 
of microorganisms (Meighen, 1991, Meighen and Dunlap, 1993). Luciferase activity occurs in the 
presence of aldehydes of greater than 8 carbons in vitro (Francisco et al., 1993) and although 
quantum yields obtained with different aldehydes are similar, bacterial luciferases exhibit decreasing 
values of Km with increasing aldehyde chain length. Whilst the greatest luminescent response is 
achieved with tetradecanal in vitro, luciferases from different bacterial sources show different 
specificities to shorter-chain aldehydes. Blisset & Stewart (1989) demonstrated that, unlike 
tetradecanal, no appreciable diffusion barrier to shorter chain aldehydes such as decanal, dodecanal 
and nonanal, exists in either Gram positive or Gram negative bacteria.  
In contrast, transformation using the entire luxCDABE operon generates luminescent bacteria 
without the need for exogenous addition of substrate, but requires that sufficient FMNH2 is present 
within the bacterial cell for high activity. Pre-cursors for aldehyde biosynthesis catalysed by the 
LuxCDE fatty-acid reductase complex are present in most, if not all, bacterial species (Meighen, 
1991). Use of the entire lux operon provides the additional advantage that a single sample 
population may be monitored continuously without interruption, whether expression of the operon 
is constitutive or inducible. 
The majority of bioluminescent reporters have been generated using plasmid constructs and 
transposon mutagenesis, either for constitutive or promoter-linked expression. Under such 
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strategies, the bioluminescent phenotype is maintained by the expression of a selective marker, 
usually genes conferring resistance to an antibiotic. However, experimental design may dictate that 
addition of selective agents to maintain plasmid expression is undesirable. In such situations the risk 
exists that plasmid loss may occur. While transposon mutagenesis may avoid effects of varying gene 
dosage and plasmid loss, such an approach may also result in insertions that alter the subject's 
normal cellular physiology or phenotype. Sensitivity may also be reduced due to the presence of only 
a single copy of the reporter within the bacterial chromosome. The issue of gene inactivation may be 
addressed by site-directed insertion, but this approach requires careful identification and 
characterisation of appropriate target sites. 
To date more than 30 different genera, both Gram positive and Gram negative, have been 
transformed to express the lux genes (Meighen, 1991).  In contrast to Gram negative bacteria, the 
native luxCDABE operon of A. fischeri, V. harveyi and P. luminescens is poorly expressed in many 
Gram-positive bacteria. Early Gram-positive transformants exhibited weak light emission due to low 
levels of endogenous FMNH2 and fatty acid aldehyde production and transformation of this group 
was limited primarily due to differing genetics and gene transcription mechanisms. Several strategies 
have been used to approach this problem. Light emission was improved by rearrangement of gene 
order to luxABCDE, and by the addition of enhanced promoters upstream of luxA, luxC and luxE (Qazi 
et al., 2001a, Beard et al., 2002a). Work continues seeking to improve expression the lux genes in 
Gram positive bacteria. Recent developments include improved expression in S. aureus (Mesak et al., 
2009) and the development of a synthetic lux reporter where modifications, based upon codon usage 
in Streptomyces coelicolor, have allowed expression high GC content bacteria (Craney et al., 2007). In 
addition, Andreu et al., (2010) have reported the first successful expression of the entire lux operon 
in Mycobacterium tuberculosis. 
1.4.4 Applications of bioluminescent bacterial reporters 
Bacterial luciferase reporters have developed into versatile tools which have been exploited by a 
wealth of different applications. Applications of bacterial luciferases include reporter gene assays, 
efficacy of antimicrobials (antibiotics and biocides), detection of compounds in environmental 
samples and as traps to identify DNA fragments with promoter activity in clone libraries (Waidmann 
et al., 2011). 
Three strategies have been developed using bacterial luciferases for determining susceptibility to 
antibiotics; the lysis test, the induced test and the phage-coupled test (Ulitzur, 1986). The lysis test 
ascertains the relative decrease in bioluminescence of a culture exposed to an antibiotic compared 
to one grown in the absence of the antibiotic (Ulitzur, 1986). Using either dark or inducer-requiring 
mutants the activity antibiotics inhibiting protein synthesis, for example aminoglycosides or 
macrolides, may be quantified. In the presence of antibiotics inhibiting protein synthesis, de novo 
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production of luciferase is retarded when compared to control cultures grown in the absence of 
antibiotic (Ulitzur and Weiser, 1981). In the phage-coupled antibiotic assay the addition of an 
antibiotic inhibiting protein synthesis, DNA or RNA replication prevents completion of the 
bacteriophage lytic cycle hence ‘rescuing’ the bioluminescent cell. In the absence of such antibiotics 
the cells lyse and levels of bioluminescence fall (Ulitzur, 1986). Continuous measurement of growing 
cultures of constitutively bioluminescent bacteria exposed to an antimicrobial agent has been used 
to determine pharmacodynamics of antibiotics in vitro (Alloush et al., 2003, Beard et al., 2002b, 
Salisbury et al., 1999). This approach allows the determination of killing or inhibition kinetics as well 
as recovery of bacterial populations exposed to sub-lethal concentrations of antibiotics. In a similar 
manner, highly bioluminescent bacterial reporters have also been employed to determine the 
efficacy of biocide-killing in liquids and on environmental or organic surfaces (Robinson et al., 2011, 
Walker et al., 1992, Jones et al., 2002). 
Using the bacterial lux operon in conjunction with a regulatory gene or promoter responsible for the 
induction of enzymes involved in the degradation of a specific substance has been shown to allow 
detection of a wide range of compounds within the environment. Examples include mercury, lead, 
cadmium and napthalene (Tauriainen et al., 1998, Selifonova et al., 1993, Heitzer et al., 1994). 
Similarly, fusions with promoters involved in DNA repair such as uvrA, recA and alkA have been used 
to detect the presence of genotoxic agents in the environment (van der Lelie et al., 1997, Ulitzur and 
Barak, 1988, Biran et al., 2010). Commercial assays utilising bioluminescent reporters to determine 
biological oxygen demand (BOD) and assimilable organic carbon (AOC) are available (CheckLight, 
Israel).  
Bacterial pathogens require the expression of multiple genes within their host to establish a 
successful infection. Gene products contributing towards the survival within and establishment of a 
disease state are termed virulence factors or virulence-associated genes. Fusions of the bacterial 
luciferase genes with promoters regulating virulence factors have been used to monitor the 
induction and expression of virulence factors by bacterial pathogens in batch culture or in co-culture 
with mammalian tissues (Pfeifer et al., 1999, Park et al., 1992, Qazi et al., 2001b, Riedel et al., 2009). 
The examples presented here are but a small representation of the myriad of applications and 
studies that have used bacterial luciferases as a reporter system. The vast number of reports within 
the literature is a testament to the versatility and utility of this system. 
1.4.5 Bioluminescence imaging 
Traditionally, applications employing bioluminescent bacterial reporters have been performed within 
tube or microplate format luminometers or scintillation counters. More recently the availability of 
intensified charge-coupled device (iCCD) and electron multiplying (EMCCD) imaging technologies, 
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initially pioneered for astronomical studies, has provided the ability to study the spatial and temporal 
distribution of light emission within experimental models, a process termed bioluminescence 
imaging (BLI). The visual dimension of image analysis allows localisation and analysis of specific 
spatial regions of interest within the applied experimental model. 
The instrumentation required for BLI is comprised of four essential components, a sensitive imaging 
detector coupled to a macro lens contained within a light tight imaging chamber and a software 
facility for imaging and device control. Optional components may include an illumination source for 
bright-field imaging or for the excitation of fluorophores, a computer controlled object stage and 
temperature control. 
The sensitivity and spatial resolution of bioluminescence imaging systems is largely dependent upon 
four elements. The imaging sensor represents the first element. Three technologies are widely used 
for scientific imaging: iCCD, EMCCD and complementary metal-oxide semiconductor (CMOS) sensors. 
Relevant sensor characteristics include quantum efficiency, number of pixels and pixel dimensions. A 
second critical element comprises the noise characteristics of the system. Within BLI systems noise 
comprises dark current noise, shot noise and readout noise. Read out noise is defined as the noise 
generated during charge-voltage conversion at the CCD amplifier while dark current noise arises due 
to the thermal generation of electron-hole pairs in the photodiode. Thermal noise is reduced to 
negligible levels by cooling of the sensor, usually to below -80oC.  Shot noise comprises the variation 
of photons reaching the detector, either from the source of the bioluminescent signal, or the 
presence of extraneous background light.  A final consideration is the spectral characteristics of the 
matrix or tissue to be examined, including but not limited to, the degree of associated reflectance, 
absorbance and scattering. 
The study and validation of BLI applied to in vivo models of bacterial infection was first demonstrated 
by Contag and co-workers (1995) using strains of Salmonella Typhimurium transformed to express 
the lux operon. They and others have subsequently extended this approach to include studies of 
infection by bioluminescent Gram positive and Gram negative bacterial reporters within a multitude 
of animal infection models. The imaging of bioluminescent bacteria in vivo requires more rigorous 
validation as the light source is located at depth within the matrix or tissue. Under such conditions 
emitted photons are subject to the effects of absorption and scattering, both of which are a function 
of the matrix or tissue under investigation. In tissues shorter wavelengths show greater absorption 
by tissues than wavelengths >600 nm, primarily due to the presence of haemoglobin which exhibits 
strong absorbance at blue-green wavelengths. At wavelengths greater than 600 nm scattering 
becomes the predominant effect (Zhao et al., 2005). The peak spectral emission of bacterial 
luciferases, at 490 nm, falls within the absorbance region of haemoglobin which results in reduced 
sensitivity in comparison to firefly or colentrazine luciferase reporter systems. However, this 
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reduction in sensitivity is offset as bacterial reporters expressing the lux operon have no requirement 
for the exogenous addition of substrate.  
In the relatively short period of time since its introduction, BLI has become an invaluable technique 
for the steady state imaging of bioluminescent bacterial reporters in a wide variety of experimental 
models (Table 3). The ability to locate, track and visualise bacteria in real time is of enormous value 
and bioluminescent imaging presents a number of significant advantages when compared to 
traditional in vivo models of bacterial infection. Firstly, infection may be monitored longitudinally and 
in the presence of intact and functional organ systems. Secondly, the measurement of light emission 
may be performed using a single animal rather than from individuals within a cohort, leading to the 
generation of statistically improved data sets (Rocchetta et al., 2001). Moreover, there is a reduced 
requirement for animal sacrifice and tissue harvesting for ex vivo analyses which in itself represents a 
time-consuming process and potentially limits large scale investigations. For applications of BLI 
involving animal models, bioluminescent bacterial reporters may be used to monitor the 
dissemination and localisation of bacteria in tissues and organs, expression of virulence factors and 
the efficacy and pharmacodynamics of antimicrobial agents in vivo. Away from animal models, BLI 
has been used to ascertain the survival and recovery of bacterial pathogens on food, biocide efficacy 
and the formation and development of biofilms. 
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Table 3. Selected microbiological applications of bioluminescence imaging. Adapted and updated 
from Close et al., (2010b).  
Organism Application References 
Escherichia coli Detection in foods and water (Siragusa et al., 1999) 
(Ripp et al., 2008) 
(Siragusa et al., 1999) 
 Colonisation and survival on foods (Warriner et al., 2001) 
 Colonisation in mice (Foucault et al., 2010) 
 Cutaneous wound infections and 
antimicrobial therapy 
(Jawhara and Mordon, 2004) 
(Hamblin et al., 2002) 
(Rocchetta et al., 2001) 
Salmonella Food safety (Karsi et al., 2008) 
 Colonisation and dissemination (Contag et al., 1995) 
 Intracellular invasion (Piwnica-Worms et al., 2008) 
 Age related susceptibility (Burns-Guydish et al., 2005) 
 Role of nitric oxide in cancer cell killing (Barak et al., 2010) 
 Vaccines & neonates (Burns-Guydish et al., 2007) 
 Thermal inactivation and recovery on 
foods 
(Lewis et al., 2006b) 
Pseudomonas  Wound infection model and antimicrobial 
therapy 
(Thorn et al., 2007) 
(Hamblin et al., 2003) 
 Parallel plate biofilm formation (Mittelman et al., 1992) 
Streptococcus pneumoniae Lung infection and antimicrobial therapy (Francis et al., 2001) 
 Dissemination (Kadurugamuwa et al., 2005) 
 Antimicrobial therapy (Beard et al., 2002b) 
Staphylococcus aureus Colonisation and dissemination in vivo (Francis et al., 2000) 
 Biomaterial/implant associated infections (Engelsman et al., 2009) 
 Catheter infection and antimicrobial 
therapy 
(Kadurugamuwa et al., 2003) 
 Intracellular replication (Qazi et al., 2004) 
 Antimicrobial therapy in vivo (Xiong et al., 2005) 
(Mortin et al., 2007) 
 Antimicrobial treatment of foreign body 
and wound infection 
(Kuklin et al., 2003) 
 Antimicrobial therapy of vascular grafts (Lorenz et al., 2011) 
 Hla expression (Steinhuber et al., 2008) 
 Photodynamic therapy of burn wounds (Lambrechts et al., 2005) 
Listeria monocytogenes Dissemination, virulence factor expression (Bron et al., 2006) 
 Colonisation and replication within murine 
gall bladder 
(Hardy et al., 2004) 
(Hardy et al., 2006) 
 Persistence within the bone marrow (Hardy et al., 2009) 
 Improved reporter construct (Riedel et al., 2007) 
Acinetobacter baumanni Photodynamic therapy of burns (Dai et al., 2009) 
Bacillus anthracis Spore germination in vivo (Sanz et al., 2008a) 
Yersinia enterolitica Colonisation and dissemination in vivo (Trček et al., 2010) 
(Gonzalez et al., 2012) 
Citrobacter rodentium Colonisation and dissemination in vivo (Wiles et al., 2004) 
Mycobacterium spp Optimisation of reporter constructs. (Andreu et al., 2010) 
(Heuts et al., 2009) 
 
To date very few studies have investigated the effects of co-incubating bioluminescent bacterial 
reporters and bacteriophages in either liquid or solid environmental matrices. Since bioluminescence 
is intrinsically linked to bacterial metabolism and thus viability, these reporters present themselves 
as a powerful tool to monitor the effects of bacteriophage-mediated lysis of bacterial populations. By 
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using bioluminescence imaging these interactions may also be able to be resolved spatially as well as 
temporally.   
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Chapter 2 Materials and Methods 
2.1 Bacterial strains and plasmids 
Bacterial strains (Table 4) were obtained from the culture collections: the National Collection of Type 
Cultures, UK (NCTC); the American Type Culture Collection, USA (ATCC); the National Collection of 
Industrial, Food and Marine Bacteria, UK (NCIMB); the Veterinary Laboratories Agency, UK (VLA) and 
Campden BRI (CBRI). Stock bacterial cultures were stored at -80oC (Protect Cryovials, ProLab, UK). 
Working cultures were maintained on Luria Bertani (LB) or Tryptone soya (TSA) agar plates. For 
cultures transformed with plasmids, solid and liquid media were supplemented with either 10 µg ml-1 
kanamycin (Km) or 10 µg ml-1 gentamicin (Gm) in order to maintain plasmid selection.  Escherichia 
coli DH5α (NCTC 10418) was used as a host for the propagation of all plasmids. A complete listing of 
the plasmids used within this study is provided (Table 5).  
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Table 4. Bacterial strains used in this study. 
No. Isolate Accession Number Source 
 Salmonella enterica serovar Enteritidis   
1 S. Enteritidis VLA S07533-07 - 
2 S. Enteritidis PT 13 VLA S04967-07 Swine 
3 S. Enteritidis PT1 CBRI 1937 Chicken 
4 S. Enteritidis PT4 VLA S07544-07 Clinical isolate 
5 S. Enteritidis CBRI 1869 Chicken 
6 S. Enteritidis CBRI 1870 Chicken 
7 S. Enteritidis CBRI 1951 Egg 
8 S. Enteritidis CBRI 1944 Chicken 
 S. enterica serovar Typhimurium   
9 S. Typhimurium   VLA S07519-07 Environmental isolate 
10 S. Typhimurium   VLA S07540-07 Animal tissue 
11 S. Typhimurium   VLA S07541-07 - 
12 S. Typhimurium DT104b VLA S01523-08 Canine faeces 
13 S. Typhimurium   CBRI 1960 Chicken 
14 S. Typhimurium   CBRI 1962 Chicken 
15 S. Typhimurium   CBRI 1005 Raw egg 
16 S. Typhimurium   CBRI 1006 Sausage 
17 S. Typhimurium CBRI 1007 Chicken 
 Other Serovars   
18 S. Agona NCTC 11377 Cattle, Ghana 
19 S. Brandenberg VLA S07530-07 - 
20 S. Braenderup VLA S02130-08 - 
21 S. Braenderup VLA S07531-07 - 
22 S. Concord NCTC 6588 Avian 
23 S. Crossness NCTC 11059 Sewage 
24 S. Derby HPA  
25 S. Dublin VLA S07539-07 - 
26 S. enterica  4, 12: e, h: - VLA S07521-07 Swine 
27 S. enterica  6, 8: -: e, n, x VLA S07523-07 - 
28 S. enterica O-Rough: z10: - VLA S07520-07 Unknown 
29 S. enterica O-Rough: e, h: e, n, x, z15 VLA S07538-07 - 
30 S. arizonae 6: 13, 14 NCTC 7308 spray-dried egg powder 
31 S. Hadar CBRI 1973 Turkey 
32 S. Heidelberg VLA S07546-07 - 
33 S. Heidelberg VLA S07529-07 - 
34 S. Infantis CBRI 1037 Prawns 
35 S. Inverness NCTC 6591 Human faeces 
36 S. Jerusalem NCTC 8146 - 
37 S. Mbandaka VLA S07524-07 - 
38 S. Molade VLA S07526-07 - 
39 S. Montevideo CBRI 1030 Animal feed 
40 S. Napoli NCTC 6853 Human 
41 S. Newport BRI 1938 Chicken 
42 S. Orion var. 15+ VLA S07525-07 - 
43 S. Panama CBRI 1045 Mussels 
44 S. Poona NCTC 4840 Infant enteritis 
45 S. Seftenberg VLA S07528-07 - 
46 S. Tennessee NCTC 6388 - 
47 S. Typhisuis NCTC 347 - 
48 S. Utrecht NCTC 10077 - 
49 S. Virchow CBRI 1012 Chicken 
50 S. Virchow CBRI 1010 Chicken 
 Other Gram-negative bacteria   
1 Escherichia coli Nissle 1917 Ardeypharm GmbH Human faeces 
2 E. coli NCTC 10418 - 
3 E. coli O157:H7 tox
-
 NCTC 12900 - 
4 Pseudomonas aeruginosa PAO1 ATCC 15692 Infected wound 
5 P. aeruginosa  NCTC 13359 - 
6 Citrobacter freundii NCTC 6266 - 
7 Klebsiella aerogenes NCTC 9660 - 
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Table 5. Plasmids used in this study. 
Plasmid Description Selective Marker Reference 
pGLITE pBBR1MCS-2 derivative containing the 
luxCDABE operon of Photorhabdus luminescens 
Kanamycin resistance cassette (Parveen et al., 
2001) 
pMCS5-LITE pBBR1MCS-5 derivative containing the 
luxCDABE operon of Photorhabdus luminescens 
Gentamicin resistance cassette (Lewis et al., 
2006a) 
 
2.2 Enumeration of bacteria 
Plate counts of bacteria were performed using either the spread plate method or by use of a spiral 
plating system (WASP, Don Whitley Scientific, UK). Bacterial counts in cfu ml-1 were calculated 
according to ISO 4833: standard methods for the enumeration of bacteria (Anonymous, 2003), where 
∑c is the sum of all colonies, d is the dilution factor corresponding to the first dilution retained and n1 
and n2 the number of plates retained at the first and second dilutions, respectively: 
         
∑  
(        )   
 
For counts comprising a single dilution, colony counts were calculated as the arithmetic mean of 
colonies from triplicate plates. 
 
2.3 Determination of bacteriophage titres 
Phage concentrations were determined using soft agar overlay assays. Briefly, 10 µl of a log-fold 
dilution of bacteriophage was added to 150 µl of host cells and allowed to adsorb for 5 minutes prior 
to addition of 4 ml of molten (45oC) soft LB agar (0.6 % w/v bacteriological agar) supplemented with 
10 mmol l-1 MgSO4 and 1 mmol l
-1 CaCl2. Soft agar mixtures were poured onto the surface of a 90 mm 
LB agar plate to create an overlay, and allowed to solidify at room temperature for 10 minutes before 
overnight incubation at 37oC. After incubation plates were examined for plaques and where possible, 
the counts of triplicate plates over two consecutive dilutions were recorded. Plaque counts in pfu ml-
1 were calculated according to ISO 4833 standard methods for the enumeration of bacteria 
(Anonymous, 2003), where ∑c is the sum of all plaques, d is the dilution factor corresponding to the 
first dilution retained and n1 and n2 the number of plates retained at the first and second dilutions, 
respectively: 
         
∑  
(        )   
 
For counts comprising a single dilution, phage titres were calculated as the arithmetic mean of 
plaques from triplicate plates. 
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2.4 Isolation of bacteriophages 
Bacteriophages were isolated by incubation of filtered (0.2 µm pore size) swine lagoon effluent, 
diluted 10-fold in LB broth supplemented with 10 mmol l-1 MgSO4 and 1 mmol l
-1 CaCl2, at 37
oC for 18 
hours in the presence of either Salmonella Enteritidis (VLA S07544-07), Salmonella Typhimurium 
DT104 (VLA S07519-07) or Salmonella Dublin (VLA S07539-07). After incubation, suspensions were 
clarified by filtration (0.2 µm pore size), serially diluted and 10 µl aliquots plated on overlay agar 
plates of LB agar (1.0 % w/v agarose) and LB overlay agar (0.6 % w/v agarose). Mid-exponential phase 
cultures of Salmonella serovars were used as host strains. After incubation, plates were examined for 
the presence of plaques. Individual plaques were numbered, excised and suspended in SM buffer for 
24 hours at 4oC in order to elute bacteriophages from the lysate in the overlay agar. Each excised 
plaque was subjected to a further 3 rounds of purification by plating on double agar overlay plates 
until a single plaque morphology was observed.  Phages isolated from plaques were named 
according to the recommendations of Kropinski et al. (2009). In this system of nomenclature the 
phage isolate name is preceded by the prefix vB or vA denoting bacterial and archaeal viruses, 
respectively.  The prefix is linked by an underscore to the host abbreviation system based upon genus 
and species used for restriction enzymes, followed by S, M or P denoting the isolate as a member of 
the Siphoviridae, Myoviridae or Podoviridae, respectively. For example, under this system myoviruses 
isolated from Salmonella enterica are named as vB_SenM. A final mnemonic comprised a three letter 
abbreviation of the host serovar from which the phage isolate was obtained, e.g. Enteritidis or 
Dublin, and a numeral allocated at the plaque identification stage. Bacteriophage T4 was obtained 
from the ATCC (ATCC 11303-B4) and Felix O1a and O1b were the kind gift of Dr Pradip Patel.  
2.5 Purification of bacteriophages 
Standard methods were used to obtain high titre stocks of bacteriophages. Plaque suspensions were 
titrated and used to inoculate 1 litre of early exponential phase cultures (OD540 0.1) at an 
approximate multiplicity of infection (MOI) of 0.1. Growth and lysis of bacterial cultures was 
monitored by hourly measurements of absorbance at 540 nm. Chloroform (1 % v/v) was added to 
each flask to terminate enrichment and prevent further microbial growth. Lysates were then treated 
with 1 µg/ml DNase I and RNase A (Sigma Aldrich, UK) prior to removal of bacterial debris by 
centrifugation at 11,000 x g for 10 minutes at 4oC. The supernatant was filtered (0.2 µm pore size) 
and bacteriophage particles precipitated by addition of NaCl to a concentration of 1 mol l-1 and 10 % 
w/v polyethylene glycol (PEG) prior to two-step cesium chloride (CsCl) density-gradient 
centrifugation (Sambrook, 2001). Briefly, PEG-precipitated bacteriophage particles were recovered 
by centrifugation at 11,000 x g for 10 minutes at 4oC. The supernatant was discarded and pellets re-
suspended in 8 ml of sodium magnesium buffer (SM; 100 mM Tris-Cl, 8 mM MgSO4, 100 mM NaCl, 
pH 7.5) for every 500 ml of clarified lysate. Re-suspended pellets were mixed with an equal volume of 
chloroform and centrifuged at 3000 x g for 15 minutes at 4oC and the aqueous phase retained. 
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Treatment with chloroform was repeated until no PEG could be observed at the interface between 
the organic and aqueous phases. Solid CsCl was added to samples to a final concentration of 0.5 g ml-
1 to yield a density of ρ = 1.15. Samples were carefully layered on top of CsCl step gradients 
consisting of equal volumes of CsCl at densities of ρ = 1.45, ρ = 1.50 and ρ = 1.7 in SM buffer. Step 
gradients were spun using a SW40 rotor and ultracentrifuge (Beckman Coulter, UK, Optima LX-P) at 
87,000 x g for 2 hours at 4oC. Bands containing bacteriophage particles were recovered using a 21 
gauge syringe, layered on top of an ultracentrifuge tube containing CsCl at a density of ρ = 1.50 and 
then centrifuged at 160,000 x g for a further 24 hours at 4oC. Bands containing bacteriophage 
particles were recovered and CsCl removed by diafiltration (MWCO 100 kDa) against two 500-fold 
volume changes of SM buffer. The resulting pure suspensions of bacteriophages were adjusted to 10 
ml with SM buffer, titrated using double agar overlay plates and stored at 4oC.  
2.6 Morphological examination of bacteriophages by transmission 
electron microscopy 
Transmission electron microscopy (TEM) of bacteriophages was performed using the method 
described by Ackermann (2009b). Purified bacteriophages were concentrated by centrifugation 
(Beckman Coulter, Optima LX-P ultracentrifuge, 70Ti Rotor) at 25,000 x g for 60 minutes and re-
suspended in 0.1 M ammonium acetate (pH 7.0). One drop of bacteriophage suspension was spotted 
on to a formvar carbon-coated 400-mesh TEM grid (TAAB Laboratory Equipments, UK) and stained by 
transferring grids to a 1 % (w/v) uranyl acetate solution (pH 4.5) for 30 seconds. Grids were examined 
using a transmission electron microscope (Phillips, UK, CM10) operated at 60 kV. Magnifications 
were calibrated by measurement of T4 bacteriophage tails and virion dimensions established by 
measurement of at least 20 intact particles. Each bacteriophage isolate was assigned to a respective 
family in accordance with the recommended guidelines of the International Committee on Taxonomy 
of Viruses (ICTV), based upon examination of virion particle morphology (ICTV, 2005). 
2.7 Determination of adsorption rate constants  
Determination of adsorption rate constants for bacteriophage isolates followed the method 
described by Kropinski (2009). Briefly, host strains were grown in LB to an OD540 of 0.1, circa 5 x 10
7 
cfu ml-1, and enumerated using a spiral plating system (Don Whitley Scientific, UK). Bacteriophages 
were added to cultures to yield a final concentration of 5 x 104 pfu ml-1 (t = 0). At 1 minute intervals, 
50 µl aliquots were transferred to 950 µl SM buffer saturated with chloroform and stored on ice. 
Upon completion of the sampling period, 10 minutes, samples were immediately titrated for 
unabsorbed bacteriophages by plating 100 µl using agar overlay plates. Absorption rate constants (k) 
were calculated as    ⁄  where N represents the initial bacterial density and m the slope of the 
linear regression equation of the natural logarithm of the measured free phage titre over time. 
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2.8 One-step growth curves of bacteriophage isolates 
The method for one step growth was adapted from that described by Ellis and Delbrück (1939). 
Shake flask cultures of the relevant bacterial host were grown in LB broth supplemented with 10 
mmol L-1 MgSO4 and 1 mmol L
-1 CaCl2 to an OD540 of c. 0.1, corresponding to 5 x 10
7 cfu ml-1. 
Bacteriophages were added to cultures at a concentration calculated to yield an multiplicity of 
infection (MOI) of approximately 0.005. After 4 minutes incubation to allow adsorption of virions to 
host cells, the culture was centrifuged at 13,000 x g for 1 minute and the supernatant discarded in 
order to remove un-adsorbed bacteriophage particles. The pellet, containing infected cells, was re-
suspended in an equal volume of pre-warmed LB broth, immediately diluted to 10-4 and placed in a 
static water bath at 37oC. Samples (100 µl) were subsequently withdrawn at 5 minute intervals over a 
period of 60 minutes to two series of tubes denoted S and L, each containing 900 µl SM buffer. S 
tubes represented a measure of the number of free phage particles and infected cells (infective 
centres) and were retained on ice until sampling was completed. Tubes in series L also contained 50 
µl of chloroform and represented the number of free and intracellular phage particles. Samples 
added to L tubes were mixed briefly and retained at room temperature for at least 30 minutes to 
allow chloroform-mediated cell lysis. Each series time-point was titrated by triplicate overlay plaque 
assay plates and phage concentrations determined by counting plaques after overnight incubation at 
37oC. 
2.9 Single-burst experiments 
Single burst experiments (Burnet, 1929, Delbrück, 1945) were performed in order to supplement and 
verify data obtained from one step growth curves. Phage infected bacterial cultures were prepared 
as described for one step growth curves. Free virions were removed from samples by centrifugation 
and pellets of bacterial cells re-suspended in RS. Infected cultures were serially diluted in RS so that 
10 tubes containing approximately 10 cfu ml-1 were obtained. From these, 1 ml volumes were 
transferred to individual tubes (n = 100). Samples were incubated at 37oC for 60 minutes in order to 
allow lysis to occur and the entire contents of each tube (1 ml) subsequently plated using overlay 
agar plates. 
2.10 Bacteriophage stability assays 
2.10.1 Temperature 
The effects of exposure to heat upon bacteriophage titres were assessed at temperatures of 50, 60 
and 70oC. Bacteriophage suspensions were adjusted to yield a titre of c. 1 x 1010 pfu ml-1 and diluted 
1:10 in pre-warmed PBSa. At each temperature, samples were taken at 15, 30, 60 and 120 minutes 
and enumerated using triplicate soft agar overlay plates. 
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2.10.2 Long-term storage 
Following CsCl purification and dialysis, 5 ml aliquots of each bacteriophage were retained for the 
purposes of assessing storage stability.  Stocks were stored in SM buffer at 4oC in polycarbonate 
screw-capped tubes and titrated by overlay plaque assay at monthly intervals over a total period of 
12 months. 
2.10.3 Bacteriophage host range: Spot plate assay 
The host range of bacteriophage isolates was first assessed by the semi-quantitative spot plate 
technique (Mazzocco et al., 2009, Kutter, 2009). Bacteriophage preparations were adjusted by 
dilution to yield a titre of 1011 pfu ml-1 on their respective propagating host. Square 120 mm plates 
containing LB agar were subdivided to yield a 6 x 6 grid, to which was added LB overlay agar 
containing 200 µl from a mid-exponential phase culture of the bacterial strain to be tested. To each 
section of the grid, 5 µl samples of bacteriophage from a log-fold dilution series were spotted onto 
the surface of the overlay agar so that each plate assessed a range of phage concentrations (Figure 
7).  
 
Figure 7. Arrangement of log-fold dilutions of bacteriophage upon spot plate assays of host range. 
Values in cells refer to the dilution factor of the phage preparations.  
Phage samples were allowed to absorb into the overlay agar prior to overnight incubation at 37oC. In 
total, 50 serovars of Salmonella and 10 strains belonging to other Gram negative genera were 
assessed. Spot plate results were interpreted by use of a semi-quantitative score-card system (Figure 
8).  
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Figure 8. Score card for the visual assessment of plaques. The scoring system was adapted from that 
described by Rees and Dodd (2006b). Photographs of plaques formed by vB_SenS-Ent1 are provided 
for illustrative purposes.  
2.10.4 Bacteriophage host range: Efficiency of plating 
All bacterial isolates exhibiting the ability to form plaques on a particular bacterial isolate in spot 
plate assays were taken forward for analysis by efficiency of plating (EOP). Efficiency of plating was 
defined as the ratio of the mean values of two plaque titrations, calculated as;  
              
                               (       )
                           (       )
 
Thus, EOP was used to estimate the susceptibility of different bacterial isolates to productive 
infection by a particular phage preparation or isolate relative to that of the propagating host serovar.  
2.11 Extraction of genomic DNA from CsCl purified bacteriophages 
Bacteriophage DNA was obtained by phenol chloroform extraction (Sambrook, 2001). Briefly, a 5 ml 
sample of CsCl-purified bacteriophages was incubated at 37oC for 1 hour in the presence of DNase I 
and RNase A in order to remove any exogenous DNA and RNA. DNase and RNase activity was halted 
by the addition of EDTA to a final concentration of 20 mmol l-1. In order to release genomic DNA from 
capsids, virions were incubated at 56oC for 1 hour in the presence of SDS (5 % w/v) and proteinase K 
(New England Biolabs, UK; 20 µg ml-1 in 10 mmol l-1 Tris pH 8.0 and 50 mmol l-1 EDTA). Samples were 
allowed to cool to room temperature before addition of an equal volume of equilibrated phenol 
(Sigma Aldrich, UK) and centrifugation at 13,000 x g for 5 minutes. This process was repeated using a 
1:1 phenol:chloroform solution and then chloroform alone, transferring the aqueous phase to fresh 
Eppendorf tubes and discarding the interface and organic phase at each stage. DNA was precipitated 
from the aqueous phase by addition of sodium acetate (0.5 mol l-1, pH 5.2) to a final concentration of 
0.3 mol l-1 and two volumes of 100 % ice-cold ethanol. Samples were rapidly frozen using a -80oC 
freezer (Sanyo, Japan) for 2 hours, after which samples were thawed on ice prior to centrifugation at 
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15,000 x g at 4oC for 30 minutes. The supernatant was removed and pellets washed and centrifuged 
(15,000 x g, 10 min, 4oC) twice with 70% v/v ethanol. Wash supernatants were removed to waste and 
residual ethanol removed from samples using a vacuum centrifuge (Vacufuge, Eppendorf, UK). 
Purified DNA was stored either in 100% ethanol or TE buffer at -20oC. 
2.11.1 Concentration, purity and yield of bacteriophage genomic DNA 
The concentration, yield and relative purity of extracted phage genomic DNA was assessed by 
ultraviolet spectroscopy. Measurements of absorbance at 230, 260, 280 and 320 nm were performed 
using a micro-volume spectrophotometer (Nanodrop 1000, Thermo Scientific, UK). The A260/A280 ratio 
was employed as an estimate of DNA purity. Ratios were calculated post subtraction of the A320 value 
which represents absorbance caused by non-nucleic acid sample turbidity. A ratio of >=1.8 was 
considered as acceptable for use in downstream experiments. 
            
          
          
 
Sample concentrations were calculated by adjusting the A260 measurement for turbidity, multiplying 
by the sample dilution factor and using the assumptions that an A260 of 1.0 = 50 µg ml
-1 under 
conditions of neutral pH and a G+C DNA content of 50%. 
                           (         )                         
    
The total yield was obtained by multiplying the DNA concentration by the total volume of purified 
samples.  
                                                (  ) 
2.11.2 Estimation of bacteriophage genome size by pulsed field gel electrophoresis  
Pulsed field gel electrophoresis (PFGE) was performed according to the method described by Lingohr 
et al. (2009). Bacteriophages, ~1010 pfu ml-1, were immobilised in agar plugs (1 % w/v agarose) and 
lysed by treatment with proteinase K (20 mg ml-1 in 10 mmol l-1 Tris pH 8.0, 50 mmol l-1 EDTA, and 1 
% w/v SDS) for 2 hours at 54oC. Agarose plugs were subsequently washed three times by soaking in 
TE buffer for 1 hour and stored at 4oC. Gels (1 % w/v agarose) were run in 0.5x TBE buffer (BioRad, 
France) at 6 V cm-1 for 15 hours at 14oC with pulses of 2.2 to 54.2 seconds using a CHEF-DR II 
Electrophoresis unit (BioRad, France). DNA size standards were provided by use of low range PFGE 
marker DNA (New England Biolabs, UK) and bands visualised by staining with 1 µg ml-1 ethidium 
bromide (EtBr). Gel images acquired using a FluorChem Q (ProteinSimple, USA) and analysed using 
ImageJ (Abramoff et al., 2004). 
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2.11.3 Restriction digests of phage genomic DNA and gel electrophoresis 
Phage genomic DNA was digested to completion by incubation for 1 hour at 37oC with 20U of the 
dsDNA-specific restriction enzymes EcoRV and SmaI, and 5U of BamHI, HindIII and XbaI in accordance 
with the manufacturer’s instructions (New England Biolabs, UK). For genomic DNA immobilised in 
agar plugs, the restriction incubation time was extended to 4 hours. DNA fragments were separated 
by PFGE, as described in section 2.11.2, and conventional agarose electrophoresis gels (0.8 % w/v 
agarose containing 0.5 µg ml-1 EtBr) in TAE electrophoresis buffer (40 mmol l-1 Tris-HCl, 20 mmol l-1 
sodium acetate and 50 mmol l-1 EDTA at pH 7.2)  at 5 V cm-1. Low-range PFGE ladder and 2-log DNA 
ladder (New England Biolabs, UK) were run alongside samples to provide size standards for PFGE and 
agarose gel electrophoresis, respectively. 
2.11.4 Determination of phage genomic termini 
To determine whether the genome termini were fixed or circularly permuted, purified genomic DNA 
was subjected to a time-limited digest with the exonuclease BAL-31 (M0231S, New England Biolabs, 
UK). Briefly, 10 µg was incubated with 10 U of BAL-31 and samples withdrawn at 0, 10, 20, 40 and 60 
minutes. The DNA was then precipitated with ethanol, re-dissolved in TE buffer and digested with 
EcoRV before separation by agarose electrophoresis.  
In order to test for the possibility of cohesive genome ends, one microgram of purified genomic DNA 
was digested to completion with EcoRV and heated to 80oC for 15 minutes using a heating block. The 
samples were then divided into equal portions. One sample was rapidly cooled by placing in an ice 
bath while the other was allowed to cool to room temperature in the heating block. The resulting 
bands were separated by agarose gel electrophoresis. 
2.12 Genome sequencing and bioinformatics analysis of bacteriophages  
Purified bacteriophage genomic DNA was sequenced externally (MWG Operon, Germany) using GS 
FLX 454 sequencing and targeted Sanger sequencing for gap closure.  Consensus sequences were 
examined using Consed (Gordon et al., 1998) and opened upstream of the gene predicted to encode 
the small terminase subunit. Ab initio prediction of open reading frames (ORFs) used a combination 
of the GeneMark.hmm algorithm for prokaryotes (Besemer and Borodovsky, 1999), Glimmer 3.02 
(Delcher et al., 1999) and ORF Finder (htto://www.ncbi.nlm.gov/projects/gorf). Overlapping 10 kb 
sections of sequenced genomes were queried against non-redundant protein databases using 
tBLASTx for intrinsic prediction of ORFs. The results of evidence-based and ab initio gene predictions 
were compared in order to evaluate the best gene models and to resolve overlaps among ORFs. All 
ORFs were inspected for the presence of convincing purine-rich ribosome binding sites upstream of 
the start codon. Annotation of sequenced bacteriophage genomes was performed using Artemis 
(Rutherford et al., 2000) and physical maps prepared using DNA plotter (Carver et al., 2009), GView 
(Petkau et al., 2010) and CGView (Stothard and Wishart, 2005).  
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Translated sequences from predicted ORFs were queried using BLASTP and PSI-BLAST against the 
non-redundant database (Altschul et al., 1990, 1997). Functional annotation of gene products was 
performed by querying translated sequences against the conserved domain database (Marchler-
Bauer et al., 2011), Prosite (Sigrist et al., 2010), Pfam (Punta et al., 2012) and InterProScan (Quevillon 
et al., 2005). The Hidden Markov Model search tool HHpred (Söding et al., 2005) was used to query 
translated sequences against protein three dimensional structures held in the Protein Data Bank. 
Translated ORFs were characterised by number of amino acids, molecular weight and isoelectric 
point using the ExPASy tool: Compute pI/Mw (Bjellqvist et al., 1993).  Prediction of transmembrane 
helices was performed using TMHMM 2.0 (Krogh et al., 2001) and searches for structural motifs and 
signal peptides were carried out using COILS and SignalP (Petersen et al., 2011). tRNAScan-SE 
(Schattner et al., 2005) and ARAGORN (Laslett and Canback, 2004) were used to scan for tRNAs.  
Next, intergenic regions were investigated for the presence of regulatory elements. Candidate 
promoter sequences and conserved intergenic motifs were identified by searches of 150 bp 
sequences upstream of ORFs using MEME (Bailey et al., 2006) and the regulatory sequence analysis 
(RSAT) toolset (Thomas-Chollier et al., 2011). Putative rho-independent terminators were predicted 
using TransTermHP (Kingsford et al., 2007) and WebGester (Mitra et al., 2010). Candidate 
terminators were assessed according to location, presence of a U-rich tail and stable predicted stem 
loop secondary structure (ΔG ≤ -10 kcal mol-1) as calculated by RNAFold (Gruber et al., 2008). 
2.13 Comparative genomics 
Comparisons of nucleotide sequences between phage genomes were performed using MAUVE 
(Darling et al., 2010) and Gepard (Krumsiek et al., 2007). Related proteins between Salmonella 
bacteriophages with completely sequenced genomes were identified by two complementary 
methods. Firstly, shared proteins were identified using CoreGenes3.5 using default settings 
(Mahadevan et al., 2009). Secondly, custom BLAST databases comprising the nucleotide and protein 
sequences from 42 Salmonella phage genomes were prepared and all-versus-all BLAST comparisons 
performed. Protein sequences conserved among the vB_SenS-Ent and related phages were analysed 
using iterative PSI-BLAST (Altschul et al., 1997) against the non-redundant databases and HHpred 
(Söding, 2005, Söding et al., 2005) against the pdb70 database maintained by the Department of 
Protein Evolution at the Max Planck Institute for Developmental biology. Diagrammatic 
representation of BLASTP comparisons were prepared using Circoletto (Darzentas, 2010) and the 
CGview comparison tool (Grant et al., 2012). Alignments were performed using ClustalX2 (Larkin et 
al., 2007) and Neighbour-joining trees constructed using MEGA5 (Tamura et al., 2011).  
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2.14 Bacteriophage structural proteins 
2.14.1 Quantification of protein 
Sample protein concentrations were quantified by the Bradford method using bovine serum albumin 
as standards (Bradford, 1976, de Moreno et al., 1986). Bradford assays were performed in a 96-well 
microtitre plate format where samples were plated alongside standardised concentrations of bovine 
serum albumin. Measurements of absorbance at 600 nm were performed using a microplate reader 
(Genios Pro, Tecan, Switzerland). Solving the linear regression line equation for absorbance of 
standard concentrations of BSA allowed estimation of the sample protein concentration. 
2.14.2 Extraction and analysis of bacteriophage structural proteins by SDS-PAGE 
Structural proteins from CsCl purified virions were extracted and concentrated using methanol-
chloroform and re-suspended in lithium dodecyl sulphate sample buffer (LDS) prior to analysis by 
one- and two-dimensional SDS-PAGE. For isoelectric focusing, linear IPG Zoom strips from pH 3 to 10 
were rehydrated overnight with the solubilised proteins and separated using a ZOOM® IPGRunnerTM 
system according to the manufacturer’s instructions (Invitrogen, UK). Prior to electrophoresis in the 
second dimension, IPG strips were equilibrated twice for 15 minutes in 1x LDS sample buffer 
containing 1x reducing agent for the first equilibration step and 125 mmol l-1 iodoacetamide for the 
second step. Protein size separation was conducted alongside Novex® Sharp unstained protein 
standard marker using a NuPAGE mini-gel system and 4-12 % bis-tris gels in MES-SDS running buffer 
(Invitrogen, UK) at 200 V. Proteins were fixed (50 % v/v methanol, 10 % v/v acetic acid) for 1 hour at 
room temperature then stained using SimplyBlueTM Safestain (Invitrogen, UK) and images of gels 
acquired and analysed as described for PFGE (section 2.11.2). 
2.15 Transformation of Salmonella with the luxCDABE operon  
The construction of plasmids pGLITE and pMCS5-LITE containing the luxCDABE operon of 
Photorhabdus luminescens under constitutive control of the lac promoter have been described 
previously (Parveen et al., 2001, Lewis et al., 2006a). Plasmids were amplified by electroporation into 
E. coli DH5α (Invitrogen, UK) and purified using a Wizard SV Miniprep kit (Promega, USA, A1330) in 
accordance with the manufacturer’s instructions. Purified plasmids were eluted in nuclease-free 
water and stored at -20oC. Plasmids contained a Kanamycin (Km) or Gentamicin (Gm) resistance 
marker for pGLITE and pMCS5-LITE, respectively (Kovach et al., 1995) and appropriate concentrations 
of antibiotics were selected from results of broth dilution MIC assays for Salmonella enterica 
serovars. Salmonella enterica sv. Dublin, used as the propagating host of Felix O1a and Felix O1b, and 
Salmonella enterica sv. Enteritidis, the propagating host of Ent1, Ent2 and Ent3 were transformed to 
express the lux operon by electroporation (GenePulser, BioRad, France) using conditions of 3.0 kV, 25 
μF capacitance and 200 Ω resistance (O'Callaghan and Charbit, 1990).  After a 1 hour recovery period 
in SOC media (2 % w/v tryptone, 0.5 % w/v yeast extract, 20 mmol l-1 glucose, 10 mmol l
-1 NaCL, 2.5 
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mmol l-1 KCl, 10 mmol l-1 MgCl2, 10 mmol l
-1 MgSO4) at 37
oC, transformants were selected by plating 
onto solid media containing the appropriate antibiotic and identified by examination with an EMCCD 
camera (iXON DV897+, Andor Technologies, UK) for evidence of light emission after 24 hours 
incubation at 37oC. Colonies exhibiting light emission were sub-cultured onto fresh media and 
identities confirmed by Gram stain morphology, plating onto selective media and biochemical 
characteristics (API 20E, Biomerieux, France). 
2.15.1 Calibration of bioluminescence and cell density 
For calibration of bioluminescence with viable counts, standard curves consisting of serial 10-fold 
dilutions of bacteria were prepared. Briefly, 10 ml batch cultures were grown to late exponential 
phase (OD540 ≥ 1.0). Cells were pelleted by centrifugation at 10,000 x g for 5 minutes, washed twice 
and re-suspended in 10 ml of ¼ strength Ringers solution (RS). The resulting suspensions were 
serially diluted to 10-8, plated onto LB agar and colonies counted after 24 hours incubation at 37oC. 
Each log-fold dilution of bacteria was assessed for light emission using a tube and a microtitre plate 
luminometer.  Measurements of light emission using tube luminometers (Sirius FB-12, Berthold 
Detection Systems GmbH, Germany) were performed at room temperature, approximately 20oC and 
employed a 1 ml sample volume. Microtitre assays (Centro LB960 XS3 Berthold Technologies GmbH, 
Germany) were performed at 37oC using a sample volume of 100 µl. All assays of bioluminescence 
included measurements of instrument and reagent blanks. Limits of detection and quantification 
were defined as 3 and 10 standard deviations of the reagent background, respectively. Calibration 
experiments were performed on 3 independent occasions for each bacterial isolate. 
2.15.2 Calibration of light emission and growth in batch culture 
Overnight batch cultures were diluted 1:1000 in Erlenmeyer flasks containing 50 ml of LB so that the 
initial concentration was approximately 1 x 106 cfu ml-1. Bacterial growth at 37oC with orbital shaking 
(150 rpm) was recorded over a period of 10 hours by measurements of bioluminescence, OD540nm 
and viable counts at hourly intervals. Measurements of bioluminescence were performed using a 
tube luminometer (Sirius FB-12, Berthold Detection Systems, Germany), a volume of 100 μl and an 
integration time of 1 second. 
2.15.3 Measurement of bioluminescence spectra 
Bioluminescent bacteria were grown in batch culture to OD540 1.0, centrifuged and pellets re-
suspended in Ringer's solution containing glucose at a final concentration of 10 mmol l-1. The 
wavelength spectrum of light emission for each bacterial transformant was determined using a 
fluorescence spectrophotometer (Fluorosens, Gilden Photonics, UK) with the excitation 
monochromator port blocked. Data were recorded using an emission scan in 1 nm steps across a 
wavelength range of 400 to 700 nm. 
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2.15.4 Microplate broth lysis assay 
Overnight batch cultures of bioluminescent Salmonella bacteria grown in LB containing the 
appropriate antibiotic were diluted 1:100 into fresh LB medium. Cultures were incubated until an 
OD540 of 1.0 was reached and then serially diluted in fresh LB media containing antibiotics, 10 mmol l
-
1 MgSO4 and 1 mmol l
-1 CaCl2. Log-fold dilutions of bacteriophages in LB broth were prepared from 
purified stock solutions. Triplicate wells of a 96-well microtitre plate (Lumitrac200, Greiner Bio-One, 
Germany) were loaded with 180 µl and 20 µl of the appropriate dilution of bacteria and 
bacteriophages, respectively, such that each plate assessed a range of multiplicities of infection at 
different bacterial concentrations (Figure 9). Reagent background measurements comprised wells 
constituting media alone or media containing only bacteriophages. Bacteria grown in the absence of 
bacteriophage were used as positive controls. 
 
Figure 9. Layout of samples on 96 well microtitre plates. Wells containing samples are shown as 
grey filled circles while outlined wells were filled with sterile water. MOI, multiplicity of infection; R 
Blank, reagent background.  
Measurements of light emission were recorded using a microplate luminometer programmed to 
measure each well using an integration time of 1 second at 5 minute intervals over a period of 12 
hours. The contents of wells were mixed by orbital shaking for 2 seconds immediately prior to each 
measurement. Data were exported as tab-delimited text files and analysed using Prism 5 (GraphPad 
Software Inc., USA) and Excel (Microsoft Corporation, USA). 
2.16 Bioluminescence imaging 
2.16.1 EMCCD system characterisation 
EMCCD camera (iXON DV897+) sensor fixed-pattern read noise was determined by capturing 100 
images using an integration time of 1 μsec with the camera shutter closed to ensure that no external 
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light was captured. Thermal noise was recorded by capture of 100 images at exposure times of 1, 5, 
10 and seconds and 1, 5, 10, 15 and 30 minutes. Exposures were then combined into stacks using Fiji 
ImageJ software (Schindelin, 2008), and z-plot images consisting of either the median value or 
standard deviation (r.m.s.) for each pixel across the 100 exposures produced. The procedure for 
obtaining sensor fixed-pattern read noise and thermal noise was repeated for electron multiplication 
gain values of 0, 100, 200 and 300 and horizontal sensor readout speeds of 1, 3, 5 and 10 MHz. The 
camera sensor was maintained at a temperature of -95oC by liquid cooling for these and all 
subsequent experiments. 
2.16.2 Limits of detection for bioluminescent bacteria using EMCCD imaging 
Cells from overnight batch cultures were harvested by centrifugation at 11,000 x g for 10 minutes, 
washed in sterile Ringer's solution and re-suspended in pre-warmed nutrient broth. The resultant 
suspension was serially diluted in nutrient broth and immediately plated onto solid media. Colony 
counts were established after 24 hours incubation at 37oC. Aliquots of 100 µl of each log-fold dilution 
were transferred to individual wells of a black 96-well microtitre plate (Greiner Bio-one, UK) in 
triplicate and images of bioluminescence acquired at integration times of 5, 10 and 30 seconds and 1, 
5, 10 and 15 minutes at an EM gain value of x300. 
2.17 Calibration of colony forming units and light emission in overlay agar 
Batch cultures were grown until an OD540 of >1.0 was achieved and cells pelleted by centrifugation 
(10,000 x g, 10 minutes), washed twice and re-suspended in Ringers solution. The resultant cell 
suspensions were serially diluted, plated onto LB agar and colony counts recorded after 24 hours 
incubation at 37oC. The same cell suspensions were serially diluted in LB overlay agar to 10-8 and 100 
µl aliquots transferred to wells of a black, 96-well microtitre plate containing 100 µl LB agar. 
Measurements of light emission were recorded using a microplate reader (Berthold Technologies 
GmbH, Centro XS3) and by EMCCD imaging. All assays included instrument and reagent blanks and 
the limit of detection was defined as 3 standard deviations of the reagent background. Calibration 
experiments were performed on three independent occasions for each bacterial isolate. 
2.18 Bioluminescence imaging of plaque formation 
Bacteriophages were diluted sufficiently in SM buffer to yield approximately 50 plaques on overlay 
agar plates. Briefly, plates were prepared by mixing 10 µl of the diluted bacteriophage sample with 
150 µl of exponential phase bacterial culture (OD540nm = 0.25, c. 1 x 10
8 cfu ml-1). After a period of 1 
minute, this mixture was diluted with 6 ml of LB-Miller overlay agar (0.6 % w/v bacteriological agar, 
10 mmol l-1 MgSO4, 1 mmol l
-1 CaCl2) supplemented with either 10 µg ml
-1 Km or Gm. The overlay 
agar was poured onto the surface of LB agar plates also containing the appropriate antibiotic. Once 
the overlay had solidified, plates were transferred to a transparent Perspex incubator preheated to 
37oC and bioluminescence recorded using an EMCCD camera and macro lens (EF 100 mm f/2.8, 
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Canon, Japan) controlled using iQ 2.2 software (Andor Technologies, UK). Image acquisition used 
three different exposure times during the experimental timeframe; 300 seconds, 10 seconds and 5 
seconds. An exposure time of 300 seconds was used for the first 160 minutes in order to facilitate 
detection of low levels of light emission. The exposure time was then altered to 10 seconds for a 
further 120 minutes before reducing to 5 seconds for the remaining experimental duration. Exposure 
times were reduced in order to prevent sensor saturation by the increased signal present at later 
points in the experimental timeframe. All exposures were acquired at 5 minute intervals over 20-
hour periods. The EMMCD sensor was liquid cooled to -95oC with device settings of 1 MHz horizontal 
shift speed, 16 bit A/D converter with a pre-amplifier gain of x4.9 and an electron multiplication 
factor of 300.  
2.19 Processing and analysis of bioluminescence images 
Initial analyses of time-lapse images were performed using the open-source software ImageJ 
(Abramoff et al., 2004). Raw images were normalised by subtraction of dark frames and converted to 
counts per second by dividing pixel values by the exposure duration. Individual, isolated plaques 
were identified and cropped from the full-size images (Figure 10). Coarse particle descriptions were 
obtained for each image by thresholding, converting to binary and fitting regions of interest to the 
plaque boundary using ImageJ’s inbuilt particle analysis function.  A basic description of the rate of 
enlargement was obtained by calculating the radius of a circle equivalent to the area of the plaque 
and taking the slope of the radius versus time. In order to obtain a more accurate description of 
plaque expansion, a routine was also developed using Matlab (Wolfram Research, Germany) to 
detect the plaque edge perimeter (Figure 10). The centroid of the earliest image in which the plaque 
becomes visible was employed as a fixed origin to plot the detected edge in a polar co-ordinate 
system. This approach allowed determination of the distance from the plaque centroid to the edge 
along rays pointing outwards at regular angle increments.  
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Figure 10. Detection of plaque formation by bioluminescence imaging. All images have been 
contrast adjusted for clarity. A. Montage of plaque formation by vB_SenS-Ent1. Moving from left to 
right, panels show the formation of a single plaque at intervals of 2.5 hours. B. Kymograph of a line of 
pixels extending through the plaque radius. The x-axis represents pixels comprising the line, coloured 
according to intensity of light emission. The y-axis represents time. C. Edge fitting and conversion to 
polar co-ordinates of a single frame.  
2.20 Imaging of Plaques by CSLM and Live:Dead staining 
Briefly, plaques and a surrounding area of the bacterial lawn were excised from plates after 24-hours 
incubation at 37oC and the underlay layer carefully cut away using a sterile scalpel. Bacteria in the 
overlay agar were stained by flooding the cored plaques with 30 µmol l-1 propidium iodide and 6 
µmol l-1 SYTO-9 (BacLITE, Invitrogen, UK) and incubating for 30 minutes at room temperature. The 
distribution of live and dead bacteria were examined at x20 magnification using an Ultraview ERS 
spinning-disk confocal microscope equipped with a 0.3 µm step z-stage (Perkin Elmer,UK), after 
excitation at 488 nm and 568 nm. Deconvolution of z-stacks was performed using the Volocity 
software package (Perkin Elmer, UK). Control samples consisted of examination of live:dead stained 
bacterial lawns grown in the absence of bacteriophages and overlay agar lacking both bacterial cells 
and bacteriophages. 
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2.21 Biocontrol of Salmonella Enteritidis in foodstuffs 
2.21.1 Stability of bioluminescent reporters 
Prior to beginning biocontrol experiments, the stability of plasmid retention by bioluminescent S. 
Enteritidis PT4 at 4oC and in the absence of selective agents was assessed. Briefly, an overnight 
culture was subcultured to fresh LB-Km broth and grown to OD540 1.0. The culture was pelleted by 
centrifugation at 10,000 x g for 5 minutes and washed twice and resuspended in an equal volume of 
RS. After serial dilution and preparation of enumeration plates, the culture was stored at 4oC and 
enumerations performed daily for 7 days. After 24 hours incubation at 37oC, enumeration plates 
were examined using an EMCCD camera to identify numbers of bioluminescent colonies.  
2.21.2 Food samples 
The ability of bacteriophages to reduce pathogen loads in artificially contaminated food matrices was 
assessed. Four food matrices were tested, sourced from a local grocery store: mixed salad leaves; 
beansprouts; cooked and raw skinless chicken breast. Each food was first screened for contamination 
with Salmonella by ISO 6579:2002 protocols (Anonymous, 2002). A bulk quantity of 720 g of each 
food matrix was split between 9 sterile LDPE containers so that each contained 80 g. Three series of 
food samples were used for each experiment. For positive controls, a food sample was inoculated 
with bacteria only, whilst the stability of bacteriophages in the different food matrices was assessed 
using a food sample inoculated with the relevant bacteriophage isolate. The third series comprised 
food samples inoculated with both bacteria and bacteriophages. 
2.21.3 Addition of Salmonella Enteritidis and bacteriophages 
Batch cultures of bioluminescent S. Enteritidis PT4 were grown in LB-Km broth to an OD540 of 0.1, 
representing a concentration of 5 x 107 cfu ml-1. The bioluminescent transformant was used as the 
presence of the plasmid provided an antibiotic resistance marker for selection and light emission for 
colony identification. Cultures were serially diluted in RS and enumeration plates prepared from two 
consecutive dilutions. Bacteria were added to foods to achieve a contamination level of 
approximately 103 cfu g-1. For food samples assessing the action of bacteriophages, the sample was 
first inoculated with bacteria and a 10 g sample withdrawn immediately after mixing. The food 
samples were then incubated at 4oC for 2 hours in order to allow bacteria to equilibrate to storage 
conditions. Bacteriophages were added to a final concentration of 1 x 108 pfu g-1 and the food 
samples mixed for 2 minutes to ensure dispersal of bacteria and bacteriophages throughout the 
matrix. After inoculation of bacteriophages, the food was sampled for a second time and then stored 
at 4oC for 7 days. 
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2.21.4 Determination of bacterial and phage counts 
Sampling was performed at daily intervals. Briefly, for each series 10 g of food was weighed into 
sterile bags (Seward, UK) and diluted 10-fold by addition of 90 ml maximum recovery diluent (MRD) 
(Oxoid, UK). Samples were homogenised for 30 seconds using a stomacher (Seward, UK) and titrated 
for the presence of Salmonella and bacteriophages as appropriate. For quantitative enumerations of 
bacteria, 500 µl and 100 µl aliquots were spread plated onto LB-Km and xylose lysine deoxycholate 
(XLD, Oxoid, UK) agar plates. Colonies present on LB-Km and XLD plates after overnight incubation at 
37oC were examined for light emission using an EMCCD camera. Infective virions recovered from 
foods were enumerated using the overlay plaque assay. Aliquots of 100 µl and 10 µl from log-fold 
dilutions of food homogenates were added to 200 µl of host cells prior to plating. Samples were held 
for 5 minutes prior to the addition of 6 ml LB overlay agar containing kanamycin.  
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Chapter 3 Characterisation of the vB_SenS-Ent Salmonella 
Bacteriophages 
Data presented in this chapter are adapted from Turner et al., (2012) Journal of General Virology 93: 
2046-2056.  
3.1 Introduction 
The bacteriophages vB_SenS-Ent1, vB_SenS-Ent2 and vB_SenS-Ent3 (Ent1, Ent2 and Ent3, 
respectively) are members of a proposed genus, the Setp3likevirus that fall within the Siphoviridae 
family of tailed bacteriophages. These phages are characterised by their ability to infect and 
reproduce within a broad range of serovars of the enteric pathogen Salmonella enterica. Apparent 
differences in host range and susceptibility to restriction enzymes were investigated by taking 
forward each isolate for genome sequencing. This report details the microbiological characterisation 
and bioinformatics analysis of these three novel Salmonella bacteriophages, vB_SenS-Ent1, vB_SenS-
Ent2 and vB_SenS-Ent3. 
Nucleotide sequence accession number. The whole-genome sequence of phage vB_SenS-Ent1 has 
been deposited in the international nucleotide sequence database under accession number 
HE775250. 
3.2 Results 
3.2.1 Isolation of the vB_SenS-Ent phages 
The vB_SenS-Ent bacteriophages were isolated from swine lagoon effluent and named according to 
the recommendations outlined by Kropinski et al., (2009), with an additional mnemonic of Ent to 
denote the host Salmonella Enteritidis serotype. A total of four Siphoviridae were isolated from a 
single effluent sample of which three were taken forward for further study. All three phages 
propagated efficiently on Salmonella Enteritidis phage type 4 (PT4) and upon plating produced 
relatively large plaques, at least 5 mm in diameter (n=30). The morphology of plaques may be 
termed as ‘bull’s-eye’, but are best described as consisting of at least three discrete zones. Plaque 
centres exhibited clearing but contained a number of small colonies. Moving outwards, the second 
zone consisted of a halo of reduced turbidity, extending to the plaque boundary with the bacterial 
lawn. A third zone, consisting of a ring of increased turbidity relative to the surrounding bacterial 
lawn, was observed occasionally just beyond the plaque boundary. Once purified, small stocks were 
propagated and each candidate phage isolate was taken forward to determine sensitivity to 
restriction digestion with BamHI, EcoRV, SmaI, XbaI and HindIII and for estimation of genome size by 
PFGE.  
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3.2.2 Propagation and Purification 
For phage Ent1 growth of the bacterial culture appeared to be inhibited for around 90 minutes prior 
to lysis, a longer period than observed  for phages Ent2 or Ent3 where lysis occurred after a period of  
>30 minutes incubation (Figure 11). Lysis was indicated by a significant drop in culture absorbance 
and was visually apparent by clearing of the bacterial culture. After 7 hours a slow increase in 
absorbance was observed for all lysates, probably representing population growth of resistant 
mutants. Growth of the phage-free control culture showed typical lag, exponential and stationary 
phases. The onset of stationary phase, indicated by a plateau in measured absorbance, was apparent 
after 8 hours. 
 
Figure 11. Propagation of bacteriophages vB_SenS-Ent1, Ent2 and Ent3 measured by optical density 
at 540nm. The chart represents a single propagation experiment. Host cells were grown in LB broth 
supplemented with 10 mmol l-1 MgSO4 and 1 mmol l
-1 CaCl2 at 37
oC with orbital shaking at 150 rpm. 
The time point of phage addition (3 hours) to bacterial cultures is marked on the graph by the 
arrows.  
Propagation using S. Enteritidis as the host routinely yielded lysates containing 1010 pfu ml-1,  which 
after clarification and precipitation with polyethylene glycol, could be concentrated to >1 x 1011 pfu 
ml-1. Purified virions were obtained using CsCl density gradient centrifugation (Figure 12). 
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Figure 12. Bacteriophage bands recovered after isopynic CsCl density gradient centrifugation. A, 
Felix O1; B, vB_SenS-Ent1; C, vB_SenS-Ent1 band after equilibration centrifugation in CsCl (ρ = 1.5). 
The white arrows indicate the location of bacteriophage bands.  
3.2.3 Restriction analysis and estimation of genome size 
Estimations of genome size by PFGE suggested that the vB_SenS-Ent phages all possessed genomes 
of approximately 45 kb. DNA from phages Felix O1 and T4 were run alongside samples to provide 
controls and estimations of 85 and 170 kb agreed closely with the length of sequences deposited in 
the International Nucleotide Sequence Databases (INSD). Whilst the predicted genome sizes were 
similar for the Ent phages, their susceptibility to digestion by restriction enzymes differed 
considerably (Figure 13). Phage Ent1 was resistant to digestion by BamHI whereas both Ent2 and 
Ent3 were susceptible to the activity of this enzyme. Conversely, both Ent2 and Ent3 were resistant 
to XbaI whereas Ent1 was not. Ent3 showed additional resistance to digestion by SmaI. On the basis 
of these differing restriction patterns, these three phages were taken forward for further 
characterisation and genome sequencing. 
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Figure 13. Sensitivity of the vB_SenS_Ent bacteriophage genomic DNA to restriction enzymes. 
Experiments were performed on at least 3 independent occasions to verify reproducibility of 
fragment banding patterns.  
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3.2.4 Virion morphology 
Examination by transmission electron microscopy revealed the vB_SenS-Ent phages as members of 
the Siphoviridiae family of dsDNA bacteriophages (Figure 14), similar to the Jersey morphotype 
(Ackermann, 2007b). The phage particle consists of an isometric head of 64 nm mean diameter 
(n=20) and flexible, non-contractile tail 116 nm in length and 8.5 nm in width. The tail appears to 
have transverse striations and 6 short tear drop shaped tailspikes can be distinguished at the 
terminal end. 
 
Figure 14. Transmission electron micrograph of A) vB_SenS-Ent1, B) vB_SenS-Ent2 and C) vB_SenS-
Ent3 stained using 2 % aqueous uranyl acetate. Scale bars represent 100 nm.  
3.2.5 Adsorption and one step growth 
The infection process of the vB_SenS-Ent phages upon co-incubation with S. Enteritidis PT4 was 
investigated by standard adsorption and one-step growth assays. At 37oC vB_SenS-Ent1 exhibited 
rapid adsorption, 6.73 x 10-9 ml min-1 (R2 = 0.992), to cells of S. Enteritidis PT4. Adsorption rate 
constants were similar for vB_SenS-Ent2 and vB_SenS-Ent3 at 6.20 and 3.82 x 10-9 ml min-1 (R2 ≥ 
0.96), respectively (Figure 15).  
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Figure 15. Adsorption of vB_SenS-Ent1 (A), vB_SenS-Ent2 (B) and vB_SenS-Ent3 (C) to cells of 
Salmonella Enteritidis shown as the fraction of free phages remaining over time. Results represent 
the mean and standard deviation of at least three independent experiments.  
One step growth curves yielded identical results for vB_SenS-Ent1, -Ent2 and -Ent3 (Figure 16).  Once 
adsorbed to host cells, the Ent phages exhibited latent and eclipse periods of 25 and 20 minutes, 
respectively. The rise period began after 25 minutes, with host cell lysis completed after 35 minutes 
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releasing 35 progeny virions per infected cell. Estimations of burst sizes were corroborated by single 
burst experiments comprising 150 samples for each bacteriophage.  
 
 
Figure 16. One step growth curve for vB_SenS-Ent1 using S. Enteritidis PT4 as host. Data presented 
are the mean and standard deviation of three independent experiments.  
3.2.6 Host range and efficiency of plating 
Host range was assessed by the ability of log-fold dilutions of vB_SenS-ENT phages to form plaques 
upon a library of Salmonella consisting of 48 different isolates. Serovars Typhimurium and Enteritidis 
were represented by 9 and 8 isolates, respectively (Table 6). At the highest dilution of 
bacteriophages, approximately 1010 pfu ml-1, Ent1 formed plaques on 25 isolates (52 %), Ent2 on 23 
isolates (48 %) and Ent3 on 24 isolates (50 %). The number of isolates showing formation of spot 
plaques reduced with increasing dilutions of bacteriophages (Figure 17). 
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Figure 17. Percentage of Salmonella isolates forming plaques by spot plate assay with decreasing 
concentrations of bacteriophage. 
Sensitive isolates were taken forward to ascertain the relative efficiency of plating (EOP). EOP 
represents a more rigorous analysis of the ability of a bacteriophage to form plaques as phage 
particles are allowed to adsorb to host cells at lower concentrations or are distributed throughout 
the overlay agar rather than presented at the lawn surface as a concentrated focal ‘spot’. Hence, the 
formation of plaques results from productive infection of a bacterium by at least a single phage 
particle rather than by non-productive infection or lysis from without.  
The ability of the Ent phages to form plaques under EOP assay conditions differed markedly from 
spot plates and the number of sensitive isolates was reduced substantially for each phage (Table 6). 
Productive lysis was reduced to 14 of 48 isolates (31.25 %) for Ent1, while Ent2 and Ent3 both 
showed productive lysis on 12 strains (25 %). Plating efficiencies ranged from 5.67 x 102 to 3.94 x 10-9 
for susceptible isolates. With the exceptions of S. Enteritidis CBRI 1944, which was resistant to 
infection, and a reduced EOP of 10-7 for S. Enteritidis PT13a, the Ent phages infected all isolates of S. 
Enteritidis at similar or greater efficiencies to the propagating strain. For S. Typhimurium, each of the 
Ent phages were able to form plaques on four of the nine isolates tested. Efficient infection relative 
to the host strain was observed for only one Typhimurium isolate, CBRI 1005. Only two isolates 
exhibited plaque formation with all three Ent phages, CBRI 1005 and S07519-07. Ent2 did not form 
plaques on S. Typhimurium isolate VLA S07541-07 while isolate VLA S07540-07 was not lysed by 
Ent3. Overall, each of the Ent phages showed broadly similar host specificity profiles and plating 
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efficiencies. It is notable that aside from serovar Napoli, only Ent1 formed plaques upon Salmonella 
serovars other than Enteritidis and Typhimurium. 
Table 6. Host range of the vB_SenS-Ent bacteriophages. Spot plate results were scored visually 
where ++++, complete lysis; +++, slight turbidity; ++, heavy turbidity; + single plaques; 0, no plaque 
formation. The reader is referred to Figure for images of plaques corresponding to these scores. 
Efficiency of plating (EOP) values represents the ratio of plaques formed upon a bacterial isolate 
relative to the propagating host, S. Enteritidis PT4. NT, Not tested; 0, no plaque formation. All data 
were determined from three independent repeats.  
  vB_SenS-Ent1 vB_SenS-Ent2 vB_SenS-Ent3 
Isolate 
Accession 
Number 
Spot 
Plate 
EOP 
Spot 
Plate 
EOP 
Spot 
Plate 
EOP 
S. enterica serovar Enteritidis 
   
    S. Enteritidis VLA S07533-07 ++++ 2.64 x 10
-1
 ++++ 9.40 x 10
-1
 ++++ 6.2 x 10
-1
 
S. Enteritidis PT 13 VLA S04967-07 ++ 4.04 x 10
-7
 ++ 2.86 x 10
-2
 ++ 8.29 x 10
-6
 
S. Enteritidis PT1 CBRI 1937 ++++ 1.47 x 10
-1
 ++++ 7.44 x 10
-1 
++++ 1.19 
S. Enteritidis PT4 VLA S07544-07 ++++ HOST ++++ HOST ++++ HOST 
S. Enteritidis CBRI 1869 ++++ 6.24 x10
-1
 ++++ 0.188034 ++++ 1.62 x 10
-1
 
S. Enteritidis CBRI 1870 +++ 10.4 ++++ 0.854701 ++++ 1.31 
S. Enteritidis CBRI 1951 ++ 567 ++++ 0.0598 ++++ 1.43 x 10
-1
 
S. Enteritidis CBRI 1944 +++ 0 - NT - NT 
S. enterica serovar Typhimurium 
S. Typhimurium   VLA S07519-07 ++ 1.27 x 10
-5
 ++ 3.87 x 10
-2
 ++ 3.43 x 10
-3
 
S. Typhimurium   VLA S07540-07 ++ 1.64 x 10
-5
 ++ 9.29 x 10
-2
 ++ 0 
S. Typhimurium   VLA S07541-07 ++++ 4.96 x 10
-4
 - NT ++ 1.14 x 10
-2
 
S. Typhimurium DT104b VLA S01523-08 ++ 0 ++ 0 ++ 0 
S. Typhimurium   CBRI 1960 +++ 0 ++ 4.71 x 10
-7
 ++ 4.29 x 10
-7
 
S. Typhimurium   CBRI 1962 +++ 0 ++ 0 ++ 0 
S. Typhimurium   CBRI 1005 +++ 1.34 x 10
-1
 ++++ 1.0683 ++++ 9.05 x 10
-1
 
S. Typhimurium   CBRI 1006 ++ 0 ++ 0 ++ 0 
S. Typhimurium CBRI 1007 +++ 0 ++++ 0 ++++ 0 
Other Serovars 
 
      
S. Agona NCTC 11377 ++ 0 ++++ 0 +++ 0 
S. Brandenburg VLA S07530-07 - NT - NT - NT 
S. Braenderup VLA S02130-08 - NT - NT - NT 
S. Braenderup VLA S07531-07 - NT - NT - NT 
S. Concord NCTC 6588 - NT - NT - NT 
S. Crossness NCTC 11059 - NT - NT - NT 
S. Derby HPA ++ 0 +++ 0 +++ 0 
S. Dublin VLA S07539-07 +++ 5.81 x 10
-5
 - - - - 
S. enterica  4, 12: e, h: - VLA S07521-07 +++ 0 +++ 0 +++ 0 
S. enterica  6, 8: -: e, n, x VLA S07523-07 - NT +++ 0 +++ 0 
S. enterica O-Rough: z10: - VLA S07520-07 - NT - NT - NT 
S. enterica O-Rough: e, h: e, n, 
x, z15 
VLA S07538-07 + 3.94 x 10
-9
 - - - 
NT 
S. arizonae 6: 13, 14 NCTC 7308 - NT - NT - NT 
S. Heidelberg VLA S07546-07 ++ 4.30 x 10
-6
 +++ 0 ++ 0 
S. Heidelberg VLA S07529-07 ++ 0 ++ 0 ++ 0 
S. Infantis CBRI 1037 - NT - NT - NT 
S. Inverness NCTC 6591 - NT - NT - NT 
S. Jerusalem NCTC 8146 - NT - NT - NT 
S. Mbandaka VLA S07524-07 - NT - NT - NT 
S. Molade VLA S07526-07 - NT - NT - NT 
S. Montevideo CBRI 1030 - NT - NT - NT 
S. Napoli NCTC 6853 ++ 4.30 x 10
-6
 ++ 3.76 x 10
-6 
++ 4.55 x 10
-6 
S. Orion var. 15+ VLA S07525-07 - NT - NT - NT 
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S. Panama CBRI 1045 - - +++ 0 +++ 0 
S. Poona NCTC 4840 - NT - NT - NT 
S. Seftenberg VLA S07528-07 - NT - NT - NT 
S. Tennessee NCTC 6388 - NT - NT - NT 
S. Typhisuis NCTC 347 - NT - NT - NT 
S. Utrecht NCTC 10077 - NT - NT - NT 
S. Virchow CBRI 1012 - NT - NT - NT 
S. Virchow CBRI 1010 - NT - NT - NT 
Other Gram-negative bacteria 
       
Escherichia coli Nissle 1917 
Ardeypharm 
GmbH 
- NT - NT - NT 
E. coli NCTC 10418 - NT - NT - NT 
E. coli O157:H7 NCTC 12900 - NT - NT - NT 
Pseudomonas aeruginosa 
PAO1 
ATCC 15692 - NT - NT - NT 
P. aeruginosa  NCTC 13359 - NT - NT - NT 
Citrobacter freundii NCTC 6266 - NT - NT - NT 
Klebsiella aerogenes NCTC 9660 - NT - NT - NT 
 
Genome sequencing results indicate that host specificity of the Ent phages is mediated by the 
presence of a P22-like tailspike. For P22, this protein binds to O-antigen 12, found in serogroups A, B 
and D1. From the panel of serovars tested, it is clear that all isolates allowing productive infection by 
the ENT phages possess the O-antigen 12. However, it was noted that vB_SenS-Ent1 formed plaques, 
albeit at low efficiency, upon the rough strain S. enterica e,h: e,n,x,z (VLA S07538-07) but did not 
plaque upon another rough isolate, S. enterica z10:- (VLA S07520-07). No lysis was observed when 
the vB_SenS-Ent phages were co-incubated with representatives of four other Gram-negative 
bacterial species. 
3.2.7 Genome properties and architecture 
A single consensus sequence for each Ent phage was obtained by 454 pyrosequencing at 30, 146 and 
92-fold coverage for Ent1, Ent2 and Ent3, respectively. The vB_SenS-Ent1 particle encapsulates a 
linear dsDNA molecule 42,391 bp in length with an average G+C content of 49.79 %, slightly lower 
than the average of 52 % reported for serovars of Salmonella enterica (McClelland et al., 2001, Reen 
et al., 2005, Thomson et al., 2008). The vB_SenS-Ent2 genome is 42,093 bp in length (49.92 % G+C) 
and for vB_SenS-Ent3 the size is 42,764 bp (49.79 % G+C). Genomes were opened upstream of the 
putative small terminase subunit, following the convention established for bacteriophages λ and P22. 
A total of 58, 56 and 60 open reading frames (ORFs) were predicted for Ent1, Ent2 and Ent3, 
respectively (Figure 18), accounting for a coding potential of >90 %. Each of the genomes may be 
structured into 4 clusters on the basis of transcriptional direction. The genes are tightly spaced at a 
density of 1.37 per kb and have an average length of 678 bp. Short overlaps between the stop codon 
of one gene and the start codon of the adjacent downstream gene are common and no tRNA genes 
were discovered with either tRNAscan-SE, WebGester or ARAGORN. As for many bacteriophages, 
only a limited number of protein functions could be predicted by sequence similarity and the 
57 
 
presence of conserved domains (Supplemental Tables 1 through 6). As such, many ORFs were 
annotated as hypothetical. 
Whilst synteny of gene order is often preserved within arrays of genes, particularly those encoding 
structural and assembly proteins in the Siphoviridae, bacteriophage genomes are strikingly mosaic 
(Hatfull, 2008). Individual genes and gene segments are exchangeable by horizontal transfer with 
members of the population by a number of potential mechanisms (Hatfull and Hendrix, 2011). 
Where similarities in nucleotide sequence are no longer apparent, the comparison of amino acid 
sequences and predicted tertiary structures are useful tools to delineate common protein ancestries. 
Like most phages, the genome structure of the vB_SenS-Ent phages exhibits a modular organisation 
with four gene clusters representing two early and two late transcriptional regions (Figure 18). Late 
clusters encompassed genes coding for proteins involved in genome packaging (gp01 to gp03), virion 
structure and morphogenesis (gp05 to gp19) super-infection immunity (gp20 to 24) and lysis (gp51 
and gp52). With the exception of gp42, all early ORFs with inferred DNA replication (gp32 to gp45) or 
regulatory functions (gp20 to gp24) are encoded on the complementary strand. A relatively large 
noncoding region of approximately 1 kb is located between gp45 and gp46, and this region contains 
the minimum G+C skew, suggesting that it may contain the replication origin site. Full descriptions 
for predicted open reading frames and the presence of domains and motifs for the vB_SenS-Ent 
phages are provided in Appendix II. 
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Figure 18. Linear map of the vB_SenS-Ent1, vB_SenS-Ent2 and vB_SenS-Ent3 genomes prepared using GView. Arrows denote coding sequences and have 
been coloured according the generalised function of each gene cluster. Grey arrows denote hypothetical proteins of unknown function. 
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3.2.8 Packaging, morphogenesis and structural proteins 
Nearly half (48 %) of the Ent virion genomes are devoted to encoding proteins involved in packaging, 
structure and morphogenesis. These genes comprise two gene clusters totalling 27 ORFs, separated 
by an immunity region spanning genes gp20-24. The arrangement of genes encoding virion structural 
and morphogenesis proteins generally follows a conserved organisation in the Siphoviridae (Casjens, 
2005; Hatfull, 2008) and have been characterised in detail for Escherchia coli phages λ and T5, 
Bacillus subtilis phage SPP1 and Lactococcus phages TP901-1 and p2. Both gene order and function 
appear highly conserved among the vB_SenS-Ent phages and related Siphoviridae.  
One dimensional SDS-PAGE of CsCl purified vB_SenS-Ent virions yielded 10 bands consisting of 4 
major bands at 72, 42, 38 and 13.5 kDa and 6 minor bands of 90, 56, 20, 18 and 9 kDa (Figure 19). 
Further proteins were identified on 2D SDS-PAGE gels and genes corresponding to spots were 
annotated on the basis of predicted molecular mass, isoelectric point and protein homologues from 
HHpred, BLASTP and PSI-BLAST queries.  
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Figure 19. vB_SenS-Ent phage structural proteins resolved by 1D and 2D SDS-PAGE. A. vB_SenS-
Ent1. B. vB_SenS-Ent2. B. vB_SenS-Ent3. Banding patterns were confirmed  Two replicates were 
performed for 2D.   
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Gene gp01 was assigned as the small terminase subunit due to its position immediately upstream of 
the large terminase subunit, gp02. BLASTP results showed limited protein sequence identity (37 %) to 
gp01 of Sodalis phage SO-1, whilst PSI-BLAST analysis yielded hits to small terminase subunits of 
phage infecting both Gram positive and Gram negative bacteria and HHpred returned a strong hit to 
the crystal structure of the Sf6 small terminase (pdb: 3hef). A terminase 6 family domain (PF03237) 
spanning residues 24-406 was identified by Pfam analysis of Gp02. Gp03 was identified as the 
putative portal protein due to its position immediately downstream of the large terminase subunit. 
Supporting this assignment, a spot of 58 kDa, slightly larger than the predicted mass of 54 kDa, was 
observed on 1D and 2D SDS gels. 
Gp05 was predicted to belong to the phage Mu protein F like family (PF04233). A member of this 
Pfam family is gp07 of phage SPP1, a non-essential minor protein participating in capsid assembly 
and DNA packaging (Dröge et al., 2000). The presence of an immunoglobulin-like I-set domain 
(PF13895) in gp06 suggests that this gene encodes a head decoration protein. Head decoration 
proteins have been described for phages L, λ and ES18 and are thought to aid stabilisation of the 
capsid structure against disruption by chelating agents (Gilcrease et al., 2005). Immunoglobulin-like 
domains are found widely within the Caudovirales and are predominantly associated with structural 
proteins. The precise role of such domains remains unclear but it has been suggested that they 
facilitate weak, non-specific binding to the cell surface or act to stabilise the virion structure (Fraser 
et al., 2007). 
No putative function could be assigned to either gp07 or gp08. However, gp08 has multiple potential 
start sites which would yield significant overlap with gp07 and gene calling routines showed 
disagreement as to the correct start codon, perhaps indicating that gp08 is expressed using a 
translational frameshift. A scaffold protein with a predicted mass of 25.7 kDa is encoded by gp09 
immediately upstream of the major coat protein (MCP) gp10. The MCP appears as a strong band of 
38 kDa on SDS gels. PSI-BLAST and HHpred results suggest that Gp11 is a distant homologue of the 
gp8.5 head fibre of Bacillus phage PZA and Phi-29, respectively. As second I-set domain (IPR007110) 
is found in gp12 and PSI-BLAST hits included Hoc and Wac proteins. The proximity to the MCP 
suggests that both these proteins are involved in head completion. 
The six open reading frames (gp13-gp18) located downstream of gp12 probably constitute head to 
tail joining and tail scaffold proteins and of these, gp15, gp16 and gp17 are candidates for spots on 
2D SDS-PAGE gels. Two ORFs, gp14 and gp16 can be linked by PSI-BLAST searches to proteins found 
in mature virions of the Pseudomonas aeruginosa phage vB_PaeS-Kakheti25 (Karumidze et al., 2012). 
HHpred analysis of Gp18 identified SPP1 Gp17 and the λ GpU minor tail protein as homologs. No 
ORFs encoding candidate ejection proteins such as those reported for P22 and SPP1 were identified 
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through database searches. Gp19 was assigned as the major tail protein (MTP) on the basis of PSI-
BLAST results and presence as a strong band of 41 kDa on SDS gels. 
Genes comprising the second structural gene cluster encode the proteins forming the virion tail. No 
candidate slippery sequence associated with a programmed translational frameshift was identified 
within the coding regions of gp25 and gp26, though this may be due to inexperience (Xu et al., 2004). 
Gp27 was assigned as the tail tape measure protein and a strong spot at 83 kDa corresponding to the 
predicted size of this gene product was observed on 2D gels. The length of the tape measure protein 
agreed precisely with the measured length of the virion tail from TEM images, assuming a ratio of 
0.15 nm per amino acid residue as reported for λ (Katsura & Hendrix, 1984), and like other tape 
measure proteins gp27 is predicted to form a predominantly helical structure. Three ORFs separate 
gp27 from the putative tail fibre gene gp31. Referring to the organisation of the structural cassette in 
SPP1, P22 and phages infecting Lactococcus species it is plausible that these genes encode the distal 
tail baseplate (Casjens & Thuman-Commike, 2011; Mc Grath et al., 2006; Veesler & Cambillau, 2011). 
PSI-BLAST analysis of gp31 revealed similarities to the GpJ host specificity protein of λ and p33 of 
phage T1. A tail spike, gp32, was identified with confidence due to the presence of a complete Pfam 
P22 tail spike domain (PF09251), indicating that adsorption of Ent1 to host cells involves recognition 
of the LPS O:12 antigen. BLASTN and BLASTP analyses revealed significant homologues in the 
Siphoviridae; SE2, KS7, SETP3, SETP5, SETP7, SETP12 and SETP13, and Podoviridae; P22, SE1, ST104, 
ST64T and SETP1, SETP14 and SETP15. A ClustalW alignment of Gp32 revealed an N-terminal 
sequence similar to other Salmonella Siphoviridae SE2, KS7 and SETP phages 3, 5, 7 and 12, but 
retaining significant conservation in the catalytic and C-terminal regions relative to P22. N-terminal 
sequences of P22-like tail spikes are involved in attachment to the virion tail structure and exhibit 
conservation between related phages within the Podoviridae, Siphoviridae and Myoviridae (Hooton 
et al., 2011). Spots and bands corresponding to the predicted mass of the putative tape measure, tail 
fibre and tailspike were apparent on 1D and 2D SDS gels. 
3.2.9 Regulatory proteins 
Phage genomes usually encode of a number of regulatory proteins which, in concert with host 
proteins, co-ordinate the expression of early and late genes. The Ent phages possess a regulatory 
module consisting of 5 early genes encoded on the complementary strand, gp20 through gp24, 
dividing the array of genes responsible for virion morphogenesis. Gp20 showed strong sequence 
similarity to winged-helix DNA binding proteins from a number of different phage and bacteria and 
contains matches to two Pfam family domains; ANT (PF03374) and pRha (PF09669). In P22 ant 
encodes an anti-repressor which inhibits binding of the c2 repressor to the PL and PR operators 
enabling the expression of genes necessary for lytic development (Byl & Kropinski, 2000). The pRha 
domain represents a family of proteins whose expression is detrimental for lytic growth in the 
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absence of integration host factor function (Henthorn & Friedman, 1995). Gp22 is predicted to 
encode a free standing HNH endonuclease (PF13392) and PSI-BLAST analysis of gp23 revealed 
similarities to recombination endonuclease subunits. Gp24 shares extended similarity to the inner 
membrane immunity (Imm) proteins effecting exclusion of superinfecting phage (Lu et al., 1993).  
BLASTP homologues included phages JS98 (Zuber et al., 2007), vB_EcoM-VR7 (Kaliniene et al., 2011) 
and IME08 (Jiang et al., 2011). Supporting the protein homologue evidence, Gp24 is predicted to 
localise at the cytoplasmic membrane (PSortb) and contain two transmembrane domains (TMHMM). 
In addition to the regulatory gene cluster two ORFs, gp04 and gp42, interrupt the sequence of the 
structural and replication gene modules, in each instance encoded in the opposite orientation to the 
transcriptional direction of the respective module. The first, gp04, separates the structural genes 
gp03 and gp05. The sequence of gp04 exhibits negative GC skew in relation to neighbouring coding 
sequences, suggestive of a historical horizontal acquisition event. Protein homologues detected by 
PSI-BLAST suggest that gp05 encodes a KilA-like protein. Gp42 interrupts the sequence of the 
replicative gene cluster and is predicted to act as a transcriptional regulator, possibly involved in 
control of late gene expression, due to the presence of an N-terminal helix-turn-helix DNA binding 
domain similar to Cro/CI (PF12844).  
3.2.10 The vB_SenS-Ent DNA replication module contains mobile elements 
The Ent phages encode at least 12 genes involved in genome replication co-localised as a distinct 
module. This gene cluster comprises a primase, helicase, DNA polymerase, a restriction 
endonuclease, two putative DNA binding proteins, a uvsX homologue and 6 hypothetical products. 
Sequence similarity to other phage-encoded helicases suggested the presence of an in-frame 
insertion containing a DOD homing endonuclease motif within the sequence of gp34. The insertion 
sequence was identified as a large intein of 348 aa, satisfying the four criteria outlined by Perler et 
al., (1997). Inteins are defined as internal protein elements that self-excise from their host protein 
and catalyse ligation of the flanking sequences with a peptide bond yielding two stable proteins, the 
mature protein and the intein. Searches conducted using BLASTP and the mature helicase resulted in 
significantly improved alignments to other bacteriophages. Notably, an intein is also present at an 
identical position within the helicase of the closely related SETP3 phage. Similarly, the DNA 
polymerase A encoded by gp37 contains a minimal intein, that is lacking an endonuclease domain, of 
299 aa consistent with those predicted for the DNA polymerase gene of SETP3, SETP5 and SETP12. To 
date, 290 inteins are documented for Eubacteria within the InBase database, of which 36 are 
associated with phages or prophages (Perler, 2002).  
Analysis with HHpred and PSI-BLAST suggests that Gp36, Gp38 and Gp40 encode a Holliday junction 
resolvase (pdb: 1hh1), helix-destabilising ssDNA-binding protein (pdb: 1je5) and RecE helicase 
subunit (pdb: 3h4r), respectively.  Gp43 encodes a putative primease containing an AAA_28 Pfam 
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domain (PF13481) suggesting that, like Enterobacteria phages T4 and T5, Ent1 employs a primosome 
complex consisting of separate primase and helicase proteins (Ilyina et al., 1992).  A further DNA 
binding protein containing a helix-turn-helix 17 domain (PF12728) with low identity to transcriptional 
regulators of bacterial and phage origins is encoded by gp45. Of the remaining hypothetical proteins, 
no putative function could be assigned. 
3.2.11 Host lysis and the late Gene Cluster 
It is notable that the vB_SenS-Ent phages show the greatest degree of sequence variation within the 
late gene cluster which begins at gp46. For phages Ent1, Ent2 and Ent3 the late region is comprised 
of 13, 11 and 15 ORFs, respectively (Figure 20). With the exception of four gene products, common 
to each phage, no putative functions could be assigned to remaining genes in this region using PSI-
BLAST or HHpred. The four common gene products comprise an ATP-dependant protease, class II 
holin, lysin and transcriptional regulator. 
 
Figure 20. Late gene cluster of the vB_SenS-Ent phages. Genes encoding products with homology to 
proteins known function are coloured.  
Phages of eubacteria employ a dual protein system comprised of a holin and lysin to effect host cell 
lysis (Young et al., 2000). A lysin with inferred glycoside hydrolyase (lysozyme) activity (PF00959) and 
is immediately preceded by a protein of 95 aa, predicted to contain two transmembrane regions, a 
feature consistent with class II holins (Young, 2002). These two genes are separated from 
downstream genes by a putative rho-independent terminator.  
The putative transcriptional regulator contains a PFAM AAA+ domain, representing a superfamily of 
ATPases. This family of proteins have a diverse range of functions.  HHpred shows a short region with 
structural similarity to the sigma54 activator ZraR of S. Typhimurium (pdb: 1ojl).  
3.2.12 Promoters  
Analysis of 150 bp regions upstream of ORFs using MEME yielded a single candidate motif of 47 bp 
width (E value = 9.4 x 10-8) containing regions resembling -10 and -35 elements (Figure 21). The RSAT 
toolset was used to convert the MEME output file to a position matrix and search upstream regions 
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for additional instances. Locations for the consensus motif were found at an average distance of 48 
bases from the start codon, suggesting a role in transcriptional regulation (Tables 7 to 9). No 
candidate sequences were identified upstream of cluster starts gp04, gp05, gp25 or gp45 and the 
absence of promoter motifs in these areas suggests that additional sequences involved in 
transcriptional regulation remain to be found. 
Table 7. Locations and DNA sequences of a MEME-identified motif in the vB-SenS-Ent1 genome. 
Name Coordinates Strand Sequence 
PORF20 13457..13503 - AGAATCTGATTTGAACGATAAGAATGTTCGAAGTTAAATATATCTAC 
PORF24 15721..15767 - AATAGCTTGCATAACCGTTAATAGTGTCCTATTATCTCTACGTCAAC 
PORF35 27932..27978 - AGAAACAGGTTGATAAATTAATAGAACACTATTATATTTAGTTCACA 
PORF38 32142..32188 - AAAATTCGGTTGACAAGTTAATAGTACTCTATTATATTCTTAATCAC 
PORF41 34372..34418 - AAAAAGTGCTTGCATAAATAATAGAGCACGATTATAGTTCTTATCAC 
PORF42 34367..34413 + AGTTGGTGATAAGAACTATAATCGTGCTCTATTATTTATGCAAGCAC 
PORF53 40887..40933 + AAATAATAGTTGACTAGTAACATTAACCCTATTATATTTAGTTCATC 
Entries highlighted in red font indicate that this sequence overlaps with the 3’ end of an upstream ORF. 
Table 8. Locations and DNA sequences of a MEME-identified motif in the vB-SenS-Ent2 genome. 
Name Coordinates Strand Sequence 
PORF24 15795..15811 - TTAATAGTGTCCTATTA 
PORF25 15794..15810 + ATAATAGGACACTATTA 
PORF35 28057..28073 - TTAATAGAACACTATTA 
PORF38 32267..32283 - TTAATAGTACTCTATTA 
PORF41 34497..34513 - ATAATAGAGCACGATTA 
PORF42 34496..34512 + ATAATCGTGCTCTATTA 
PORF46 38423..38439 + ATAATAGGGTACTATTA 
PORF52 40726..40742 + ATAATAGTTGACTAGTA 
Entries highlighted in red font indicate that this sequence overlaps with the 3’ end of an upstream ORF. 
Table 9. Locations and DNA sequences of a MEME-identified motif in the vB-SenS-Ent3 genome. 
Name Coordinates Strand Sequence 
PORF20 13522..13568 - AGAATCTGATTTGAACGATAAGAATGTTCGAAGTTAAATATATCTAC 
PORF24 15786..15832 + AATAGCTTGCATAACCGTTAATAGTGTCCTATTATCCCTACGTCAAC 
PORF35 27997..28043 - AGAAACAGGTTGATAAATTAATAGAACACTATTATATTTAGTTCACA 
PORF38 32207..32253 - AAAATTCGGTTGACAAGTTAATAGTACTCTATTATATTCTTAATCAC 
PORF41 34437..34483 - AAAAAGTGCTTGCATAAATAATAGAGCACGATTATAGTTCTTATCAC 
PORF42 34432.34478 + AGTTGGTGATAAGAACTATAATCGTGCTCTATTATTTATGCAAGCAC 
PORF53 40952..40998 + AAATAATAGTTGACTAGTAACACTAACCCTATTATATTTAGTTCATC 
Entries highlighted in red font indicate that this sequence overlaps with the 3’ end of an upstream ORF. 
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Figure 21. Weblogo of consensus motif from sequences identified using MEME and aligned with 
ClustalW for the vB_SenS-Ent phages.  
3.2.13 Terminators 
Seventeen intergenic sequences representing potential rho-independent transcription terminators 
were identified in each of the Ent phage genomes (Table 10, Table 11 and Table 12). Candidate 
terminators were assessed according to location, presence of a U-rich tail and stable predicted stem 
loop secondary structure (ΔG ≤ -10 kcal mol-1) as calculated by RNAFold (Gruber et al., 2008). Seven 
of these are predicted to be on early transcripts and ten on late transcripts. Of these, eight form four 
bi-directional terminators separating the 3’ junctions of opposing transcriptional gene clusters.  
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Table 10. Putative rho-independent terminators identified in the vB_SenS-Ent1 genome. 
Name Coordinates Strand Sequence Stability (ΔG) 
TORF03 3342..3368 + AAGGCCCCATGACGGGGCCTTAGTTTT -15.7 kcal/mol 
TORF04 3337..3362 - AAGGCCCCGTCATGGGGCCTTTTGTT -15.5 kcal/mol 
TORF06 5691..5717 + AAGGCCCCTTCAAGGGGCCTTAATTTT -16.1 kcal/mol 
TORF08 6540..6559 + ACACCGGGAGGCCCGGTGTC -13.4 kcal/mol 
TORF10 8357..8378 + GAGGGACTTCGGTCCCTCTTTT -12.6 kcal/mol 
TORF12 9056..9074 + GCGGCCTCCGGGCCGCTTT -13.7 kcal/mol 
TORF19 12739..12764 + AAGGCCCCGAAAGGGGCCTTAGTTTT -16.6 kcal/mol 
TORF20 12736..12758 - AAGGCCCCTTTCGGGGCCTTTTT -15.5 kcal/mol 
TORF21 13515..13538 - GCCCCTTTCGGGGCTTTTTTTTAT -9.7 kcal/mol 
TORF32 24974..25000 + AAGGCCCCTTACGGGGCCTTAATTTAT -15.7 kcal/mol 
TORF33 24964..24993 - AAGGCCCCGTAAGGGGCCTTTACTATTTAT -16.4 kcal/mol 
TORF38 31424..31447 - GGCGGCTTCGGTCGCCTTTTCTAT -10.0 kcal/mol 
TORF41 33793..33811 - GCGGCCTTCGGGCCGCTTT -12.7 kcal/mol 
TORF42 34693..34717 + GGGGCCTGATGGCCCCTTTCTTTTT -13.7 kcal/mol 
TORF43 34692..34709 - AGGGGCCATCAGGCCCCT -14.1 kcal/mol 
TORF49 39696..39735 + TCTCCGAAGGATAAACCAACTTTCGGAGATTTTTTATTGT -12.9 kcal/mol 
TORF52 40842..40876 + TCCCGGTAACTGACCCTACCGGGATTTTTTTTTAT -12.8 kcal/mol 
Nucleotides forming stem structures are underlined.  Stability refers to the predicted minimum free energy of 
the entire sequence by RNAFold (http://rna.tbi.univie.ac.at/). 
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Table 11. Putative rho-independent terminators identified in the vB_SenS-Ent2 genome. 
Name Coordinates Strand Sequence Stability (ΔG) 
TORF03 3320..3346 + AAGGCCCCATGACGGGGCCTTAGTTTT -15.7 kcal/mol 
TORF04 3315..3340 - AAGGCCCCGTCATGGGGCCTTTTGTT -15.5 kcal/mol 
TORF06 5669..5695 + AAGGCCCCTTCAAGGGGCCTTAATTTT -16.1 kcal/mol 
TORF08 6518..6537 + ACACCGGGAGGCCCGGTGTC -13.4 kcal/mol 
TORF10 8335..8356 + GAGGGACTTCGGTCCCTCTTTT -12.6 kcal/mol 
TORF12 9117..9135 + GCGGCCTCCGGGCCGCTTT -13.7 kcal/mol 
TORF19 12800..12825 + AAGGCCCCGAAAGGGGCCTTAGTTTT -16.6 kcal/mol 
TORF20 12797..12819 - AAGGCCCCTTTCGGGGCCTTTTT -15.5 kcal/mol 
TORF21 13576..13599 - GCCCCTTTCGGGGCTTTTTTTTAT -9.7 kcal/mol 
TORF32 25035..25061 + AAGGCCCCGTAAGGGGCCTTAATTTAT -16.6 kcal/mol 
TORF33 25025..25054 - AAGGCCCCTTACGGGGCCTTTACTATTTAT -15.5 kcal/mol 
TORF38 31536..31559 - GGCGGCTTCGGTCGCCTTTTCTAT -10.0 kcal/mol 
TORF41 33905..33923 - GCGGCCTTCGGGCCGCTTT -12.7 kcal/mol 
TORF42 34805..34829 + GGGGCCTGATGGCCCCTTTCTTTTT -13.7 kcal/mol 
TORF43 34804..34821 - AGGGGCCATCAGGCCCCT -14.1 kcal/mol 
TORF49 39531..39570 + TCTCCGAAGGATAAACCAACTTTCGGAGATTTTTTATTGT -12.9 kcal/mol 
TORF52 40677..40711 + TCCCGGTAACTGACCCTTACCGGGATTTTTTTTTT -12.9 kcal/mol 
Nucleotides forming stem structures are underlined.  Stability refers to the predicted minimum free energy of 
the entire sequence by RNAFold (http://rna.tbi.univie.ac.at/). 
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Table 12. Putative rho-independent terminators identified in the vB_SenS-Ent2 genome. 
Name Coordinates Strand Sequence Stability (ΔG) 
TORF03 3324..3350 + AAGGCCCCATAACGGGGCCTTATTTTT -15.7 kcal/mol 
TORF04 3317..3344 - AAGGCCCCGTTATGGGGCCTTTTTCTTT -15.5 kcal/mol 
TORF06 5673..5699 + AAGGCCCCTTCAAGGGGCCTTAATTTT -16.1 kcal/mol 
TORF08 6522..6541 + ACACCGGGAGGCCCGGTGTC -13.4 kcal/mol 
TORF10 8339..8360 + GAGGGACTTCGGTCCCTCTTTT -12.6 kcal/mol 
TORF12 9121..9139 + GCGGCCTCCGGGCCGCTTT -13.7 kcal/mol 
TORF19 12804..12829 + AAGGCCCCGAAAGGGGCCTTAGTTTT -16.6 kcal/mol 
TORF20 12801..12823 - AAGGCCCCTTTCGGGGCCTTTTT -15.5 kcal/mol 
TORF21 13580..13603 - GCCCCTTTCGGGGCTTTTTTTTAT -9.7 kcal/mol 
TORF32 25039..25065 + AAGGCCCCTTACGGGGCCTTAATTTAT -15.7 kcal/mol 
TORF33 25029..25058 - AAGGCCCCGTAAGGGGCCTTTACTATTTAT -16.4 kcal/mol 
TORF38 31489..31512 - GGCGGCTTCGGTCGCCTTTTCTAT -10.0 kcal/mol 
TORF41 33858..33876 - GCGGCCTTCGGGCCGCTTT -12.7 kcal/mol 
TORF42 34758..34782 + GGGGCCTGATGGCCCCTTTCTTTTT -13.7 kcal/mol 
TORF43 34757..34774 - AGGGGCCATCAGGCCCCT -14.1 kcal/mol 
TORF49 39761..39800 + TCTCCGAATGGTAAACCAACTTTCGGAGATTTTTTATTGT -12.2 kcal/mol 
TORF52 40907..40939 + TCCCGGTAACTGACCCTACCGGGATTTTTTTTT -12.8 kcal/mol 
Nucleotides forming stem structures are underlined.  Stability refers to the predicted minimum free energy of 
the entire sequence by RNAFold (http://rna.tbi.univie.ac.at/). 
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3.2.14 Physical genome ends 
Heat treatment of restriction fragments followed by either rapid or slow cooling did not alter 
restriction patterns (data not shown), excluding the possibility of cohesive genome ends. Time 
limited treatment with the exonuclease BAL-31 resulted in even, simultaneous degradation of all 
restriction fragments (Figure 22). These data, combined with apparently circular consensus sequence 
assemblies, suggests that the vB_SenS-Ent genomes are terminally redundant and circularly 
permuted (Loessner et al., 2000). Circularly permuted genomes are characteristic of head-full 
packaging strategy where the packaged DNA length is between 102-110 % of the total genome 
length and would account for the >1 kb discrepancy between genome sizes as estimated by PFGE and 
DNA sequencing.  
 
Figure 22. Time limited digestion of vB_SenS-Ent1 genomic DNA with the exonuclease BAL-31. The 
hashed line indicates the removal of the 20 minute digestion due to improper migration of DNA 
through the gel. M, marker lane; Numerical values refer to length of digestion with BAL-31 in 
minutes.   
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Discussion 
The vB_SenS-Ent bacteriophages show a relatively broad host range, capable of infecting isolates 
from serogroups A, B and D1. While initially thought to be independent species due to differences in 
host range and susceptibility to digestion by restriction endonucleases, the extremely high nucleotide 
similarity, gene content and conserved location of putative promoters and rho-independent 
terminators suggest that these isolates may actually represent strains of the same parent species. It 
is noteworthy that these isolates are differentiated almost exclusively by differences in the number 
of candidate genes flanking the lysin and holin, suggesting that this late region is subject to high gene 
mobility.  
As yet there is no evidence that the vB_SenS-Ent phages exhibit a temperate lifecycle. No gene 
products were found which exhibited homology to characterised integrases, resolvases or 
excisionases and preliminary results suggest that the growth of small colonies within plaques arises 
due to host resistance rather than by a phage-related immunity mechanism. In addition the related 
Siphoviridae SS3e, SETP3 and K1-Phages are reported to be lytic (Bull et al., 2010, De Lappe et al., 
2009). In contrast, PHACTS analysis (McNair et al., 2012) denotes that the vB_SenS-Ent1 lifestyle is 
temperate, but the result is marginal with only 0.51 of trees in the forest algorithm yielding this 
decision. However, without an absolute answer as to whether the vB_SenS-Ent phages possess a 
temperate lifecycle the use of these phage as either biocontrol or therapeutic agents ex vitro is 
precluded, a necessary condition due to the association of temperate phage with the horizontal 
transfer of bacterial virulence factors (Canchaya et al., 2003a, Figueroa-Bossi et al., 2001). 
Notwithstanding, the establishment of an efficient and productive lytic infection cycle depends upon 
the function and interaction of multiple early and late proteins with both self and host encoded 
proteins (for a review see (Roucourt and Lavigne, 2009). As such, and like other bacteriophage 
genomes, the vB_SenS-Ent phages may harbour multiple gene products that have potential for 
exploitation as antimicrobial agents (Liu et al., 2004). Whilst much information still remains to be 
elucidated for the vB_SenS-Ent phages, the study reported here advances the annotation of a distinct 
genus of Siphoviridae infecting Salmonella serovars. The relationships between the vB_SenS-Ent 
phages and other fully sequenced Salmonella phages are explored in detail in the following chapter. 
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Chapter 4 A proposed new genus of bacteriophage: the 
“Setp3likevirus” 
4.1 Introduction  
4.1.1 Bacteriophage taxonomy and mosaicism 
Under the latest revision of virus taxonomy by the ICTV, members of the order Caudovirales are 
segregated into three morphological families (King et al., 2011): the Siphoviridae (9 genera) 
possessing flexible, non-contractile tails, the Myoviridae (3 subfamilies; 17 genera), characterised by 
complex, rigid contractile tails and the short-tailed Podoviridae (2 subfamilies; 11 genera). 
Bacteriophage taxonomy continues to be subject to lively debate and disagreements with Lawrence 
(2002) describing the field as a battle ground of phenetics versus cladistics. 
Despite being considered as clonal organisms, bacteriophage genomes have been shown to be 
pervasively mosaic (Lawrence et al., 2002). Each genome may be envisioned as a unique combination 
of modules representing individual and groups of genes (and intragenic segments) that are 
interchangeable between other viruses and host cells. The mosaic arrangement of phage genomes 
was recognised early on, due to the ability of P22 and λ to recombine to form functional hybrids 
(Susskind and Botstein, 1978). Several other phages have been shown to recombine including ES18, 
Fels-1 and P22 (Yamamoto, 1978, Yamamoto and McDonald, 1986) and a mechanism of homologous 
recombination occurring at linker sequences was initially proposed to explain these observations 
(Susskind and Botstein, 1978). It is now thought more likely that mosaicism arises at random 
positions in the genome through the a number of different mechanisms including homologous and 
illegitimate recombination, site-specific recombination, transposition and action of homing 
endonucleases (Hendrix et al., 1999, Nilsson and Haggård-Ljungquist, 2001, Hatfull, 2008). The 
horizontal transfer of modules is constrained by at least three aspects. Firstly, the host preference of 
the infecting bacteriophage influences the potential for contact with prophages and other (co-
infecting) bacteriophages. Second, that the loss, gain or exchange of modules does not render the 
phage replication-incompetent. Lastly, the viral genome should be of an appropriate size for 
packaging into the capsid (Lawrence et al., 2002).  
The availability of an increasing number of genome sequences and improvements in gene prediction 
methods has resulted in a sizeable shift towards the inclusion of genomic and proteomic data for the 
taxonomic/phylogenetic classification of bacteriophages (Lawrence et al., 2002). A number of 
different approaches have been reported in the literature for the purposes of delineating 
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evolutionary relationships between the bacteriophages including the phage proteomic tree (Rohwer 
and Edwards, 2002), numbers of shared homologous/orthologous proteins (Lavigne et al., 2009, 
Lavigne et al., 2008) and reticulate classification based on gene content (Lima-Mendez et al., 2011, 
Lima-Mendez et al., 2008). 
4.2 The Salmonella bacteriophages with completely sequenced genomes 
The Salmonella bacteriophages are numerous and varied. The morphology of 177 Salmonella phages 
has been reviewed by Ackerman (2007b) and are predominantly represented by the Siphoviridae, 
Myoviridae and Podoviridae. A small number of phages representing filamentous and isometric 
phages have also been documented. Whilst a number of partial sequences are present for 
Salmonella bacteriophages within the INSD (e.g. MB78, ST4), this manuscript focuses solely upon 
those bacteriophages with completely sequenced genomes. At the time of writing, the complete 
genomes of 42 bacteriophages infecting Salmonella were held in the international nucleotide 
sequence data bases, far fewer than the total number of 170 reported in the literature by 2007 
(Kropinski et al., 2007b). Of the 42 complete genomes, 20 fall into 8 genera as defined by the latest 
revision of virus taxonomy by the ICTV (Table 13). Several papers describing new genome sequences 
for Salmonella bacteriophages have recently been published and two proposals relevant to 
bacteriophages infecting Salmonella are currently awaiting ratification by the ICTV. The first proposes 
the creation of a new genus, the Viunalikevirus comprising Salmonella phages Vi01, SFP10, φSH19, 
and Escherichia, Shigella and Dickeya phages vB_EcoM_CBA120, PhaxI, φSboM-AG3 and 
vB_DsoM_LIMEstone1, respectively. The second concerns the inclusion of phage SPC35 (Kim and 
Ryu, 2011), reported to be capable of infecting both Salmonella Typhimurium and Escherichia coli, 
within the genus T5likevirus. In addition two further bacteriophages, vB_SenS-Ent2 and vB_SenS-
Ent3 have recently been sequenced, both of which exhibit high nucleotide sequence similarity to 
phage vB_SenS-Ent1. Considering that all but one of the Siphoviridae infecting Salmonella are 
unclassified, a review of these bacteriophages is timely.  
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Table 13. Caudovirales infecting the genus Salmonella with complete genome sequences held in 
GenBank.  
I. Myoviridae    
Genus Accession No. Name Reference 
Viunalikevirus
a 
JN126049.1 ɸSH19 (Hooton et al., 2011a) 
Viunalikevirus
a
 NC_016073.1 SFP10  (Park et al., 2011) 
Viunalikevirus
a
 NC_015296.1 Vi01 (Pickard et al., 2010) 
P2likevirus NC_010463.1 Fels-2    (McClelland et al., 2001) 
P2likevirus NC_005340.1 PsP3 (Bullas et al., 1991) 
Felixounalikevirus NC_005282.1 Felix01 (Whichard et al., 2010) 
Unclassified NC_016071.1 PVP-SE1 (Santos et al., 2011b)  
Unclassified HM770079.1 RE-2010 (Hanna et al., 2012) 
Unclassified JN641803.1 SPN3US  (Lee et al., 2011) 
II. Siphoviridae    
Genus INSD Accession Name Reference 
T5likevirus
c 
NC_015269.1 SPC35 (Kim and Ryu, 2011) 
Unclassified NC_016763.1 SE2 (Tiwari et al., 2012) 
Unclassified NC_009232.1 SETP3 (De Lappe et al., 2009) 
Unclassified JQ288021 SPN3UB (Lee et al., 2012) 
Unclassified NC_006940.2 SS3e (Kim et al., 2012b) 
Unclassified NC_018279.1 vB_SosS_Oslo (Nelson et al., 2012) 
Unclassified NC_010495.1 Vi II-E1 (Pickard et al., 2008) 
Unclassified NC_006949.1 ES18    (Casjens et al., 2005b) 
Unclassified JQ965645.1 SSU5 (Kim et al., 2012a) 
Unclassified  JX202565.1 wksl3    (Kang et al., 2013) 
Unclassified  HE775250.1 vB_SenS-Ent1    (Turner et al., 2012) 
Unclassified  PRIVATE vB_SenS-Ent2 Unpublished 
Unclassified  PRIVATE vB_SenS-Ent3 Unpublished 
Unclassified NC_010583.1 EPS7 (Hong et al., 2008) 
Unclassified Prophage NC_010391.1 Fels-1    (McClelland et al., 2001) 
Unclassified Prophage NC_010392.1 Gifsy-1    (McClelland et al., 2001) 
Unclassified Prophage NC_010393.1 Gifsy-2    (McClelland et al., 2001) 
III. Podoviridae    
Genus INSD Accession Name Reference 
epsilon15likevirus NC_004775.1 ԑ15 (Kropinski et al., 2007a) 
P22likevirus NC_002371.2 P22-pbi (Byl and Kropinski, 2000) 
P22likevirus NC_004348.1 ST64T (Mmolawa et al., 2003b) 
P22likevirus NC_011976.1 ԑ34 (Villafane et al., 2008) 
P22likevirus NC_013059.1 g341c - 
P22likevirus NC_011802.1 SE1 (Llagostera et al., 1986) 
P22likevirus NC_014900.1 ST160 (Price-Carter et al., 2011) 
P22likevirus NC_018275.1 vB_SemP_Emek (Nelson et al., 2012) 
P22likevirus NC_005841.1 ST104 (Tanaka et al., 2004) 
Sp6likevirus NC_004831.2 SP6 (Dobbins et al., 2004) 
T7likevirus NC_010807.1 ɸSG-JL2 (Kwon et al., 2008) 
Unclassified NC_015271.1 Vi06 (Pickard et al., 2010) 
Unclassified NC_016761.1 SPN1S (Shin et al., 2012b) 
Unclassified NC_017985.1 SPN9CC - 
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Unclassified  NC_015938.1 7-11 (Kropinski et al., 2011) 
Defective prophage NC_004313.1 ST64B (Mmolawa et al., 2003a) 
Key:
 a
Proposed genus not yet ratified by ICTV. 
b
Prophage. 
c
Proposed inclusion within genus not yet ratified by ICTV. 
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4.3 Comparative genomics of the Salmonella bacteriophages 
Dot plot analysis of the genomes of 42 Salmonella bacteriophages demonstrates that while 
significant genetic diversity exists between these phage, clusters may be delineated on the basis of 
nucleotide sequence similarity (Figure 23).  Of the 42 sequenced phages, twenty fall into seven major 
clusters, which reflect current ICTV genera. A further thirteen phages form three additional clusters 
which are not yet represented by an official genus epithet. Excluding the unclassified prophages 
Gifsy-1, Gifsy-2 and Fels-1, six phage genomes, PVP-SE1, SPN3US, 7-11, SSU5, ST64B and ViII-E1 
appear as ‘singletons’ which do not fall under any current taxonomic designation.  
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Figure 23. Nucleotide similarity dotplot of 42 Salmonella phage genomes. Clusters of nucleotide similarity corresponding to current ICTV genus 
designations are outlined in blue, with unclassified genera outlined in red. The reverse complement of the genomic sequences of phages SS3e and wksl3 
were used.  
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The pairwise comparison of genomes using CoreGenes provides a measure of the total similarity at 
the protein level between pairs of bacteriophage genomes (Mahadevan et al., 2009). The program 
returns pairs of proteins scoring above a predefined BLASTP score threshold allowing, where 
appropriate, the putative assignment of function for genes previously annotated as unknown or 
hypothetical. A total of 42 genomes were compared using the CoreGenes3.0 webserver 
(http://binf.gmu.edu:8080/CoreGenes3.0/), representing a total of 1764 comparisons. To facilitate 
this analysis a JavaScript was developed allowing the automated and iterative submission of pairs of 
genomes to the CoreGenes webserver (Turner et al., 2013). Following the methods of Lavigne et al., 
(2008, 2009), the output of each paired comparison was stored in a matrix, converted to relative 
(percentage) correlation values and reciprocally compared. A similarity threshold value of 40 % 
orthologous protein was employed to delineate high level relationships (Figure 24).  
79 
 
 
Figure 24. Hierarchical clustering of 40 bacteriophages by numbers of shared proteins determined by CoreGenes3.0. Relationships are shown for pairs of 
genomes which share at least 20 % homologous proteins. Current ICTV genus designations are outlined in blue, while proposed genera are outlined in red.  
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4.4 The Setp3likevirus 
Comparative genomic analysis of the Salmonella phages reveals that 5 phages form a coherent group 
within the Siphoviridae and supports the establishment of a new genus, the Setp3likevirus. The 
proposed genus is comprised of virulent bacteriophages infecting members of genera Salmonella, 
SETP3, SS3e (KS7), SE2, wksl3 and vB_SenS-Ent1, Escherichia coli, K1ind1, K1ind2 K1ind3, K1G and 
K1H. The SETP3-like viruses are distinguished by a shared morphology, similar genome size with co-
linear organisation of coding sequences and high numbers of protein homologues. These phages 
have not been shown to encode tRNAs and to date, none have been shown capable of lysogeny nor 
harbour homologues to known integrases, recombinases or excisionases. This lack of a temperate 
life-cycle presents members of this group as candidates for biocontrol applications.  
4.5 Members of the proposed genus 
4.5.1 SETP3 
Bacteriophage SETP3 represents the only sequenced member of the Salmonella Enteritidis phage 
typing scheme (SETP) (Ward et al., 1987) and is therefore presented as the type species of the genus 
proposed here. The SETP scheme consists of 16 bacteriophages denoted as SETP1 through to SETP16  
(De Lappe et al., 2009). Of these 6 are Podoviridae (SETP1, 8, 10, 14 & 15) and 6 Siphoviridae (SETP3, 
5, 7, 11, 12 & 13) each with an estimated genome size of 45 kb as determined by PFGE. The 
remaining 4 belong to the order Myoviridae. All SETP phages adsorb to serovars expressing group B1 
and D1 O-antigens. SETP3 is the only fully sequenced member of this group of typing phages, 
although partial sequences for other members are available. The genome of SETP3 is 42,575 bp in 
length (49.85 % G+C) with 53 annotated ORFs.  
4.5.2 vB_SenS-Ent1, vB_SenS-Ent2 and vB_SenS-Ent3 
Phage vB_SenS-Ent1 (Ent1), isolated from swine lagoon effluent in the UK, propagates efficiently on 
S. Enteritidis PT4 (Turner et al., 2012). This phage was demonstrated to exhibit a broad host range 
activity against Salmonella serovars but unlike SS3e was not observed to lyse other genera of the 
Enterobacteriaciae. Ent1 harbours a 42.39 kb genome (49.79 % G+C) encoding 58 ORFs. Two further 
bacteriophages, vB_SenS-Ent2 and vB_SenS-Ent3, have been isolated from the same environmental 
sample and sequenced. These phages were originally selected for genome sequencing due to their 
exhibiting differences in genome size, as determined by PFGE, and restriction fragment banding 
patterns. The extremely high nucleotide sequence similarity for the vB_SenS-Ent phages is 
unsurprising considering that all three phages were isolated from the same environmental sample 
and are therefore most likely to be strains of the same species. Interestingly and notwithstanding 
minor sequence variations in proteins from the structural, immunity and replication gene clusters, 
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the primary locale for variation between these isolates appears to be confined to the late gene 
cluster containing the lysin and holin coding sequences.  
4.5.3 SS3e 
SS3e was isolated from poultry farm sewage in South Korea and the sequenced genome is 40.79kb 
(50.1 % G+C) encoding 58 ORFs (Kim et al., 2012b). Notably, SS3e is reported to be capable of lysing 
other Enterobacteria, including E. coli, Shigella sonnei, Enterobacter cloacae and Serratia marcescens. 
As almost all the ORFs are annotated as hypothetical proteins a preliminary analysis of the SS3e 
genome was undertaken and confirmed that the same collinear arrangement of gene order and 
function in SETP3, wksl3, SE2 and vB_SenS-Ent1 is followed. However, it was noted that the SS3e 
genome appeared to lack an ORF corresponding to the major tail protein and was missing the 
immunity and regulation gene cluster. Sequence similarity searches located a truncated candidate for 
the major tail protein residing at bases 1 to 888 on the complementary strand and a further region 
(nucleotides 40165..40791), homologous to the first 208 amino acids of the vB_SenS-Ent1 putative 
recombination endonuclease subunit. The latter is located at the 3’ end of the immunity cluster in 
vB_SenS-Ent1. These data suggest that the genome sequence of SS3e may be incomplete. 
4.5.4 SE2 
SE2 was also isolated from sewage samples from poultry farms in South Korea and is propagated on 
S. Enteritidis PT4. The genomic sequence is 43,221 bp in length (49.6 % G+C), and with 64 predicated 
ORFs, encodes the largest number of genes amongst the SETP3-like phages (Tiwari et al., 2012). 
While, the arrangement of coding sequences follows the same collinear organisation as observed for 
other SETP3-like phages, SE2 shows some notable differences within both the immunity and 
replication gene clusters.  
4.5.5 wksl3 
The deposited sequence for phage wksl3 is 42.63 kb in length with a G+C content of 50.32 % and 
encodes 64 ORFs, maintaining the high coding potential (91.6 %) characteristic of the SETP3-like 
phages (Kang et al., 2013). Sequence analysis and comparison to other phages strongly suggest that 
this isolate is a SETP3-like Siphoviridae. Core genes analysis demonstrates that wksl3 shares 50, 54, 
56 and 53 proteins with SETP3, vB_SenS-Ent1, SE2 and SS3e, respectively.  
4.5.6 Escherichia coli phages K1G, K1H, K1ind1, K1ind2 and K1ind3 
The nomenclature of the K1 phages refers to the requirement for the presence of the K1 capsular 
antigen for productive infection. K1ind indicates that the phage does not require the presence of the 
K1 antigen for productive infection. In contrast K1-dep indicates that productive infection requires 
the presence of K1 antigen. This specificity is mediated by the presence of different tailspikes. Phages 
K1H and K1ind1 were isolated from sewage in Atlanta (Bull et al., 2002). Phage K1G was isolated 
from sewage in Austin while K1ind2 and K1ind3 were selected due to high growth rates in 
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competition experiments (Bull et al., 2010). Each of these phages uses E. coli O18:K1:H7 as the host 
(Table 14). 
Table 14. Genome properties and aliases of phages K1G, K1H, K1ind1, K1ind2 and K1ind3. 
Phage Genome size (bp) Mol %G+C No. ORFs Aliases 
K1G 43,587 51.07 52 K1-dep(4) 
K1H 41,632 51.17 50 ɸLH, K1-dep(1) 
K1ind1 42,292 51.27 51 ɸLW, K1ind(1) 
K1ind2 42,765 51.32 48 K1ind(2) 
K1ind3 43,461 51.15 49 K1ind(3) 
 
4.6 Virion morphology 
The SETP3-like virion structure highly resembles the morphology of Salmonella Paratyphi B typing 
phage Jersey (Ackermann et al., 1972). This group of Siphoviridae possess an icosahedral capsid, a 
relatively short flexible tail, for which horizontal striations are sometimes observed and six short 
tailspikes. vB_SenS-Ent1 is composed of an isometric capsid 64 nm in diameter and a flexible, non-
contractile tail 116 x 8.5 nm. Wksl3 is reported to possess a 63 nm capsid, 121 x 7.9 nm tail and 20nm 
baseplate, similar to SETP3 which has a capsid 62.5 nm in diameter and 120 x 7 nm tail (De Lappe et 
al., 2009). A similar morphology has also been described for phages 2 and 3 of the S. Heidelberg 
phage typing scheme (Demczuk et al., 2004) and phage MB78 appears to be morphologically similar 
to phage Jersey (Joshi et al., 1982). Binding to the LPS O-antigen of target host cells is facilitated by 
the presence of 6 tailspikes located at the tail terminus, suggesting that the baseplate or tail terminal 
protein has a six-folded symmetry. Two-dimensional SDS-PAGE analysis of vB_SenS-Ent1 suggests 
that the mature virion is composed of at least 12 proteins, though these results have not been 
confirmed using mass spectrometry. 
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Figure 25. Morphology of the Setp3likevirus. Images represent electron micrographs of 
bacteriophages Jersey (1 & 2), vB_SenS-Ent1 (3) and Heidelberg typing phage 2 (4). Scale bars 
denote distances of 100 nm. Micrographs of phages 2 and Jersey were supplied by H.W. Ackermann 
and are reproduced with permission.  
4.7 Host specificity 
Host specificity is conferred by six tailspikes attached to end of the tail. The tailspike protein is 
characterised by the presence of a highly conserved N-terminal head binding domain, common to all 
members of the SETP3-like phages, and a P22-like catalytic C-terminal domain. Alignments using 
ClustalX2 demonstrates that the tailspikes of all Setp3likevirus possess a conserved N-terminal 
domain of 50 residues which, with the exception of wksl3 (residues 2-53), is located at residues 11-60 
(Figure 26). Downstream of this region conservation is maintained, although to a lesser degree 
overall, with three conserved blocks of four residues (GGTL, VLWP and GGDG). 
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Figure 26. ClustalX2 alignments of the N-terminal region of the Setp3likevirus tailspike proteins. 
Conserved residues were shaded using Boxshade.  
Several podoviral phage tailspikes, including P22, Sf6 and HK620, have been shown to exhibit a 
modular architecture consisting of N-terminal head binding and C-terminal catalytic domains. As such 
it is not unreasonable to suggest that the N-terminal domain identified for the Setp3likevirus is 
involved in attachment of the tailspike to the virion baseplate. 
Each of the SETP3-like phages infecting the Salmonella encodes a P22-like tailspike. Phage P22 
adsorbs to Salmonella O-antigen 12 which is found in serogroups A, B and D1 (Wollin et al., 1981). 
The presence of repeating O-antigen subunits are required for adsorption as both rough and semi-
rough strains are resistant to infection by P22 (Naide et al., 1965). The mature P22 tailspike exists a 
homotrimer of the 72 kDa gp09 product and crystal structures have been determined for the N-
terminal head binding and C-terminal catalytic domains (Steinbacher et al., 1997, Steinbacher et al., 
1996, Steinbacher et al., 1994). The tailspike forms a right handed parallel beta-helix structure first 
observed for a pectin lyase in Erwinia chrysanthemi EC16 (Weigele et al., 2003). P22-like tailspikes 
exhibit endo-N-rhamnosidase activity (Wollin et al., 1981). Consistent with P22 tailspike specificity, 
SETP3 infects members of serogroups B & D1. Examining host range data for vB_SenS-Ent1 and wksl3 
suggests that productive infection by these phages is also limited to isolates of those serogroups. 
Unusually, SS3e is reported to lyse other genera of the Enterobacteriacae in addition to Salmonella, 
including E. coli, Shigella sonnei, Enterobacter cloacae and Serratia marcescens. No additional 
putative receptor binding proteins could be identified in SS3e, so perhaps this observation is due to 
these strains sharing a common LPS structure. Host range studies have not been reported for SE2 
which is propagated on S. Enteritidis PT4.  
Sequences coding for P22-like tail-spike proteins (PF09251) are widespread and highly conserved 
among Podoviridae and Siphoviridae but appear less frequently among the Myoviridae (Figure 27). To 
date, P22-like tailspikes have been reported for 3 Myoviridae; Det7 (Walter et al., 2008), SFP10 (Park 
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et al., 2011) and ɸSH19 (Hooton et al., 2011a). Despite reduced sequence identity (<50 %) the 
residues involved in the catalytic mechanism are preserved in all these TSPs. Of these, the Det7 TSP is 
most closely related to the SP6 P22-like fragment.  
 
Figure 27. Sequence identity amongst the P22-like tailspikes of the Salmonella bacteriophages. The 
diagram was created using Circoletto from a BLASTP comparison (-e 1e-20) of Salmonella phage P22 
gp22 against other P22-like tailspikes of Salmonella phages reported within the literature. Names of 
phages for which the tailspike sequence is annotated as partial are indicated in bold type. Ribbon 
colour indicates sequence identity ranging from low (green) to high (red).  
Phylogenetic analysis of the sequenced P22-like tailspikes in Myoviridae, Podoviridae and 
Siphoviridae demonstrates that the SETP3-like bacteriophages form a discrete clade (Figure 28). 
86 
 
 
Figure 28. Condensed Neighbour joining tree of the P22-like tailspikes. Values at the nodes are the 
percentage results of 1000 bootstrap replicates. Names of phages for which the tailspike sequence is 
annotated as partial are indicated in bold type.  
The Escherichia phages K1G, K1H, K1ind1, K1ind2 and K1ind3 possess tailspikes of similar size, which 
share the conserved N-terminal domain but possess different C-terminal domains indicative of 
separate host specificities. Tailspikes from K1ind phages exhibit high similarity to the HK620 tailspike 
(pdb:2x6w) and each returns matches to the pectate lysase 3 family (PF12708). The HK620 tailspike 
possess endo-N-acetylglucosaminidase activity that degrades the O-antigen of E. coli serotype O18A1 
(Barbirz et al., 2008). In contrast, K1 dependant phage tailspikes exhibit endo-N-acyl-neuraminidase 
(endosialidase) activity and are nearly identical to the tailspike of K1F (pdb:3ju4). Endosialidases bind 
to and degrade the K1 capsular polysaccharide, a homopolymer composed of α2,8-linked sialic acid 
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residues. Each of the K1 dependant tailspikes is predicted to contain a Peptidase_S74 domain 
(PF13884) suggesting that these tailspikes undergo a different maturation process to counterparts in 
the Salmonella and K1 independent SETP3-like bacteriophages. 
4.8 Genome structure 
The SETP3-like phages encapsulate a genome of approximately 43 kb and 50 % G+C, predicted to be 
circularly permuted and terminally redundant. The genomes show high nucleotide sequence identity 
(Figure 29) and encode at least 49 genes that follow a common clustered architecture, where the 
order and function of genes within each cluster is highly conserved. The genomes of all SETP3-like 
phages are organised into four clusters or modules of coding sequences which may be categorised 
according to the function of the component genes. These gene clusters represent two early and two 
late transcriptional regions.  
 
Figure 29. Clustering of the related SETP3-like Salmonella phage by nucleotide sequence similarity. 
The genome sequences of phages SS3e and wksl3 were reverse complemented to conform to 
convention of presenting structural genes on the forward strand.  
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4.8.1 Immunity and regulatory region 
The first early gene cluster encodes proteins predicted to be involved in regulation and immunity to 
superinfecting phage. Each of the Salmonella phages encodes 5 proteins in this cluster, while the 
Escherichia phages encode four and no single protein is shared between all SETP3-like phages. For 
vB_SenS-Ent1 and wksl3, the regulatory cluster encodes a regulatory protein containing ANT and 
pRHa PFAM family domains, predicted to be involved within the regulation of lytic growth, a T4-like 
inner-membrane superinfection immunity protein, a HNH endonuclease and a recombination 
endonuclease subunit. SETP3 differs from vB_SenS-Ent1 and wksl3 in that it lacks the HNH 
endonuclease. Whilst SE2 retains the T4-like immunity protein and putative recombination 
endonuclease subunit, like SETP3 it lacks the HNH endonuclease. In its place SE2 encodes a DNA 
methylase (gp51) containing the PFAM family N6_N4_Mtase domain (PF01555). An additional 
annotated ORF is located on the opposite strand situated between the DNA methylase and putative 
transcriptional regulator (gp49). This protein appears to be unique to SE2 as it lacks known homologs 
in the non-redundant sequence databases. Furthermore, the SE2 regulatory protein (gp49) contains 
the ANT but not the pRHA domain. Only the immunity protein is annotated in SS3e, though this 
appears to be due to an incomplete genome sequence rather than an absence of further proteins in 
this region. 
The E. coli SETP-like phages encode 4 proteins in the immunity and regulation gene cluster, two of 
which are shared with related phages infecting Salmonella. All except K1H possess the T4 
superinfection immunity protein and putative recombination endonuclease subunit. The two 
remaining genes encode a putative polynucleotide kinase and a protein with inferred ATPase activity. 
In place of the immunity protein, K1H encodes a protein unique amongst the SETP3-like phages. 
4.8.2 DNA maintenance and replication 
The second early cluster is devoted to the maintenance and replication of the virion genome. The 
number of coding sequences in this region ranges from 9 ORFS in K1ind2 to 17 in SS3e. Each member 
of the SETP3-like phages encodes a replicative family A DNA polymerase, DEAD-box helicase-primase 
and helicase. Analysis of the replication gene cluster for the SETP3-like phages with HHpred provides 
additional evidence for the presence of a Holliday junction resolvase (pdb:1hh1), helicase subunit 
(pdb:3h4r) and a helix-destabilising ssDNA-binding protein  similar to that encoded by gp2.5 of phage 
T7 (pdb:1je5). Each of the Escherichia coli SETP-like phages encodes two ORFs not found in the 
Salmonella phage, a putative cytosine-specific methylase which overlaps the complete sequence of a 
putative MTE-like protein. A number of other hypothetical proteins are found in this region in some, 
but not all, SETP3-like phages. 
Several of the Salmonella SETP3-like phages are predicted to possess inteins in either the helicase or 
DNA-polymerase or both. Inteins are defined as protein sequences embedded within a precursor 
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protein sequence which upon translation self-excise from their host protein and catalyse ligation of 
the flanking sequences with a peptide bond yielding two stable proteins, the mature protein (extein) 
and the intein (Perler et al., 1994). Each of the helicase and DNA-polymerase protein sequences from 
the SETP3-like phages were searched against the InBase intein database (Perler, 2002). A minimal 
intein is found in the helicase of wksl3 (gp36), SETP3 and vB_SenS-Ent1 but not SS3e or SE2. A second 
intein containing an endonuclease domain is found in the DNA polymerase of SETP3, vB_SenS-Ent1 
and SE2. Phage SE2 exhibits notable differences within the replication gene cluster and of particular 
interest is the identification of two proteins, gp05 (200 aa) and gp06 (794 aa) with predicted DNA 
polymerase activity, suggesting that the SE2 DNA polymerase is composed of two subunits. The large 
subunit, gp06, is predicted to possess an intein similar to that found in SETP3 and vB_SenS-Ent1, 
spanning residues 447 to 747. Relative to the DNA polymerase of SETP3 and vB_SenS-Ent1, gp06 
aligns across the first 783 residues with 95 % identities. A gap of 100 aa is then observed prior to the 
alignment of gp05 which spans residues 833 to 1032 at 99 % identity. Like SE2, the DNA polymerase 
of SS3e also appears to be split into two coding sequences (gp41 and gp43) although in this case the 
subunits are interrupted by an additional gene (gp42). Notably gp41, gp42 and gp43 show short 
matches to the SETP3 intein. A 91 residue sequence with 88 % identity to the SETP3 intein is located 
at the N-terminal end of gp42 spanning residues 2-92. Searches conducted using this gene product 
and HHpred suggests the presence of a C-terminal HNH endonuclease domain while BLASTP returns 
a hit to gp39 of Sodalis phage SO-1. Of the two subunits identified as the SS3e DNA polymerase, gp41 
shows a sequence spanning residues 447-459 at the C-terminal end which aligns to the beginning of 
the SETP polymerase intein. Conversely, gp43 returns a 21 aa match across N-terminal residues 1-21 
which aligns with the C-terminal end of the intein sequence (Figure 30). No inteins were identified in 
the genomes of K1H, K1G, K1ind1, K1ind2 or K1ind3. 
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Figure 30. Presence and location of inteins in the DNA polymerases of the Setp3likevirus. The blue 
rectangles delineate proteins with inteins represented in dark blue. Regions of homology are 
represented in light blue where values indicate percentage identities from results of alignments using 
BLASTP and InBase.  
4.8.3 Structural and morphogenesis regions 
The first of the late gene clusters contains the coding sequences facilitating genome packaging and 
the structural components necessary to form mature progeny virions. The structural and 
morphogenesis cluster is large, comprising up to 26 ORFs, and accounts for almost 50 % of the 
genome. The cluster follows a strongly conserved gene order, encoding the DNA packaging apparatus 
followed by the virion capsid, tail and terminal tail structures (Figure 31). The structural genes are 
split into two sections, divided after the major tail protein by the early regulation and immunity gene 
cluster. 
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Figure 31. Synteny of gene order and function in the structural and immunity regions of the SETP3-like phage genomes. Genes are coloured according to 
putative function using data obtained from Blastp, HHpred, Pfam and InterProScan. The ruler beneath each gene map denotes the location within the 
genome sequence.  
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The three genes facilitating genome packaging in all Salmonella SETP3-like phages are separated 
downstream of the portal from the capsid structural and assembly genes by a single gene encoded 
on the opposite strand. This gene product has been annotated as an amidase in SETP3 (gp32), SE2 
(gp33) and wksl3 (gp01) and as a hypothetical protein for vB_SenS-Ent1 (gp04) and SS3e (gp14). 
Analysis with HHpred against the conserved domain database returns a single significant hit to the 
PFAM KilA-N domain (PF04383) and iterative searches performed using PSI-BLAST confirm a 
relationship to other phage proteins encoding this domain suggesting a role in DNA-binding. These 
results do not however, return homologues with known amidase activity. This description has 
stemmed from SETP3 where gp32 is annotated as “similar to amidase of Arabidospsis thaliana”. 
BLASTP of this sequence does result in a low scoring hit to this protein, but the alignment is not 
significant. Notably, this protein is absent from the Escherichia phages and exhibits negative GC skew 
in relation to neighbouring coding sequences, suggesting a past horizontal acquisition event. Three 
proteins are unique to the Escherichia phages within the structural gene cluster, two hypothetical 
proteins in K1H (ORF13) and K1ind3 (ORF4) and a HNH endonuclease with low identity to MobE of 
phage T6 in K1G  (ORF12). 
The identity of the capsid morphogenesis, major capsid, major tail, tape measure and tailspike 
proteins are apparent in each phage using PSI-BLAST and BLASTP. HHpred provides additional 
evidence allowing the tentative identification of neck, tail terminator and baseplate proteins. Using 
vB_SenS-Ent1 as an example, gp14 returns a match to the head-tail connector protein gp6 from HK97 
(pdb:3jvo) and this association is reflected with HHpred searches against the Conserved Domain 
Database where several domains involved in head to tail joining are returned (cd08023, cd08054). 
The product of gp18 shows similarity to the minor tail protein U or tail terminator of phage λ (Pell et 
al., 2009b). Lastly, gp44, a large ORF directly upstream of the tailspike shows a region of similarity to 
the baseplate protein of phage Mu (pdb:1wru).  
4.8.4 Lysis cluster 
The second late gene cluster contains proteins facilitating lysis of the host cell, allowing egress of 
newly formed virion particles into the environment. The function of only two proteins in the late lysis 
region have been inferred, the lysin and holin. The phage lysin is a glycoside hydrolase, easily 
identified by the presence of a conserved lysozyme catalytic domain with searches of PFAM and the 
conserved domain database. Holins are categorised as Class I or Class II depending upon the 
presence of three or two transmembrane domains, respectively (Young and Bläsi, 1995, Young, 
2002). Phage SE2 is predicted to encode a holin-independent lytic system (Tiwari et al., 2012). 
However, an analysis of the lysis gene cluster identifies gp021, encoded immediately upstream of the 
lysin, as a candidate holin. Searches conducted using PSI-BLAST with gp21 returns matches to gene 
products annotated as holins in all SETP3, wksl3, vB_SenS-Ent1, Shigella phage EP23, Enterobacteria 
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phages HK578 and JL2, Sodalis phage SO-1. Furthermore, three trans-membrane domains are 
predicted by TMHMM v2.0 and HHpred shows some similarity to an ion transport membrane protein 
in Bacillus weihenstephanensis (pdb:3vou). Similarly, no candidate genes for either a lysin or a holin 
have been identified in SS3e. Analysis of the genome sequence identifies gp25 as a putative lysozyme 
(PF00959) and gp26 as a putative class II holin due to the predicted presence of two transmembrane 
domains by TMHMM. On the basis of predicted transmembrane domains using TMHMM v2.0, 
phages SE2 and wksl3 are presumed to encode Class I holins while Class II holins are encoded by 
SETP3, SS3e and vB_SenS-Ent1. Each of the Escherichia coli phages encode both a class I and class II 
holin.  
While the functions of the majority of genes are unknown, the lysis cluster appears to represent an 
area of significant diversity amongst these phages. Each of the SETP3-like phages encode between 8 
and 13 proteins from a total pool of 19. Of these, 10 and 3 are exclusive to those phages infecting 
Salmonella and Escherichia, respectively, but aside from the holin and lysin only one other 
hypothetical protein is shared amongst all SETP-like phage in this cluster. Searches with HHpred using 
a ClustalX2 alignment returns a match to Phage_NinH pfam domain (PF06322).  
4.8.5 Regulatory sequences 
DNA sequences (150bp) upstream of ORF start codons were extracted using Artemis and submitted 
for analysis using MEME (Bailey et al., 2006). A single motif is found within all Salmonella SETP3-like 
phages with sequence TAATA[N5]CTATTA, although further experimental investigation is required to 
ascertain whether this motif truly represents a promoter or operator binding sequence. This motif is 
not shared by members infecting Escherichia coli.  
4.9 CoreGenes 
At the protein level, analysis with CoreGenes demonstrates that the Salmonella SETP3-like phages 
share at minimum 44 homologous proteins relative to the proposed type species SETP3 (Table 15). 
This number is reduced to 34 for members infecting Escherichia coli. A detailed listing of the proteins 
shared between members of the proposed genus is provided in Appendix II. 
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Table 15. Number and percentage of shared proteins between the Setp3likevirus relative to the 
proposed type species, SETP3. 
Phage No of Shared Proteins % Similarity 
SETP3 53 100 
wksl3 50 94 
vB_SenS-Ent1 49 92 
SE2 46 87 
SS3e 44 83 
K1ind1 35 66 
K1ind2 34 64 
K1ind3 35 66 
K1H 34 64 
K1G 36 68 
 
The high degree of similarity between proteins encoded by the SETP3-like phages is clearly visible in 
graphical representations of whole genome BLASTP protein similarity searches (Figure 32), 
conducted using the CGView Comparison Tool (Grant et al., 2012).  
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Figure 32. CGView Comparison Tool map comparing vB_SenS-Ent1 to other bacteriophages 
belonging to the predicted Setp3likevirus genus. Starting from the outermost ring the feature rings 
depict forward strand coding sequences, reverse strand sequence features. The remaining rings show 
regions of sequence similarity detected by BLASTP comparisons conducted between translated 
coding sequence translations from the reference genome and comparison genomes.  
4.10 Phylogenetic analysis 
Phylogenetic analysis was performed by construction of neighbour-joining trees using MEGA5 using 
the large terminase subunits, major capsid proteins and DNA polymerases of the Setp3likevirus and 
those of species representing other phage genera (Figure 33, Figure 34 and Figure 35). The results for 
each protein support the proposal that SETP3likevirus represents an independent genus within the 
family Siphoviridae. 
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Figure 33. Neighbour-joining phylogenetic tree of major capsid proteins from the Setp3likevirus 
and representatives of other bacteriophage genera. The proposed Setp3likevirus are indicated by 
square brackets.  
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Figure 34. Neighbour-joining phylogenetic tree of the large terminase subunit from the 
Setp3likevirus and representatives of other bacteriophage genera. The proposed Setp3likevirus are 
indicated by square brackets.  
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Figure 35. Neighbour-joining phylogenetic tree of the DNA polymerases from the Setp3likevirus 
and representatives of other bacteriophage genera. The proposed Setp3likevirus are indicated by 
square brackets.  
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4.11 Discussion 
Analysis of the Salmonella bacteriophages held in international nucleotide sequence databases with 
CoreGenes showed broad agreement with current ICTV designations and reinforce current proposals 
for the Viunalikevirus (Adriaenssens et al., 2012) and designation of SPC35 as a member of the 
T5likevirus (Kim and Ryu, 2011). These data also strongly supports the creation of a novel genus; the 
Setp3likevirus, consisting of 5 Salmonella and 5 Escherichia phage. Members of the Setp3likevirus 
share a common morphology, consisting of an isometric head, relatively short flexible tail and six 
terminal tailspikes. Bacteriophages of Setp3likevirus morphology appear to be restricted to enteric 
bacteria, predominantly Salmonella (Ackermann, personal communication) and the literature 
contains a number of additional bacteriophages which may belong to the Setp3likevirus but for which 
no or only partial genome sequences are available. Additional defining features of the group are a 
high degree of nucleotide homology, near identical organisation of coding sequences within the 
genome and at least 64 % shared proteins relative to SETP3. Comparisons between the SETP3-like 
bacteriophages indicate several historical insertion events, a feature which may aid in delineating the 
evolutionary lineage of these bacteriophages. Inteins are present in the DNA polymerase and 
helicase encoding genes of some, but not all members. The presence of inteins is an interesting 
finding and one which would be worth confirming with in vitro studies. Of particular note is the 
apparent fragmentation of the DNA polymerase of SE2 and SS3e. Similarly, homing endonucleases 
are present in some members but absent in others. Host specificity is conferred by the tailspike 
protein. The tailspike N-terminal sequence is conserved amongst all proposed members of the 
Setp3likevirus while the C-terminal varies dependent upon the host. The C-terminal region for each 
of members infecting the Salmonella encodes a P22-like catalytic domain. For members infecting 
Escherichia, two C-terminal regions are present, representing a differentiation between the 
requirements for the K1 capsular antigen for infection by these phages. It may also be that different 
tailspike C-terminal domains remain to be found in as yet un-sequenced Salmonella bacteriophages.  
Data obtained using CoreGenes3.5 indicates an additional number of high level relationships 
amongst other Salmonella bacteriophages which are summarised but not discussed in detail. For the 
Myoviridae, the data suggests the assignment of RE-2010 to the genus P2likevirus. RE-2010, termed 
ELɸS in the associated publication, was isolated from S. Enteritidis PT8 strain LK5 by induction with 
mitomycin C (Hanna et al., 2012). The genome is 34.11 kb flanked by 84 bp direct repeats and 
encodes 46 ORFs, three of which are unique to this phage. Several features suggest that RE-2010 is a 
P2-like virus. Firstly, RE-2010 shares 41, 31 and 27 proteins with Fels-2, PSP3 and P2, respectively. 
Secondly, RE-2010 has been demonstrated capable of forming functional lysogens and the attB site 
overlaps the respective sites for SopEɸ and Fels-2 within the tmRNA gene ssrA (Hanna et al., 2012, 
Pelludat et al., 2003). Lastly, RE-2010 encodes a significant number of structural homologues with P2. 
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With no observed relationships to other phages, PVP-SE1, Felix O1 and SPN3US remain singletons 
amongst the Salmonella Myoviridae. 
For the Podoviridae, the genus P22likevirus is expanded to 10 members infecting Salmonella with the 
proposed additions of vB_SemP_Emek and SPN9CC. These designations are in agreement with 
recommendations outlined in the associated literature (Nelson et al., 2012). In addition, SPN1S and 
Vi06 are predicted to belong to genera epsilon15likevirus and T7likevirus, respectively. Two genomic 
orphans remain within the Salmonella Podoviridae, ST64B and 7-11, while SP6 remains the sole 
representative of the Sp6likevirus genus. 
Phages ES18, SPN3UB and vB_SosS_Oslo may also form a novel genus within the Siphoviridae, 
although the relationship is not as distinct for the Setp3likevirus. Relative to ES18, vB_SenS_Oslo 
shares 46 proteins (58 % similarity) and SPN3UB 30 (38 %). Each of these phages encodes a number 
of proteins also found in Enterobacteria phage ʎ and P22. Strikingly, ES18 and vB_SosS_Olso share a 
large number of proteins, at least 20 %, with members of the P22likevirus. For ES18 these include 
genes within the integration, recombination and lysis gene clusters. This relationship is less 
pronounced for SPN3UB which shares only 7 proteins for P22 but retains the ʎ-like tail structural 
genes. This number is reduced for SPN3UB which shares 7 proteins with P22. SPN3UB also shares a 
significant number of proteins, 39 % and 35 %, with the prophages Gifsy-1 and Gifsy-2, respectively. 
Lastly, EPS7 joins SPC35 as a T5likevirus with 122 proteins shared between the two genomes (71.8/84 
%) including the pre-early proteins encoded within a large terminal repetition at right end of genome 
analogous to T5. Phages SSU5, Vi II-E1 and the siphoviral prophages Gifsy-1, Gifsy-2 and Fels-1 
remain unclassified. 
The clustering performed here represents a simple method to identify and investigate groups of 
related genes among viral isolates, although the caveat of Lavigne et al., (2008) still stands. 
Specifically the validity of this analysis is dependent upon correct annotation of coding sequences 
and crucially, the correct determination of gene boundaries. However, with the exponential increase 
in bacteriophage sequences deposited in the international sequence databases, the value of storing 
such data in relational databases, an approach exemplified by ACLAME and Phamerator, cannot be 
under-estimated. With the implementation of appropriately coded script pipelines, relational 
databases have the ability to include additional sequence data and analyses and update this data 
dynamically. In contrast, the approach presented here represents but a single snapshot in time. 
SETP3, Vi01 and ViII-E1 represent the only members of the Salmonella phage typing sets that are 
publically available within the INSD, though we note that sequences for the Vi phages are available 
via FTP (ftp://ftp.sanger.ac.uk/pub/pathogens/Phage/). Whilst the phages used for typing of serovars 
Enteritidis and Typhimurium have been described (De Lappe et al., 2009, Schmieger, 1999), it would 
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be of value to sequence and annotate more members comprising the international phage typing sets 
for Salmonella given that at least a partial record of their genealogy exists.  
With an estimated 1031 bacteriophages present in the biosphere, and considering the striking 
example of the Mycobacteriophages, it is assured that the diversity of Salmonella phages is even 
greater than that represented by the current set of sequenced genomes. Similarly, extension of the 
analysis reported here to all sequenced bacteriophage genomes would likely reveal relationships for 
the genomic orphans amongst the Salmonella phages. Despite these limitations it is hoped that this 
review will provide a useful starting point for the future investigation of relationships between 
Salmonella bacteriophage genomes. Given the improvement of existing genome sequencing 
technologies and rapid development of new approaches, the number of sequenced phage genomes 
deposited in EMBL and GenBank will continue to increase exponentially.  
4.12 Addendum 
This study was limited to sequences deposited in Genbank and the INSD prior to the 17th of 
September 2012. Since then an additional three Salmonella phage sequences have been deposited, 
SKML-39 (JX181829.1), STML-198 (JX181825.1) and SSE-121 (JX181824.1). An extension of the core 
genes analysis to include these phages suggests that SKML-39 is a member of the Viunalikevirus, SSE-
121 is highly related to PVP-SE1 with 221 shared proteins (91 % similarity), while STML-198 shows 
little similarity to other characterised Salmonella phages.    
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Chapter 5 Measuring bacteriophage-mediated lysis of Salmonella 
using bioluminescence 
 
5.1 Introduction 
The use of microtitre plate assays is attractive for studies of bacteriophage-mediated lysis. Microtitre 
plate readers allow for automated and regular measurement of many samples under controlled 
conditions of temperature and agitation. Several microtitre assays for phage lysis have been 
described in the literature using either absorbance or colorimetric methods. Decreases in culture 
absorbance due to phage-mediated lysis have been monitored in a microtitre format for a number of 
host and phage combinations (Niu et al., 2009, Fridholm and Everitt, 2005, Cooper et al., 2011). 
However, measurements of absorbance are limited to relatively high host cell concentrations, 
generally between greater than 105 and 10
6 cfu ml-1, and can be influenced by the presence of cell 
debris. Colorimetric methods using the reduction of tetrazolium dyes have been applied for the study 
of bacteriophages upon Salmonella serovars (McLaughlin, 2007), Bacillus anthracis (Henry et al., 
2012) and Pseudomonas aeruginosa (Knezevic and Petrovic, 2008). Tetrazolium redox dyes scavenge 
electrons from microbial redox reactions and are intracellularly reduced to form insoluble coloured 
formazan precipiates, which may be measured at specific wavelength (Mosmann, 1983). Differential 
fluorescent stains, such as SYTO-9 and propidium iodide, may also be employed to provide endpoint 
measurements of live and dead bacterial cells (Jassim and Griffiths, 2007).  
 
Despite the widespread use of the lux operon in bacteria as a biosensor and reporter of gene 
expression, the application of bioluminescent bacterial reporters in conjunction with bacteriophages 
is limited. Several groups have reported the construction of recombinant reporter bacteriophage 
engineered to encode the luxAB genes. These bacteriophages are designed to deliver the luxAB 
genes to a specific host, which are subsequently translated alongside expression and replication of 
the phage genome. The addition of an aldehyde substrate results in the generation of a 
bioluminescent signal should the target host be present. This approach has been employed for the 
detection of Yersinia pestis (Schofield et al., 2009), Bacillus anthracis (Schofield and Westwater, 
2009) and Listeria (Loessner et al., 1996, Loessner et al., 1997). Detection of the enteropathogenic E. 
coli serotype O157:H7 has also been achieved using phage transformed to encode the luxI quorum 
sensing signal transducing molecule (Brigati et al., 2007). Infection results in expression of this gene 
which can then be detected by a phage-insensitive reporter harbouring the luxCDABE operon. Only a 
single manuscript could be found in the literature detailing the use of constitutively bioluminescent 
E. coli DH5α with T4 phage at different multiplicities of infection. Lysis was monitored using light 
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emission at 40 minute intervals for a period of 13 hours. The authors suggest that decreases in light 
emission at 5.3 and 3.3h after infection correlates to phage concentration (Kim et al., 2009). 
 
This chapter details the transformation of Salmonella serovars Typhimurium and Enteritidis to a 
bioluminescent phenotype by introduction of a plasmid encoding the luxCDABE operon of 
Photorhabdus luminescens under control of the constituitive lac promoter. Light emission was 
correlated with log-fold dilutions of batch cultures, growth in batch culture and optical density. 
Finally, the effects of applying the bacteriophages vB_SenS-Ent1 –Ent2 and –Ent3, at different 
multiplicities of infection and host cell concentrations were determined using bioluminescent S. 
Enteritidis within a microtitre plate broth assay. 
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5.2 Results 
5.2.1 Calibration curves 
Calibration curves were constructed to relate optical density at 540nm, bioluminescence and colony 
forming units. Values of optical density at 540nm, bioluminescence and viable counts were 
transformed to base 10 logarithms prior to analysis by linear regression (Figure 36). Absorbance 
increased linearly with viable counts between OD540nm values of 0.05 and 1.200. Values of R
2 were 
0.994 and 0.989 for S. Typhimurium and S. Enteritidis, respectively. Regression line equations from 
calibration curves were subsequently used for the estimation of bacterial numbers when preparing 
inocula. Light emission increased linearly with absorbance and colony forming units until a 
concentration 1 x 108 cfu ml-1, after which the intensity of light emission was at a level causing 
saturation of the photo-multiplier tube. 
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Figure 36. Calibration curves of optical density at 540 nm, light emission and colony forming units. 
One ml samples from a two-fold dilution series of batch cultures of S. Enteritidis and S. Typhimurium 
expressing the luxCDABE opron were measured. Data represent the mean of triplicate samples from 
three independent experiments. Error bars indicate standard deviation.  
Since optical density at 540 nm could not detect bacterial concentrations less than 106 cfu ml-1 a 
second set of calibration curves were constructed measuring bioluminescence against 10-fold 
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dilution series of batch cultures of S. Enteritidis and S. Typhimurium. Units of relative light emission 
(RLU) and viable counts were transformed to log10 values. The detection limit was defined as the log10 
value of the mean plus 3 standard deviations of the reagent blank control while the limit of 
quantification was defined as the 10 standard deviations above the reagent blank control (Mosmann, 
1983). Light emission exhibited strong correlation with viable counts from log phase batch cultures 
with R2 values of 0.98 and 0.99 for Salmonella serovars Enteritidis PT4 LITE and Typhimurium DT104 
LITE, respectively (Figure 37). Slope values from linear regression were 1.22 and 1.26 suggesting that 
the relationship between light emission and viable counts is not perfectly linear. Most photocathode 
based detection systems show two non-linear response regions: at or below the limit of detection of 
the sensor and the onset of non-linear gain at levels near to sensor saturation. Linearity might be 
improved by excluding values that fall within the non-linear regions of the response detector. Using 
bioluminescence, limits of detection were established at 2.18 x 102 and 5.76 x 102 cfu ml-1 and limits 
of quantification at 8.71 x 102 and 2.39 x 103 cfu ml-1 for serovars Enteritidis and Typhimurium, 
respectively. 
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Figure 37. Calibration curves of light emission versus bacterial cell concentrations performed on 
batch cultures of S. Enteritidis and S. Typhimurium expressing the luxCDABE operon. 
Measurements were performed using 100 µl samples from log-fold dilutions of exponential phase 
batch cultures. Data represent the mean of triplicate samples from three independent experiments. 
The red dotted line denotes the limit of detection, representing the mean reagent blank plus 3 
standard deviations.  
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Comparisons of growth curves of wildtype and bioluminescent Salmonella serovars Enteritidis and 
Typhimurium in batch culture were performed to establish whether expression of the lux operon 
resulted in any significant alteration to the growth characteristics of these serovars (Figure 38).   
 
Figure 38. Growth of wild-type and bioluminescent S. Enteritidis and S. Typhimurium in batch 
culture. Data presented are the mean and standard deviation of absorbance measurements of three 
independent cultures.  
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No significant difference (Student’s t-test, P = 0.05) was observed for growth of wild-type and 
bioluminescent transformants in batch culture. 
5.2.2 Bioluminescence emission spectra 
Bioluminescence emission, measured using a monochromator-based fluorometer with the excitation 
port blocked (Fluorosens, Gilden Photonics, UK), was observed as a single peak for bacteria 
transformed with the lux operon (Figure 39) ranging from approximately 410 nm to 640 nm. Area 
under curve analysis identified peak emissions at 482 nm for S. Enteritidis PT4 and 481 nm for S. 
Typhimurium DT104. The diluent control was constant with a mean emission value of 3952 ± 347.8 
(s.d.). The accuracy of wavelengths reported by the instrument was confirmed by water Raman. The 
peak wavelength values reported differs from that reported in the literature for bacterial luciferase, 
which is 490 nm (Meighen, 1991). This apparent lack of agreement could be due to scattering caused 
by the turbidity of the bacterial culture, or by the association of proteins with the bacterial luciferase.  
 
Figure 39. Emission spectra across 400 to 750 nm for bioluminescent reporters S. Enteritidis and S. 
Typhimurium. Emission values were obtained for 1nm steps using an integration time of 1 second.  
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5.2.3 Growth of bioluminescent bacteria 
Overnight cultures were diluted 1:1000 upon addition into fresh pre-warmed LB broth to yield a 
starting concentration of approximately 1 x 106 cfu ml-1. LB broth was supplemented with 
appropriate antibiotics to maintain plasmid selection. Growth curves were ascertained by 
measurement of optical density at 540nm, bioluminescence and viable counts over a 10 hour period. 
All bioluminescent bacterial reporters exhibited lag, exponential and stationary phases (Figure 40). 
All cultures exhibited a lag phase for the first hour after inoculation, where viable counts either 
remained stationary or increased very slightly. In contrast to viable counts, values of absorbance 
increased during this period, perhaps indicating an increase in cell biomass with little or no increase 
in population number. Exponential phase growth was characterised by rapid, exponential increase in 
viable counts and OD540nm. The onset of stationary phase was indicated by a deceleration of the rate 
of increase of absorbance and viable counts. Stationary phase was characterised as a constant or 
very slow increase in absorbance and viable counts. Growth rates and generation times for the 
exponential phases of bioluminescent reporters were calculated from log10 mean values of viable 
counts (n=3). Of the bioluminescent reporters, S. Enteritidis exhibited the fastest generation time at 
just over 20 minutes with an observed growth rate (k) of 2.89 generations per hour. Growth of the 
bioluminescent serovar Typhimurium was somewhat slower, with a generation time of 25 minutes. 
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Figure 40. Growth of bioluminescent Salmonella serovars Enteritidis (top) and Typhimurium (bottom) over time in batch cultures measured by colony 
counts, absorbance at 540nm and relative light emission. Data represent mean and standard deviation of triplicate measurements of three independent 
batch cultures.  
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5.2.4 Multiplicity of infection 
The effects of co-incubation of the vB_SenS-Ent bacteriophages and their host bacteria, S. Enteritidis 
PT4, at 37oC and varying multiplicities of infection were investigated using a broth microplate assay 
format. Initially these effects were to be measured using both absorbance and bioluminescence. 
Bioluminescence was chosen as light emission from S. Enteritidis PT4 showed high correlation with 
cell numbers and yielded typical growth curves not significantly different to that observed with the 
wild-type strain. Additionally, bioluminescence afforded a lower limit of detection than that 
obtainable by measurements of absorbance. Unfortunately, the use of dual luminescence and 
absorbance readings was precluded due to the effects of sample evaporation when plates were 
incubated at 37oC in the instrument for periods greater than 4 hours. Attempts to mitigate this effect 
using plate sealing films resulted in skewed absorbance data due to the formation of droplets by 
condensation on the inner surface of the sealing film. As such bioluminescence was measured using a 
single-mode microplate reader (Centro XS3, Berthold GmBH, Germany) where the heating system did 
not result in such extensive evaporation.  
Bacteriophages were added to bacterial cultures to yield multiplicities of infection (MOI) of 
approximately 10, 1 and 0.1. As at the time of addition of bacteriophages bacterial counts were 
estimated from calibration curves of optical density, actual multiplicities of infection were not exactly 
10, 1 and 0.1 (Table 16). 
Table 16. Multiplicity of Infection (MOI) ratios employed for microtitre broth lysis experiments. The 
MOI, as used here, is the ratio of plaque forming units to colony forming units, established from 
triplicate enumerations performed in tandem.  
Phage Isolate Bacterial concentration  
(cfu ml-1) 
Multiplicity of Infection (MOI) 
vB_SenS-Ent1 1.50 x 107 11.53 1.53 0.14 
2.22 x 105 7.78 0.78 0.08 
2.64 x 103 6.54 0.66 0.07 
vB_SenS-Ent2 1.50 x 107 12.67 1.27 0.13 
2.22 x 105 8.14 0.82 0.07 
2.64 x 103 6.86 0.69 0.07 
vB_SenS-Ent3 1.50 x 103 10.47 1.05 0.11 
2.22 x 105 7.06 0.71 0.06 
2.64 x 103 5.95 0.58 0.06 
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Profiles of bioluminescence for control cultures of S. Enteritidis showed typical bacterial growth 
curves consisting of exponential, deceleration and stationary phages. In contrast, growth in the 
presence of bacteriophages resulted in substantially different profiles of light emission. 
At low host cell concentrations in the region of 1 x 103 cfu ml-1, light emission for bacteria grown in 
the presence of bacteriophages increased initially at a similar rate to cells grown in the absence of 
phage (Figure 41). Light emission began to decline at different times dependent upon the multiplicity 
of infection employed, with the highest MOI resulting in earliest declines. At the highest MOI, 
bioluminescence began to plateau after 60 minutes and reduce at 120 minutes. For MOIs of 1 and 
0.1, declines in bioluminescence began after 160 and 180 minutes, respectively. Bioluminescence in 
all phage treated samples fell to levels at or below the reagent blank control after 200, 240 and 260 
minutes for MOIs of 10, 1 and 0.1, respectively, representing declines of 1.1 to 1.7 log10 RLU sec
-1. 
With the exception of vB_SenS-Ent3 at an MOI of 0.1, regrowth was observed for all samples after 
300 minutes by a slow rate of increase in light emission that continued for the remainder of the 
experimental duration.  
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Figure 41. Bioluminescence for S. Enteritidis at low density (103 cfu ml-1) incubated in the presence 
and absence of vB_SenS-Ent bacteriophages. Light emission was recorded every 5 minutes for a 
total duration of 12 hours using an integration time of 1 second. Data points represent the mean and 
standard deviation from measurements of triplicate wells.  
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At a concentration of 1 x 105 cfu ml-1 samples treated with bacteriophages showed a near immediate 
decline in light emission, beginning after 35 minutes (Figure 42). The rate of decline decreased after 
120 minutes, reaching a minimum between 260 and 300 minutes. At the minimum, light emission 
levels remained three times greater than the reagent control mean. All wells showed reductions in 
bioluminescence of 3.0 log10 RLU sec
-1, but after 300 minutes increasing levels of light emission were 
observed at all multiplicities of infection. The control culture showed evidence of a prolonged lag 
phase in the data presented here, lasting for around 2 hours, during which light emission exhibited a 
slow rate of increase.   
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Figure 42. Bioluminescence for S. Enteritidis at medium density (105 cfu ml-1) incubated in the 
presence and absence of vB_SenS-Ent bacteriophages. Light emission was recorded every 5 minutes 
for a total duration of 12 hours using an integration time of 1 second. Data points represent the 
mean and standard deviation from measurements of triplicate wells.  
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At concentrations of greater than 1 x 107 cfu ml-1, control cultures grown in the absence of 
bacteriophage showed initial increases in bioluminescence, followed by a period of near constant 
light emission for the entire duration of experiments (Figure 43). At this high concentration of host 
cells, the addition of the vB_SenS-Ent phages to yield different MOIs resulted in a near immediate 
reduction in bioluminescence. In all phage treated samples bioluminescence initially declined by 
approximately 2 log10 RLU sec
-1, reaching a minimum between 240 and 300 minutes. As for other 
host cell densities, after 300 minutes each of the cultures incubated with the vB_SenS-Ent phages 
showed a recovery of light emission which, after 480 minutes, achieved levels equivalent to that of 
untreated growth controls. 
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Figure 43. Bioluminescence for S. Enteritidis at high density (107 cfu ml-1) incubated in the presence 
and absence of vB_SenS-Ent bacteriophages. Light emission was recorded every 5 minutes for a 
total duration of 12 hours using an integration time of 1 second. Data points represent the mean and 
standard deviation from measurements of triplicate wells.  
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5.3 Discussion 
Salmonella serovars Typhimurium and Enteritidis were transformed to stably express a 
bioluminescent phenotype by expression of plasmid-borne luxCDABE operon of Photorhabdus 
luminescens. Light emission showed linear correlation with bacterial cell concentration and growth in 
batch culture. The limit of detection is three orders of magnitude lower for light emission than for 
optical density making this reporter system ideal for investigating the effects of bacteriophages at 
relatively low host cell concentrations. Profiles of light emission over time clearly demarked bacterial 
lysis in all phage-treated samples, represented by a plateau followed by diminishing bioluminescence 
intensity. As such, the use of bioluminescent reporter bacteria within a microplate format provides a 
high-throughput system (up to 96 samples) for the indirect monitoring of bacteriophage mediated 
lysis. Continuous and automated measurement is maintained throughout the assay time period. 
Moreover, this approach could be further employed to investigate combinatorial applications of 
bacteriophages with other antimicrobial agents. 
The differences in light emission observed for lysis at different host concentrations appears to be a 
function of the dilution of host cells and bacteriophages. In simplistic terms, mass action kinetic 
theory dictates that higher concentrations of phage and bacteria within a fixed volume are more 
likely to randomly encounter one another, whereas the presence of lower concentrations in the 
sample volume reduces the probability of these encounters. At low host concentrations, 
bacteriophages must replicate sufficiently and produce enough progeny virions to reach a critical 
mass where the number of productive infection events surpasses the rate of bacterial replication. 
This critical mass of infection is observed in these assays by a plateauing and decline in 
bioluminescence and has been described as the ‘innundation threshold’ (Payne and Jansen, 2001). 
The data presented here suggests that time to this event is function of the initial concentration of 
bacteriophages added to the sample, at least between multiplicities of 10 and 0.1, which would 
account for the increasing time delay before the reduction in light emission for the different MOIs.  
With the singular exception of vB_SenS-Ent3 incubated with 1 x 103 cfu ml-1 S. Enteritidis at a MOI of 
0.01, it is highly notable that for every combination of host and bacteriophage concentration, 
individual replicates showed evidence of regrowth, as evidenced by increasing light emission after an 
initial period of suppression and decline. At high host concentrations, every replicate well exhibited 
regrowth regardless of the multiplicity of infection, a phenomenon reproducible across independent 
experiments. While the mean value of triplicate wells are presented in graphs, individual wells 
treated with bacteriophages showed different profiles of light emission, resulting in large variation as 
shown by error bars depicting standard deviation. Two possible reasons may be presented to explain 
this variation. Firstly that the concentration of bacteriophages added to wells was not consistent 
caused either by pipetting errors or by inhomogeneous distribution within dilution tubes. Second, 
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that wells contained different numbers of cells of S. Enteritidis that were or became resistant to 
infection by the vB_SenS-Ent phages. Numerous studies have highlighted the growth of 
bacteriophage insensitive mutants (BIMs) after challenge with lytic bacteriophages. A purely lytic 
phage forces clonal selection and thus acts towards the generation of resistant mutants. In many 
cases these BIMs have resulted from mutations to the host surface receptor used by the 
bacteriophage for adsorption and show altered properties in comparison to the parental strain. For 
example, BIMs resistant to the Salmonella phage ɸAB2 and E. coli O:157 phages e11/2, e4/1c and 
pp01 were demonstrated to exhibit a rough phenotype and possess a smaller coccoid shape in 
comparison to the rod shape of parental strains (Berchieri Jr et al., 1991, O'Flynn et al., 2004). Whilst 
the characteristics of resistant populations observed after exposure to the vB_SenS-Ent phages were 
not established, a likely explanation is the conversion to a rough LPS phenotype. Several mechanisms 
conferring resistance to infection by bacteriophages have been characterised including alteration or 
blocking of cell surface receptors, DNA restriction-modification, the CRISPR-Cas (clustered regularly 
interspaced palindromic repeats) system, abortive infection systems and the acquisition of lysogens 
encoding superinfection immunity or antigen modification systems (Labrie et al., 2010). Parallels 
have been drawn between the occurrence of phage and antibiotic resistance, specifically with regard 
to the mutation selection hypothesis (Cairns and Payne, 2008). The mutation selection hypothesis 
which describes the development of antibiotic resistance in relation to dose concentrations (Zhao 
and Drlica, 2001). The development of resistance to antimicrobials requires two events; firstly 
mutations generating resistant mutants and secondly, the presence of a selective pressure allowing 
for enrichment of the mutant population. In clinical therapy, the susceptibility of a bacterial isolate is 
established to determine the minimum concentration of antibiotic required to prevent growth of the 
bacteria at the site of infection, termed the minimum inhibitory concentration or MIC. The mutation 
selection hypothesis defines a window of selection that ranges from the MIC to a greater 
concentration, termed the mutation prevention concentration (MPC). Delivery of antibiotic 
concentrations above the MIC results in suppression of susceptible bacteria but provides a selective 
pressure for single mutations conferring resistance. For antibiotic concentrations at or above the 
mutation prevention concentration, multiple mutations are required to confer resistance. Since 
spontaneous mutations occur at low frequency, between 10-6 and 10-8, the probability that an 
individual cell will incur multiple mutations conferring resistance is greatly decreased.   
The interpretation of data from lux+ reporters is not trivial, due in part to the complexity of the 
pathway to light emission and also to the metabolic rate of the bacteria. Differences in the intensity 
of light emission between different bioluminescent reporters may arise due to plasmid copy number, 
processes involved in transcription or translation, choice of promoter and the availability of 
substrates and precursors. While it is well established in the literature that good correlation with 
viable counts may be achieved within exponential growth of bacterial cultures but that this 
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correlation is lost upon entry into stationary phase (Koga et al., 2005, Duncan et al., 1994). The 
extent that expression of the lux genes has upon cell physiology, specifically the metabolic load 
exerted upon the cell, is unclear. In fact, it is a major assumption that introduction of the lux genes 
have little or no effect upon cell physiology. Chen et al., (2008) have reported alterations to Gram-
positive bacterial surface hydrophobicity in luminescent transformants of Lactobacillus casei ATCC 
11578, Streptococcus mitis ATCC 9456 and Micrococcus luetus ATCC 15176. Considering that the 
formation of aldehyde by luxCDE is dependent upon endogenous ATP, NADPH and the availability of 
an appropriate fatty acid substrate, expression of the lux operon is likely to represent a metabolic 
burden upon the recipient cell. Moreover, the utilisation of FMNH2, a part of the electron transport 
chain, and the requirement for ATP and NADPH for generation of the fatty acid aldehyde suggests a 
diversion of energy to different components of electron transport systems for the production of 
luminescence. Similarly, substrates utilised by the luxCDE reductase are involved within the critical 
processes of lipid biosynthesis. However, it is also this requirement for FMNH2, NADPH and ATP that 
demonstrates that the production of light from recombinant bacteria containing the lux genes 
depends upon an intact and functional intracellular redox potential and herein lays the power of this 
system as an analytical tool; any physico-chemical or environmental factor that impairs the redox 
potential or results in alterations to cellular viability leads to a change in light emission. Stewart 
defines this as the "capacity of cells to supply high energy biochemical intermediates during or after 
some form of cellular insult" (Stewart, 1990). The application of intact luminescent reporters 
presents a number of analytical advantages. Firstly, cells present a high and steady signal allowing 
continuous and non-destructive measurements of a single population. Secondly, light emission may 
be constitutive or induced, providing a means to measure viability or transcriptional activation of 
genes and operons. In this capacity the lux genes have provided an invaluable tool to microbiologists 
since the early 1980s, providing flexible, sensitive and non-destructive methods by which to 
investigate bacterial physiology and transcriptional responses to stimuli. A recent development has 
extended the application of this system even further, with the announcement that the lux operon is 
expressed and fully functional within mammalian cells after codon optimisation (Close et al., 2010a). 
This chapter demonstrates that the lux operon may be employed as a rapid, sensitive and non-
destructive measure of the effects of lytic bacteriophage upon bacterial populations in batch culture. 
Moreover, this approach enabled measurement of regrowth of resistant bacterial populations over 
time. These data suggest that S. Enteritidis PT4 is able to acquire resistance to infection by the 
vB_SenS-Ent phages, an important consideration with regard to the design of biocontrol strategies 
using these phages. One shortcoming of the data reported here were that titres of bacteria and 
phages over time were not established. Therefore, the precise levels of bacterial regrowth in terms 
of colony forming units are not known. Similarly, the concentration of bacteriophage remaining after 
the initial period of lysis observed, and any decay effects caused by phage loss also remain 
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undetermined. Future experiments should seek to include such enumerations to provide a secondary 
measure of growth and loss of bacteria and bacteriophages, however the time-consuming nature of 
such measurements would reduce throughput.  
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Chapter 6 Control of Salmonella in raw and ready-to-eat foods by the 
vB_SenS-Ent bacteriophages 
6.1 Introduction 
The control of Salmonella within the food chain is essential for both minimising the risk of illness to 
consumers and alleviating the detrimental economic effects associated with lost labour productivity, 
cost of clinical treatment and impact of product recalls and media health scares (Santos et al., 
2011a). Salmonella enterica serovar Enteritidis remains the most common serovar associated with 
human gastroenteritis in the UK comprising 30 % of cases, followed by serovars Typhimurium, 
Newport and Infantis at 25.9, 2.0 and 1.9 %, respectively, from a total of 8,937 isolations in 2011 
(Lawes and Kidd, 2011). Over the same period 1,978 incidents were reported within animal 
husbandry in the UK. 
It is now widely accepted that the use of antibiotics in agriculture and animal husbandry has led to an 
increase in the emergence and dissemination antibiotic resistance amongst food-borne pathogens 
(Marshall and Levy, 2011). Antibiotics are used with livestock for three main purposes: to provide a 
prophylactic treatment in order to prevent disease in flocks and herds; for the veterinary treatment 
of diseased animals; as growth promoters to improve the digestion and utilisation of feed. Due to the 
association with resistance, the use of antibiotics agents for agricultural purposes has come under 
increased scrutiny and is subject to a number of restrictions in the EU. However, the same 
restrictions are not practised internationally. Animal usage still accounts for the majority of 
antibiotics produced in the USA, estimated to represent 80 % of all produced antibiotics (FDA, 2009).  
Antibiotic resistance in the Salmonellae is now widespread in developed and undeveloped countries 
(Rowe et al., 1997, Rowe et al., 1990) and of key concern is the resistance to key antimicrobials such 
as the flouroquinones (Herikstad et al., 1997), extended spectrum β-lactamases (Vahaboglu et al., 
2001) and cephalosporins (Gray et al., 2004). Of particular note has been the emergence and spread 
of multiple drug resistant strains of S. Typhimurium DT104, which now has a worldwide distribution 
(Helms et al., 2005). The S. Typhimurium DT104 pandemic arose in the 1980s with isolates in the UK 
characterised as resistance type ACSSuT with resistance to ampicillin (A), chloramphenicol (C), 
streptomycin (S), sulfonamide (Su) and tetracycline (T). This resistance type was found to be 
chromosomally encoded within Salmonella genomic island 1 (Mulvey et al., 2006). The same genomic 
island has also been identified in other serovars including Agona, Paratyphi B, Albany, Newport and 
Infantis, suggesting that this genomic island has undergone horizontal gene transfer (Levings et al., 
2005). Notably this genomic island confers resistance to four of the five main classes of 
antimicrobials frequently employed within veterinary medicine: tetracyclines, β-lactams, 
aminoglycosides and sulphonamides. 
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The control of pathogens in the food chain is addressed by hazard analysis and the implementation 
of critical control points in order to minimise the risk of contamination at all stages of production. 
This HACCP strategy has become known as the “farm to fork” approach. In the EU approaches to the 
statutory control of zoonoses and zoonotic agents have been harmonised under the European 
Council Directive 2003/99/EC. The directive outlines bacteriological surveillance of animals, animal 
feeds, foods, human infections in addition to antimicrobial resistance in Salmonella and other 
foodborne pathogens such as Campylobacter spp. The poultry industry represents the only food 
animal production sector in the UK that has a structured bacteriological surveillance programme for 
Salmonella due to imposed statutory testing requirements (Lawes and Kidd, 2011).  
The Salmonellae appear to be unsuitable targets for clinical phage therapy in humans for two 
reasons. Firstly, infections by non-typhoidal Salmonella serovars are generally self-limiting and are 
managed by supportive therapy. Secondly, a trait of typhoidal and some other serovars is the 
intracellular invasion of cells of the host immune system. This tactic of immune evasion renders 
intracellular Salmonella resistant to infection by bacteriophages. However, bacteriophages infecting 
Salmonella can be employed at different stages of the production and processing of food products. 
This concept of using bacteriophages for the specific targeting of bacterial pathogens in foods is not 
new and a number of reviews have been published on the subject (Rees and Dodd, 2006b, Hagens 
and Loessner, 2010, Mahony et al., 2010, Stone, 2002, Sulakvelidze and Barrow, 2004). 
Bacteriophages represent an attractive alternative to conventional methods for the control of 
foodborne pathogens. Phages are highly specific for their target host, and unlike antibiotics, host 
specificity does not usually cross species boundaries. Infection with lytic phages results in lysis and 
death of host cells with a concurrent increase in the number of bacteriophages, representing a 
process of site specific replication. Finally, phages are highly abundant in the environment and are 
easily isolated using standard methods. Two broad areas are identified for intervention strategies 
using bacteriophages; pre-harvest and post-harvest (Hagens and Loessner, 2010). In the first 
instance, phages may be used to reduce intestinal colonization of live, agriculturally important 
animals that act as reservoirs for foodborne pathogens. In the second instance, phages may be 
applied directly onto carcasses during slaughter, onto raw and ready-to-eat foods, or upon 
environmental surfaces used in food processing.  
It is clear that virulent or obligatory lytic phages are a prerequisite for biocontrol applications. Phages 
with this lifestyle lack the array of genetic factors required for integration of the viral genome into 
the bacterial chromosome and infection. Disregarding the presence of host- and prophage-encoded 
immunity systems, infection with lytic phages always leads to lysis and death of the host cell. In 
contrast, many temperate phages have been shown to carry toxins, effector proteins or regulatory 
factors that play a role in the development of host pathogenicity (Allison, 2007, Canchaya et al., 
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2003a, Brussow et al., 2004). Similarly, phages which exhibit generalised transduction, that is where 
host DNA is packaged into a functionally viable virion, should be avoided due to the potential for 
horizontal transfer of new genes into target hosts. Hagens and Loessner (2010) outline several 
properties that are desirable or prerequisite for phages to be employed as biocontrol agents. 
Absolute requirements, in addition to those described above, include genome sequencing and 
stability studies encompassing storage, thermal stability and pH tolerance. Desirable properties 
include the ability to propagate the phage on a non-pathogenic host and evidence that preparations 
exhibit no toxicity in animal feeding studies. Of late, several bacteriophage-based products have 
gained accreditation from the US Food and Drug Administration for use as food additives. The Listeria 
bacteriophage preparation ListShield (www.intralytix.com), consisting of a cocktail of 6 
bacteriophages, was approved in 2006 for use with ready to eat foods (Bren, 2007, Hagens and 
Loessner, 2010). Similar products for Listeria, Salmonella, E. coli O157 and plant pathovars of 
Pseudomonas putida are available (www.micreos.com, www.omnilytics.com). 
Several studies have been published that investigate the efficacy of bacteriophage preparations upon 
the control and removal of Salmonella from animal hosts and food produce destined for human 
consumption. The use of bacteriophages to reduce colonisation of livestock by Salmonella has been 
investigated in pigs and poultry, applied by oral ingestion of water and feed or by aerosol dispersal. 
In order to be effective, orally administered bacteriophages must be able to survive transit through 
the acidic environment of the gastric fluid in order to reach the digestive tract. This requires either 
the selection of bacteriophages with known acid-tolerance or encapsulation of the virions in a 
protective material. For example, phages ST104a and Felix O1 exhibited good tolerance to porcine 
gastric juice adjusted to pH 2.5 over 120 minutes while, conversely, phage ST104b could not be 
detected by plaque assay after only 30 minutes exposure to this environment (O'Flynn et al., 2006). 
Clearly different phages show different tolerances to pH and temperature. Encapsulation of Felix O1 
within chitosan-alginate microspheres has been demonstrated to aid survival of this phage from 
exposure to gastric fluid, presenting a method for the improved delivery of bacteriophages to the 
digestive tract of livestock animals (Ma et al., 2008, Saez et al., 2011). A microencapsulated phage 
cocktail provided with feed or by gavage was shown to reduce concentrations of S. Typhimurium in 
swine ileal and caecal contents compared to a control group, although this effect was only 
determined at 6 hours after the bacterial challenge (Saez et al., 2011).  
Much focus has been placed on the control of Salmonella in the breeding and raising of poultry 
destined for meat production. Treatment with bacteriophages by aerosol or oral application has 
been shown to reduce levels of colonisation of broiler chickens by S. Enteritidis (Borie et al., 2008, 
Borie et al., 2009, Fiorentin et al., 2005). Oral application of the phage ɸSG-JL2 showed significant 
protective effects when applied orally prior to inoculation of broiler chickens with S. Gallinarum, the 
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causative agent of fowl typhoid (Kwon et al., 2008). Another Gallinarum specific bacteriophage 
curtailed the rate of horizontal transmission from infected birds to a contact group treated with the 
phage before and during the contact period (Lim et al., 2011). In a similar study, the phage ɸCJ07 
resulted in a reduction in bacterial burden of S. Enteritidis for infected birds and frequency of 
horizontal transfer to contact birds (Lim et al., 2012). Treatment of chicks inoculated with S. 
Enteritidis with the phages CB4ɸ and WT45ɸ resulted in a reduction in viable bacteria recovered 
from caecal tonsils at 24h. However, this reduction was transient and after 48 hours no significant 
difference was observed relative to untreated controls (Andreatti Filho et al., 2007).    
A variety of different food types have been used in phage biocontrol studies including raw and 
cooked meats, eggs, fresh fruit, cheese, and sprouting seeds (Goode et al., 2003, Leverentz et al., 
2001, Modi et al., 2001, Pao et al., 2004, Whichard et al., 2003, Guenther et al., 2012). The 
contamination of ready to eat foods by Salmonella represents a major hazard as these food types are 
not subject to the sterilising effects of cooking prior to consumption. The broad host range myovirus 
Felix O1 was shown to suppress growth of S. Typhimurium DT104 in broth and frankfurter sausages, 
resulting in a 2 log10 suppression of growth compared to bacteria incubated in the absence of this 
bacteriophage (Whichard et al., 2003). Similarly, Felix O1-E2, a variant possessing a 2 kb deletion, 
reduced viable numbers of Salmonella in turkey deli meat, chocolate milk, hot dogs, egg yolk and 
seafood at 8oC and retarded growth at 15oC (Guenther et al., 2012). However, the same study 
highlighted the recovery of Salmonella from foods which had developed resistance to infection by 
this phage after 6 days incubation at 15oC. Phages P22 and 29C were shown to elicit up to a 2 log10 
reduction in recoverable numbers of S. Enteritidis over 48 hours when phages were added at MOIs of 
>100 to chicken skin (Goode et al., 2003). However, P22 is both lysogenic and a generalised 
transducer, precluding the use of this phage within a commercial context. Hooten et al., (2011b) 
investigated the application of a cocktail comprising three bacteriophages, ɸSH17, ɸSH18 and ɸSH19 
upon pig skin artificially contaminated with S. Typhimurium. Addition of this phage cocktail, 
containing a combined concentration of 108 pfu ml-1, resulted in significant reductions of Salmonella 
when the MOI was in excess of 10. Reductions have also been reported for bacteriophage treated 
broiler caracasses and carcass rinse water (Higgins et al., 2005) 
In this chapter, the positive action of bacteriophages in reducing numbers of contaminating 
Salmonella in foods appears to occur when bacteriophages are added to excess, that is, at a high 
multiplicity of infection. Bigwood et al., (2009) investigated the inactivation of S. Typhimurium by 
phage P7 as a function of MOI and host concentration and suggest that lysis from without may 
represent the predominant decontamination effect. Payne and Jansen (2001) outline the activity of 
bacteriophages in biocontrol applications as a density dependant kinetic process and define the 
action of bacteriophages as passive or active. Passive therapy is defined as a net reduction in 
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bacterial numbers caused by high concentrations of bacteriophages resulting in lysis from without 
and no increase in phage population. Active therapy is defined as where the bacteriophages actively 
replicate and the subsequent infection of bacteria by progeny virions outweighs the rate of phage 
decay.  
In this chapter, the application of three closely related individual bacteriophages vB_SenS-Ent1, -Ent2 
and -Ent3 and their effect at high MOI upon viable numbers of Salmonella artificially spiked food 
matrices are reported. Additionally, in order to ascertain the suitability of these phages for biocontrol 
applications, the stability over long term storage and upon exposure to different temperatures was 
established. 
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6.2 Results 
6.2.1 Long term storage of bacteriophages 
Each of the vB_SenS-Ent phages exhibited a slow decline in infectious titre over a 12 month period 
(Figure 44). After purification by CsCl density gradient centrifugation, the starting titres for each 
phage were approximately 5 x 1012 pfu ml-1. Ent1 showed the greatest decrease in titre, representing 
a 1.91 log reduction, though recorded titres showed variability after 8 months. One possibility 
accounting for the observed variation might be the aggregation of virion particles which were not 
fully dispersed by mixing prior to titration. Decreases in titre were less pronounced for Ent2 and Ent3, 
which exhibited reductions of 1.21 and 0.37 log10 pfu ml
-1, respectively. 
 
Figure 44. Stability of bacteriophage titres stored at 4oC in SM buffer over a 12 month period 
measured by overlay plaque assay. Data points represent weighted mean of triplicate counts for 
two consecutive dilutions.  
6.2.2 Thermostability of bacteriophages 
Each of the vB_SenS-Ent phages showed identical thermal tolerance profiles. Titres were unaffected 
by incubation at temperatures of 50 and 60oC. At 70oC a 5 log10 reduction in infective titre was 
observed after 120 minutes.   
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Figure 45. Thermal stability profile for vB_SenS-Ent1. Data presented are the mean and standard 
deviation of replicates (n=3) from three independent experiments.  
6.2.3 Stability of lux plasmid retention by Salmonella at 4oC  
Resuspended pellets of S. Enteritidis PT4 LITE stored at 4oC in PBS buffer were enumerated at daily 
intervals by plating diluted samples onto LB agar with and without the plasmid selective agent, 
kanamycin (10 µg ml-1). No significant decline in cell numbers was observed over the 7 day period. 
The examination of both plate types by bioluminescence imaging did not identify any non-
bioluminescent colonies nor was the relative emission diminished for colonies on non-selective agar. 
6.2.4 Inoculation and recovery of bacteriophages and bacteria 
Salmonella present on spiked matrices were recovered using two selective media from log-fold 
dilutions of sample homogenates prepared using a stomacher. LB agar, supplemented with 10 µg ml-1 
kanamycin, was employed to suppress growth of the endogenous microflora native to the food 
matrix and to actively select for S. Enteritidis harbouring the lux plasmid. The second media, Xylose-
Lysine-Desoxylcholate agar (XLD) is commonly used within the international standard horizontal 
culture method for the qualitative detection of Salmonella in food matrices, ISO 6579 (2002). 
Colonies of Salmonella are differentiated on the basis of their ability to ferment xylose, 
decarboxylate lysine and produce hydrogen sulphide, appearing on this medium as red colonies with 
back centres (Figure 46). 
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Figure 46. Typical colonies of Salmonella Enteritidis PT4 grown on XLD agar. Growth of Salmonella 
on this agar results in the decarboxylation of lysine and increased alkalinity, shown as a change in 
medium colour surrounding colonies by the indicator phenol red. The black colouration of colonies 
arises from the production of hydrogen sulphide.  
To further aid in the identification of Salmonella colonies on solid media, each agar plate was 
examined using an EMCCD camera to detect bioluminescent colonies (Figure 47).  
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Figure 47. Example of identification of bioluminescent S. Enteritidis in mixed cultures recovered 
from fresh mixed salad on plate count agar supplemented with 10 ug ml-1 kanamycin. A) light 
photography and B) bioluminescence imaging. C) Merged light and bioluminescence images 
demonstrating the location of colonies of bioluminescent S. Enteritidis PT4.  
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The detection limit of the recovery method used here is dependant firstly upon the requirement to 
dilute and homogenise the solid sample matrix and, secondly, upon the volume used for plating. Two 
plating volumes, 1.0 and 0.5 ml were used, representing detection limits of 10 and 20 cfu g-1, 
respectively, after a 10-fold dilution of the sample matrix. Bacteriophages were enumerated from 
log-fold dilutions of the sample matrix homogenate using the standard overlay plaque titration 
method, but employed media containing kanamycin as a selective agent. Counts of bacteria and 
bacteriophages are presented as the weighted mean calculated from triplicate plates from two 
consecutive dilutions. 
6.2.5 Food Matrix 1 – Bean sprouts 
Control series of S. Enteritidis inoculated onto fresh bean sprouts in the absence of bacteriophages 
exhibited a consistent decline in numbers of colony forming units recovered over the experimental 
period (Figure 48). In contrast, relatively stable titres were recovered from control series of the 
vB_SenS-Ent phages after addition and storage in this food matrix. Bacterial concentrations similar to 
the predicted spike density of 1.15 x 103 cfu ml-1 were recovered from food samples prior to the 
addition of bacteriophages. After the addition of bacteriophages and storage for 24 hours, no 
Salmonella colonies were recovered above the assay detection limit, representing nearly a 2 log10 
reduction in phage treated samples in comparison to the untreated control. No further counts of 
Salmonella were obtained from samples performed on consecutive days. 
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Figure 48. Recovery of Salmonella Enteritidis and bacteriophages from artificially contaminated 
raw beansprouts. Bacterial concentrations recovered using A) LB agar supplemented with kanamycin 
and B) XLD. C) Concentration of bacteriophage recovered as pfu g-1. The y-axis is limited to 20 cfu g-1 
to reflect the limit of detection imposed by sampling.  
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6.2.6 Food Matrix 2 – Mixed salad 
During this period, control stability series of the vB_SenS-Ent phages added to mixed salad in the 
absence of S. Enteritidis appeared to show declining titres, representing losses of between 1 and 1.5 
log10 pfu ml
-1 over 7 days (Figure 49). No Salmonella were recovered from samples after treatment 
with bacteriophages on days 1 and 2. However, on day 3, colonies of S. Enteritidis were again 
recovered from all phage-treated samples. For vB_SenS-Ent1, S. Enteritidis was recovered on days 3 
through 6 but not on day 7. For samples treated with vB_SenS-Ent2, S. Enteritidis was recovered on 
days 3 through 7, while for vB_SenS-Ent3, colonies recovered on days 3, 4, 6 and 7. These data might 
suggest that food samples were improperly mixed upon addition of bacteriophages meaning that 
some bacteria would not come into contact with bacteriophages or alternatively, may indicate a 
problem with the sampling method employed. 
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Figure 49. Recovery of Salmonella Enteritidis and bacteriophages from artificially contaminated 
mixed salad leaves. Bacterial concentrations recovered using A) LB agar supplemented with 
kanamycin and B) XLD. C) Concentration of bacteriophage recovered as pfu g-1. The y-axis is limited to 
20 cfu g-1 to reflect the limit of detection imposed by sampling.    
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6.2.7 Food Matrix 3 – Cooked skinless chicken breast 
Numbers of S. Enteritidis and bacteriophages recovered from skinless cooked chicken breast 
remained relatively stable for the experimental duration (Figure 50). Similar to trials performed using 
other food types, plating onto XLD exhibited a lower overall recovery of Salmonella than for LB agar 
supplemented with kanamycin. No colonies of S. Enteritidis were recovered above the assay 
detection limit within 24 hours after the addition of bacteriophages, representing a decline of 2 log10 
cfu ml-1.   
 
137 
 
 
Figure 50. Recovery of Salmonella Enteritidis and bacteriophages from artificially contaminated 
cooked chicken breast. Bacterial concentrations recovered using A) LB agar supplemented with 
kanamycin and B) XLD. C) Concentration of bacteriophage recovered as pfu g-1. The y-axis is limited to 
20 cfu g-1 to reflect the limit of detection imposed by sampling.    
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6.2.8 Food Matrix 4 – Raw skinless chicken breast 
Controls series demonstrated that numbers of S. Enteritidis stored in the absence of bacteriophages 
remained stable and that each of the vB_SenS-Ent bacteriophages retained the ability to infect host 
cells over 7 days in raw skinless chicken breasts (Figure 51). The reduction in S. Enteritidis appeared 
to occur in an identical manner to that observed for beansprouts and cooked chicken with no 
colonies recovered after 24 hours incubation at 4oC, representing a 1.75 log10 reduction from the 
calculated spike of 1.13 x 103 cfu g-1. 
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Figure 51. Recovery of Salmonella Enteritidis and bacteriophages from artificially contaminated 
raw chicken breast. Bacterial concentrations recovered using A) LB agar supplemented with 
kanamycin and B) XLD. C) Concentration of bacteriophage recovered as pfu g-1. The y-axis is limited to 
20 cfu g-1 to reflect the limit of detection imposed by sampling.    
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6.3 Discussion 
The bacteriophages vB_SenS-Ent1, vB_SenS-Ent2 and vB_SenS-Ent3 show promise as putative 
biocontrol agents for Salmonella contaminating raw and ready to eat food matrices. With the 
exception of mixed salad leaves, the application of each bacteriophage elicited up to a 2 log10 
reduction in viable bacteria within 24 hours at an incubation temperature of 4oC. Due to the high 
nucleotide and protein similarity of the vB_SenS-Ent phages it was decided to investigate each 
bacteriophage individually rather than as a mixed cocktail. However, considering that the host range 
of these phages is limited to Salmonella serogroups A, B, and D1 the inclusion of additional phages in 
any treatment formulation would be required to extend coverage to other serogroups.  
In food matrices other than mixed salad leaves, the reduction in Salmonella by the vB_SenS-Ent 
phages mirror the observations of Guenther et al., (2012) who monitored reductions in foods of S. 
Typhimurium after challenge with the lytic Myovirus Felix O1-E2. Similarly this study demonstrated 
no significant losses in phage infectivity for storage with different food matrices. At an incubation 
temperature of 8oC, Felix O1-E2 reduced counts of S. Typhimurium by 3 log10 cfu g
-1 to below the 
detection limit within 24 hours. However, at 15oC bacterial counts reduced by 2 log10 cfu g
-1 over an 
initial period of two days prior to exhibiting recovery, although to levels below that of untreated 
control samples. As for other studies, the authors report the occurrence of bacteriophage-insensitive 
mutants after 6 days incubation. Pure cultures of Salmonella Enteritidis show evidence of the 
development of resistance to the vB_SenS-Ent phages in both semi-solid and liquid media, hence it 
cannot be discounted that similarly resistant mutants could arise in food matrices. However, the 
detection of such mutants is made difficult by conventional culture methods which show at best an 
inherent limit of detection of 10 cfu g-1. Additionally, the low storage temperature used in this study 
effectively inhibits growth of these bacteria (Smith, 1985). It would be interesting to determine the 
effect of a 4oC incubation temperature upon bacteriophage replication under one-step growth 
conditions. Considering that growth of Salmonella under these conditions is greatly reduced or 
halted, it is likely that the phage replication cycle would be either considerably extended or, 
alternatively, not begin to proceed until there is an increase in ambient temperature allowing the 
commencement of bacterial growth. For these reasons, a particularly high multiplicity of infection of 
bacteriophages to bacteria was employed, approximately 10,000:1. The presence of high 
concentrations of bacteriophages serves to ensure appropriate distribution and coverage of the food 
matrix but may also lead to ‘lysis from without’ (Abedon, 2011b). Lysis from without is a 
phenomenon whereby the sheer number of infecting bacteriophages attaching to the bacterial cell 
surface results in destabilisation of the cell membrane leading to osmotic disruption and ultimately, 
lysis. Distinct from lysis from without is that high multiplicities of infection may also render the cell 
incapable of producing functional progeny due to overwhelming numbers of phage competing for 
the same cellular machinery (Molineux, 2006). In both scenarios the bacteriophage infection is 
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unproductive, in that the cell is lysed prior to an infecting bacteriophage being able to replicate its 
genome and form progeny virion particles. The reduction in viable numbers of Salmonella observed 
here occurs within the first 24 hours and might suggest that unproductive infection is the 
predominant killing mechanism in the study reported here. As such, it would be of interest to 
establish the kill kinetics of Salmonella by these bacteriophages over the first 12 or 24 hours of 
incubation and determine whether there is any increase in phage titre during this period. Establishing 
whether or not phage titre alters could elucidate whether the action of the vB_SenS-Ent phages is 
active or passive, that is whether the killing effect occurs with or without phage replication. 
The use of constitutively bioluminescent bacteria allowed for rapid and simple quantification of 
target species within mixed cultures composed of microflora endogenous to the food matrix being 
tested and the spike isolate. The lux system provides the benefits of a dual marker system. Firstly, 
the presence of the antibiotic resistance marker allows for selection of cell recovery whilst inhibiting 
susceptible background flora. Secondly, light emission allows the identification of colonies within 
mixed cultures on agar plates with the use of EMCCD cameras or equivalent technologies. 
Unfortunately, the selected spike concentration was below the limit of detection using the EMCCD 
camera system, otherwise it would have been interesting to follow kill kinetics of the bacteriophages 
directly in situ. This type of approach has been employed to assess the effects of heat inactivation 
and recovery of Salmonella Typhimurium DT104 inoculated at high cell densities upon the surface of 
a range of food matrices (Lewis et al., 2006b). Additionally, whilst S. Enteritidis PT4 LITE showed good 
plasmid stability over 7 days at 4oC in the absence of selective antibiotics, it does not preclude the 
possibility that some plasmid loss may occur in the competitive environment of the food matrix.    
However, the data presented here shows only one independent trial per food matrix. Whilst some of 
the variations observed for enumerations may be the result of heterogeneous distribution of phages 
and bacteria in the sample matrix, additional trials are required to confirm and consolidate the 
results presented here. In hindsight, the methodology could be further improved upon by the use of 
larger diameter Petri dishes for plating, facilitating the plating of sample volumes 1 ml or greater. 
Secondly, additional data could be provided by performing a paired analysis using the standard ISO 
methodology, which would provide a qualitative gold standard indicating the presence or absence of 
Salmonella at each sampling time.  
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Chapter 7 Bioluminescence Imaging of Bacteriophage Plaque 
Expansion 
7.1 Introduction  
Over 75 years after its introduction the overlay agar plaque assay, accredited to Gratia, continues to 
constitute a primary technique within the research of bacteriophages (Adams, 1959). The method is 
used for titration, the identification of bacteriophage isolates from environmental sources, to 
investigate physiological characteristics such as adsorption, burst size and host range, and to test for 
phage viability. Plaques are defined as localised, visible zones of clearing within otherwise confluent 
bacterial lawns that arise after a primary adsorption and productive infection event that initiates the 
focal infective centre (Koch, 1964). 
Phage population expansion following the primary infection event is mediated by multiple rounds of 
adsorption to individual bacteria. The release of progeny particles with lysis of individual host cells 
acts to offset diffusion mediated declines in local phage particle densities, and population growth 
continues so long as sufficient quantities of susceptible bacteria are present.  Thus, the expansion of 
plaques may be envisioned as a travelling wave of infection that moves radially outwards in three 
dimensions from the focal infective centre, leaving lysed, resistant or shielded bacterial cells in its 
wake (Abedon and Yin, 2008, Rabinovitch et al., 2003). Several theoretical models  that seek to 
describe this travelling wave of infection by reaction-diffusion mechanisms have been presented 
(Koch, 1964, Kaplan et al., 1981, John, 1991, Yin and McCaskill, 1992, Yin, 1994, You and Yin, 1999, 
Fort and Méndez, 2002, Ortega-Cejas et al., 2004). These models have been summarised in 
comprehensive reviews by Abedon and co-workers (Abedon and Culler, 2007b, Abedon and Culler, 
2007a, Abedon and Yin, 2008, Abedon and Yin, 2009, Krone and Abedon, 2008).  
Since environmental mixing, virion diffusion, and host-cell mobility are more limited in solid than for 
liquid media, the formation of plaques in agar overlays provides a useful, simple and cost effective in 
vitro model for the approximation of the localised infection, expansion and spread of bacteriophage 
populations within semi-structured environments, such as biofilms (Abedon and Yin, 2009, Gallet et 
al., 2009, Abedon, 2011a, Abedon and Thomas-Abedon, 2010, Jouenne et al., 1994). As the 
formation and enlargement of plaques is a spatial process, empirical assessment requires 
visualisation and localisation of bacteriophages, intact bacteria, or bacterial lysis.  
Classically, visual assessment of the reduction in turbidity of the bacterial lawn has been used to 
delineate the plaque. A number of hours must elapse before the bacterial lawn becomes visible to 
the naked eye, which precludes accurate measurements at the initial and early stages of plaque 
formation. Recent methods of recording plaque enlargement kinetics have comprised automated 
measurements using time-lapse photography and fluorescence microscopy (Alvarez et al., 2007, Lee 
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and Yin, 1996b). An imaging modality not explored within the literature is bioluminescence imaging 
(BLI). Over the past decade reports detailing the use of BLI have increased significantly due to 
technological advancements, resulting in the widespread commercial availability of highly sensitive, 
intensified and electron multiplying CCD image acquisition systems. BLI has predominantly found use 
within the study of bacterial pathogenesis in vivo due, in part, because it allows non-invasive 
longitudinal monitoring and visualisation of individual test subjects. For bacterial pathogens, BLI has 
been employed to follow localisation and dissemination in vivo and for the quantification of 
antibiotic pharmacodynamics (Rocchetta et al., 2001, Contag, 2008, Kadurugamuwa and Francis, 
2008, Sanz et al., 2008b). 
The requirement of the light-emitting reaction for ATP, NADPH and FMNH2 means that the ability of 
a cell to emit light is dependent upon an intact intracellular redox potential. Any physico-chemical 
factor affecting bacterial metabolism results in an alteration in relative light emission, presenting a 
rapid, sensitive and non-destructive means of monitoring bacterial cell metabolic viability. These 
characteristics have led to the widespread use of bioluminescent reporter bacteria across a range of 
applications including studies upon the pharmacodynamics of antibiotics, biocide kill kinetics, biofilm 
models and the design of biosensors for the detection and quantification of environmental pollutants 
(Ulitzur, 1986, Ben-Israel et al., 1998, Alloush et al., 2003, Ulitzur and Ulitzur, 2006, Kadurugamuwa 
and Francis, 2008, Robinson et al., 2011). Bacteria transformed to constitutively express the lux 
operon thus present a means to study the effects of co-incubation of lytic bacteriophages or 
recombinant bacteriophage proteins, such as lysins, with bacterial populations in broth, semi-solid 
media or associated with solid substrata as biofilms. 
The aim of this study was to employ bioluminescent bacterial reporters to investigate the effects of 
co-incubation of bacteria and bacteriophages under conditions of plaque formation. Experimental 
objectives included the transformation of Salmonella enterica serovars Dublin and Enteritidis, used 
as the propagating hosts of the myovirus Felix O1 and siphovirus vB_SenS-Ent1 respectively, to 
constitutively express the luxCDABE operon of Photorhabdus luminescens.  Secondly, these 
bioluminescent serovars were utilised in conjunction with an EMCCD imaging system to record 
plaque formation in agar overlays. Lastly, an image processing workflow was developed, based on 
that reported by Lee and Yin (1996b), to allow quantification of plaque expansion and to provide 
descriptions of plaque morphology in relation to light emission from host cells.   
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7.2 Results 
7.2.1 Calibration of cell density and light emission 
Serovars S. Enteritidis PT4 and S. Dublin were successfully transformed to stably express a 
bioluminescent phenotype. For calibration curves, the detection limit (LOD) was defined as 3 
standard deviations of the reagent blank control and the limit of quantification (LOQ) as 10 standard 
deviations of the reagent blank control. Light emission of log-fold dilutions of bacteria immobilised in 
overlay agar within microtitre plate wells showed strong correlation with colony forming units (R2 > 
0.95), affording a detection limit of approximately 1 x 103 cfu per well for S. Dublin and S. Enteritidis, 
respectively (Figure 52). The dynamic range of detection was reduced using BLI and detection limits 
were 1 x 104 cfu per well for S. Dublin and S. Enteritidis, respectively. 
 
Figure 52. Calibration curve of log-fold dilutions of bioluminescent bacteria immobilised in overlay 
agar using a microplate luminometer. Values represent mean RLU/s of triplicate readings from three 
independent experiments.  
Lawns of bioluminescent reporters grown in overlay agar in both microtitre plates and 90 mm petri 
dish formats exhibited similar trends of light emission to those grown in liquid batch culture. After an 
initial lag phase, logarithmic phase growth was characterized by a rapid exponential increase in light 
emission. Stationary phase onset was indicated by a deceleration of the rate of increase of 
bioluminescence, followed by a period of constant then reducing light emission (Figure 53).  
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Figure 53. Bioluminescence imaging of a growing lawn of S. Enteritidis absent of bacteriophages. 
Values represent the mean and standard deviation of three independent platings, determined using 
a square region of interest comprising an area of 100 pixel2. Bacterial lawns were incubated within a 
clear Perspex incubator at 37oC and imaged at 5 minute intervals over a period of 20 hours.  
7.2.2 Plaque morphology 
The siphovirus vB_SenS-Ent1 produces relatively large plaques (mean diameter 5.69 ±1.72 mm, n=10) 
when titrated upon S. Enteritidis. Visually, plaques on overlay plates were best described as 
consisting of three discrete zones. Moving outwards from the plaque centre, the first zone consists of 
a region of clearing with little or no visible turbidity. The second zone is represented by an area of 
slight turbidity extending to the third zone; the boundary between the plaque and the bacterial lawn. 
Elution of bacteriophages in SM buffer from individual excised plaques yielded a mean productive 
titre of 8.6 ± 9.6 x 109 pfu ml-1 (n=15). Plaques formed by the myovirus Felix O1 were smaller (mean 
diameter 2.15 ±0.34 mm, n=10) but morphologically similar to plaques formed by vB_SenS-Ent1. 
Plaques formed by Felix O1 yielded a mean titre of 2.68 ± 2.56 x 108 pfu ml-1 (n=15) and consisted of a 
small central zone of clearing, zone of turbidity and a boundary at the junction with the bacterial 
lawn (Figure 54).  
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Figure 54. Photographs of plaques formed by Felix O1 and vB_SenS-Ent1. Roman numerals refer to 
regions of plaque morphology; I) zone of clearing; II) zone of turbidity; III) plaque boundary; IV) 
bacterial lawn. Dashed lines indicate the boundary between the zone of clearing and turbidity and 
solid lines the boundary between the plaque edge and the bacterial lawn.  
7.2.3 Plaque development 
Using bioluminescence imaging, developing plaques could be identified within a period of 2 to 4 
hours. Profile plots of lines extending through the plaque centroid and into the bacterial lawn 
showed a distinct profile. The plaque centre is present as a region of low light emission and the 
plaque boundary as a gradient of increasing light emission rising to that emitted by the bacterial 
lawn. Histograms of plaque images exhibited a bimodal distribution. The mean and standard 
deviation of pixel grey values of control regions within the bacterial lawn were used to create coarse 
threshold values (TRH) which were subsequently used to segment images of plaques. After 12 hours 
the segmentation process resulted in images representing three regions (Figure 55).  
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Figure 55. Thresholding of plaques. A) Light photograph of plaques formed by vB_SenS-Ent1. 
Bioluminescence imaging: B) Pixels of value equal to the mean ± 2sd light emission of the bacterial 
lawn. C) Pixels of value less than mean - 2sd light emission of the bacterial lawn D) Pixels of value 
greater than the mean + 2sd light emission of the bacterial lawn.  
Using segmented images it is envisaged that region I (TRH1 ≤ mean -2σ) encompasses an area 
containing lysed bacterial cells where the infective process is predominantly finished and a region of 
on-going bacterial lysis, where a gradient of light emission represents increasing bacterial cell density 
as one moves outwards towards the plaque periphery. Region II (TRH2 = mean ±2σ) represents the 
average (±2σ) bioluminescence of the bacterial lawn. Region III (TRH3 > mean +2σ) corresponds to an 
area around the visible plaque boundary where light emission is greater than the bacterial lawn. This 
region, observed for both vB_SenS-Ent1 and FelixO1, is absent initially and becomes more 
pronounced after 12 hours. The increased emission from region III could arise due to two possible 
scenarios. Firstly, that the number of cells remained constant but with increased metabolism 
resulting in a greater number of RLU produced per cell. Second, that the bacteria in this region were 
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actively multiplying and the observed light emission reflects increasing cell density. The localisation 
of this region relative to the plaque boundary suggests that either scenario could arise from the 
presence of increased nutrient density in regions where plaque formation has suppressed bacterial 
growth (Lorian and Strauss, 1966). An alternative conjecture might be that this regions contains cells 
infected with bacteriophages and that the increased bioluminescence reflects increases in 
metabolism associated with the production of progeny virions. In order to test this possibility 
separate 1 µl spots of bacteriophages in SM buffer, representing a dose of 108 pfu, SM buffer alone 
and fresh LB media were applied to the surface of mature lawns of stationary phase bacteria and 
light emission monitored over a period of 2 hours (Figure 56).  
 
Figure 56. Profiles of bioluminescence from stationary phase lawns (24 hours old) after application 
of 1 µl spots of fresh LB media and SM buffer with and without bacteriophages.  
Application of media to mature lawns resulted in a rapid increase of bioluminescence to a peak six 
times greater than the untreated bacterial lawn, which then decayed over 90 minutes. Notably, 
applying SM buffer containing bacteriophages resulted in a transient increase in bioluminescence to 
a peak level twice that of the bacterial lawn. Light emission decayed more rapidly than for addition 
with fresh LB medium. In contrast spots of SM buffer alone resulted in only a very slight rise in 
bioluminescence. However, analysis of peak emission by one-way ANOVA suggests the difference 
after addition of phages is not significant. The transient increase in bioluminescence caused by 
application of bacteriophages to stationary phase bacterial lawns is interesting, but as to how and 
why this phenomenon arises remains undetermined. Further experiments, representing a more 
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thorough examination are required to ascertain whether this effect is due to the presence of 
bacteriophages or diffusion of nutrients. 
7.2.4 Examination of plaques with confocal microscopy   
Examination of mature lawns by confocal microscopy demonstrated that bacterial cells were not 
homogenously distributed in the volume of overlay agar. Individual cells and smaller aggregates of 
bacteria were predominantly located at the surface of the overlay agar. Bacteria at the upper surface 
of agar overlays also exhibited motility, suggesting that these bacteria might act as an additional 
transit mechanism for the dispersal of bacteriophages within the overlay layer. However, this 
observation could be an artefact arising from hydration of the agar layer during the staining process. 
At depth, bacteria were distributed as numerous micro-colonies of varying sizes. For plaques, regions 
of clearing were characterised by an overt absence of bacteria. The boundaries of plaques initiated 
by Felix O1 were well defined with a high density of dead aggregates meeting a high density of live 
aggregates. In contrast, the plaque boundary was less definite for vB_SenS-Ent1, appearing as a 
gradual reduction in the density of micro-colonies stained with propidium iodide (Figure 57). 
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Figure 57. Spinning disk confocal images (extended focus) of microcolonies at the plaque boundary 
of A) Felix O1 and B) vB_SenS-Ent1 at x20 magnification. The scale bar represents a distance of 40 
µm. Red denotes dead bacteria stained with propidium iodide. Green denotes live bacteria stained 
with SYTO-9.   
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7.2.5 Plaque enlargement  
The rate of expansion was first measured by taking the slope of the area equivalent radius (Re) over 
time. The area equivalent radius provides a coarse estimate of the rate plaque expansion and takes 
as an assumption that the plaque is a perfect circle and hence provides no indication of asymmetries 
at the plaque boundary. Using the area equivalent radius two distinct phases of enlargement were 
observed, common to both vB_SenS-Ent1 and Felix O1. In the first phase, which lasted up to 10 
hours, the plaque radius expands at a near constant linear rate. This is followed by a period of 
deceleration into the second phase where the rate of expansion is greatly reduced and becomes near 
stationary (Table 17, Figure 58). 
Table 17. Rates of enlargement, size and circularity after 20 hours for plaques formed by 
bacteriophages Felix O1 and vB_SenS-Ent1. Plaque numbers correspond to labels shown in figure 
58.  
vB_SenS-Ent1 Adsorption: 6.73 x 10-9 ml min-1 Latent Period: 
Burst Size: 
35 minutes 
35 virions 
Plaque Velocity (mm hr-1)1. Velocity (mm hr-1) 2. Diameter (mm) 3. Circularity3. 
1 0.2102 0.0163 4.90 0.82 
2 0.2182 0.0273 4.67 0.58 
3 0.1828 0.0180 3.97 0.76 
4 0.1382 0.0082 3.09 0.76 
Felix O1 Adsorption: 5.4 x 10-9 ml min-1 Latent Period: 
Burst Size: 
40 minutes 
46 virions 
Plaque Velocity (mm hr-1)1. Velocity (mm hr-1) 2. Diameter (mm) 3. Circularity3. 
1 0.1548 0.0083 2.08 0.54 
2 0.1467 0.0041 2.38 0.31 
3 0.1622 0.0056 2.33 0.49 
4 0.1316 0.0116 2.54 0.84 
5 0.1505 0.0136 2.71 0.76 
1. Velocity determined from slope of the area equivalent radius between 5 and 9 hours. 
2. Velocity determined from slope of the area equivalent radius between 15 and 19 hours. 
3. Determined after 20 hours incubation 
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Figure 58. Increases in area equivalent radius with time for Salmonella phages Felix O1 (n=5 
plaques) and vB_SenS-Ent1 (n=4 plaques). Data are plotted at 5 minute intervals.  
For the first phase of enlargement, increases in the plaque area equivalent radius occurred at an 
average rate of 0.148±0.011 mm h-1 and 0.186±0.035 mm h-1 between 5 and 9 hours for Felix O1 
(n=5) and vB_SenS-Ent1 (n=4), respectively. A period of deceleration preceded the second phase 
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where rates of expansion reduced to 0.019±0.021 mm h-1 and 0.017±0.008 mm h-1 between 15 and 
20 hours for Felix O1 and vB_SenS-Ent1, respectively. 
The observed differences in final plaque size are due to the limited time allowed for adsorption of 
virion particles to bacteriophages prior to mixing in the overlay agar. After one minute, only a limited 
proportion of the bacterial population would have undergone adsorption and injection by 
bacteriophages and a significant fraction of bacteriophages would be free in the agarose matrix. 
Bacteria encountering these extracellular phages, either by the expansion of microcolonies through 
cell division or by diffusion of the bacteriophages, would do so at later time points meaning that the 
initiating infection event would occur at different times.  
Taking velocity as the difference of the average plaque radius across 360 angular orientations at 
hourly intervals demonstrates that the rate of plaque enlargement changes with time (Figure 59). It 
appears that plaque enlargement shows high initial values of velocity, which decreases over time in 
conjunction with growth of the bacterial lawn. However the accuracy of the data presented here are 
likely to be influenced by differences between the times of the plaque initiating infection.  
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Figure 59. Velocity of plaque expansion by Salmonella bacteriophages Felix O1 and vB_SenS-Ent1 
on lawns of Salmonella serovars Dubin and Enteritidis, respectively. Velocity was determined at 
hourly intervals. Quadratic lines of best fit are illustrated.  
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7.2.6 Resistant bacteria 
The survival and subsequent growth of bacteria within plaques is clearly visible using 
bioluminescence imaging. These resistant bacteria are present as small circular regions of light 
emission that arise within the plaque zones of clearing and turbidity (Figure 60). These microcolonies 
were observed frequently within plaques formed vB_SenS-Ent1 and infrequently within plaques of 
Felix O1. 
 
Figure 60. Kymograph of a line extending through the plaque boundary and a resistant bacterial 
microcolony for vB_SenS-Ent1. Arrow 1 indicates the plaque boundary. Arrow 2 indicates the 
location of the microcolony.  
7.3 Discussion 
The use of bioluminescent bacteria is a novel approach facilitating continuous high resolution 
imaging of plaque formation in agar overlays. This methodology presents two significant advantages 
in comparison to traditional methods. First, the growing bacterial lawn may be detected prior to 
becoming visible to the naked eye and earlier than afforded by turbidometric methods. Second, the 
intensity of light emission around the plaque, at and within the plaque boundary may be used to 
provide insights into the host’s metabolic rate in addition to yielding geometric descriptions and 
rates of enlargement. For bacteriophages Felix O1 and vB_SenS-Ent1, plaques could be visualised 
within a period of between two and four hours incubation. However, whilst light emission from the 
bacterial lawn could be detected immediately, the boundary detection routine did not robustly 
detect the plaque at early stages of formation. However, it is worth noting that the use of BLI 
required a somewhat lengthy optimisation of exposure time for each reporter serotype and that 
using the methods reported here, the presence of individual plaques within the imaging area is not 
guaranteed. Additionally, early time frames using long exposure times run the risk of sensor 
saturation, at which point the correlation between bioluminescence and cell density is lost. In 
hindsight, this methodology could be further improved by the use of a triggered light source to 
facilitate light photography in addition to measurements of bioluminescence. Providing an 
appropriately modified reporter bacteriophage, fluorescence could also be employed to form a tri-
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modal imaging approach facilitating detection of both bacteria and bacteriophages during the course 
of plaque formation. 
Descriptions of plaque morphology are either quantitative or qualitative (Abedon and Yin, 2008, 
Abedon, 2011a). Quantitative differences describe the geometric characteristics of the plaque, for 
example; size, area, perimeter and circularity, whereas qualitative differences are descriptive and 
may include plaque turbidity, morphological variations, the presence of debris or resistant colonies. 
It has been proposed that plaques may be separated into at least four regions extending outwards 
from the plaque centre (Krone and Abedon, 2008). These regions comprise an area of clearing (i), an 
area of reduced turbidity (ii), a narrow periphery constituting the plaque boundary (iii) and the 
bacterial lawn (iv). Using bioluminescence imaging the zone of clearing is clearly apparent as an area 
of low light emission and the zone of turbidity as an area of reduced light emission. The plaque 
boundary is represented as a region where, moving outwards, bioluminescence increases until the 
bacterial lawn is reached. The reasons for an additional area of increased bioluminescence existing 
around and beyond the plaque boundary are unclear. It is pure speculation that this is a result of 
interactions with bacteriophages which have diffused beyond the visible plaque boundary; a further 
and more extensive investigation is required to elucidate the cause of this phenomenon. As yet, no 
accurate technique exists for assessing the very early stages of plaque formation, that is, the chain of 
infection events beginning with the focal infection and encompassing the first hours of expansion. It 
would be interesting to ascertain whether these primary stages exhibit fast initial velocities or 
accelerates as the turnover of infection and lysis events gathers momentum and the bacteriophage 
population increases. 
The visual assessment of plaques has long been used to denote differences within viral populations; 
changes in gross plaque morphology allow the identification of rapid lysis mutants, minute and large 
plaque-forming mutants as well as temperate phage mutants producing clear rather than turbid 
plaques (Adams, 1959). Similarly, descriptions of plaque geometry can provide evidence of phage 
population heterogeneity within a single plaque. For example, Lee and Yin (Lee and Yin, 1996a) 
employed circularity as an indicator of population heterogeneity by proposing that asymmetries at 
the plaque perimeter arise from the emergence of mutant strains at the expanding region of 
infection. Using recombinant E. coli transformed to express the T7 RNA polymerase, it was found 
upon plating that with increasing distance from the centre of the plaque, mutant T7 bacteriophages 
were detected which had undergone deletions within the genome region encoding the RNA 
polymerase (Yin, 1993). This study clearly demonstrates that evolution occurs within expanding 
populations of bacteriophage during plaque formation. 
The expansion of plaques is described as a travelling wave, that is, an expanding front of infection 
moving radially outwards where diffusion-mediated declines in phage concentration are offset by 
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continued lysis and release of progeny virions. Plaque wavefront velocity can be measured 
empirically by determining plaque size as a function of time. Plaque fecundity, also referred to as 
plaque productivity or yield, is defined as the total number of virions produced during plaque 
formation (Abedon and Culler, 2007b). Plaque productivity is thus a function of the number of 
bacteria infected, average burst size and those virions lost to decay, non-productive infection and 
secondary infections of host cells. A number of reaction-diffusion model have been developed to 
provide simulations of plaque formation in order to determine estimates of plaque wavefront 
velocity, in response to different physiological characteristics of bacteriophages. Each of the 
published models of plaque expansion has been systematically reviewed in terms of plaque 
wavefront velocity and productivity by Abedon and colleagues (Abedon and Culler, 2007b, Abedon 
and Culler, 2007a, Abedon and Yin, 2009).  
As a general rule, plaque wavefront velocity directly influences plaque size, with faster velocities 
resulting in larger plaques. However, despite an apparent simplicity, the formation of plaques is 
subject to a number of physiological and environmental factors, all of which form a complex interplay 
impacting both upon wavefront velocity and plaque productivity. Physiological factors can be divided 
between bacteriophage and host, though are not altogether independent of each other. For the 
bacteriophage isolate these factors comprise rates of diffusion, adsorption (and desorption) rates 
during the extracellular phase, while the intracellular phase is represented by the latent or lysis time 
and burst size.  
In the extracellular phase of plaque development, phages are governed by their diffusion coefficient 
and rate of adsorption to host cells. Since bacterial cells are immobile within the agar matrix, plaque 
size increases as a quadratic function of the virion diffusion coefficient (Gallet et al., 2011). In 
addition to rates of diffusion, the time taken by a phage to find a host cell for infection is defined by 
the adsorption rate constant and the density of available host cells. In liquid cultures high adsorption 
rates are to be preferred, at least in order to minimise the time spent seeking a new host cell. Those 
bacteriophages exhibiting slow rates of adsorption will take significantly longer to obtain new host 
cells, effectively limiting the available time for production of progeny. However, a high adsorption 
rate can be detrimental to plaque formation. Using isogenic mutants of phage λ exhibiting different 
adsorption rates and marked by the addition of the lacZ gene to the viral genome, Gallet et al., 
(2009) demonstrated that the phages with higher adsorption rates settled more rapidly on lawns of 
host cells but resulted in smaller plaques. It was suggested that diffusion of virions within the plaque 
is retarded due to the high affinity for host cells. These observations and further studies suggest that, 
for plaque formation, an adsorption optimum exists, above which plaque size and productivity is 
negatively impacted (Shao and Wang, 2008, Abedon and Culler, 2007b, Abedon and Yin, 2009). 
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Burst size is a measure of virion progeny yield per infected host cell, usually determined from one-
step growth experiments in a liquid medium. With increasing burst size, greater numbers of progeny 
virions are released into the environment. Intuitively, greater burst sizes should result in larger 
plaques and or, greater plaque productivity (Abedon and Culler, 2007b). However this effect 
diminishes, as for some bacteriophages at least, there is a positive linear relationship between lysis 
time and burst size (Wang, 2006). Hence, the more time spent replicating progeny before lysis, the 
less time is available in the extracellular phase (Shao and Wang, 2008). The antagonism between 
these two factors has led to the suggestion that an optimal latent period exists which maximises 
plaque size and productivity (Abedon and Culler, 2007b, Abedon and Culler, 2007a). 
Physiological factors pertinent to the host bacterial cell include the growth phase and initial 
concentration of the seed culture, specific growth rate, and duration of the exponential phase as well 
as final cell concentrations. Environmental factors are represented by variables of incubation 
temperature, available nutrients for the host lawn, pH, agar concentration and the availability of 
cofactors for the adsorption of virions to host cells.  
Gallet et al., (2011) describe an elegant study where a library of isogenic mutants of phage λ 
exhibiting altered morphology, rates of adsorption and latent periods, were used to ascertain how 
different virion traits impacted upon plaque formation. Plaque sizes and productivities from 
experimental observations were compared against the available models but none could 
quantitatively reproduce the experimentally observed data. Plaque size and productivity was found 
to diminish with increasing adsorption rates while lysis time exhibited a concave relationship with 
plaque size. Whilst this study made no attempt to empirically test the various mathematical models, 
we suggest that combining the use of isogenic phages exhibiting different physiological 
characteristics with bioluminescence or multi-modal imaging of plaque formation would form a 
useful tool for assessing discrepancies between experimental observations and estimates of plaque 
wavefront velocities by current models. Perhaps one reason for a lack of systematic experimental 
studies assessing the proposed models of plaque expansion for different bacteriophage isolates 
arises from the difficulty, perceived or otherwise, in obtaining accurate measurements of 
bacteriophage diffusion coefficients. Recently, Hu et al., reported a simple modification of a two-
chamber Stokes diffusion apparatus to allow the quantification of virion particle diffusion rate 
through agarose gel membranes for the myovirus T4 and filamentous phage fNEL (Hu et al., 2010). 
The same group have recently extended this method to study the effects of adsorption and 
proliferation to phage diffusion coefficients (Hu et al., 2012). Fluorescence correlation spectroscopy 
has also been used to characterise the diffusion of the Lactobacillus phage C2 in biofilms of 
Stenotrophomonas maltophilia (Lacroix-Gueu et al., 2005). Additionally, while it is easy to adjust 
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phage traits within model equations, it is not always such a simple process to modify these in vitro 
(Gallet et al., 2009). 
The plaque assay represents a batch culture system, that is, a finite pool of resources is available to 
support bacterial population expansion. Bacterial cells entering stationary phase undergo 
pronounced changes in cell morphology and physiology (Navarro Llorens et al., 2010, Nyström, 
2004). The entry into stationary phase is highly regulated, resulting in patterns of gene expression 
which serve to prepare the bacterial cell for survival in a growth-limiting or hostile environment. Cells 
reduce in size, become more spherical and exhibit significant alterations to all structures of the cell 
envelope. Not only does this reduced size effectively reduce the cell surface area available for phage 
adsorption, the increased thickness of the peptidoglycan cell wall and reduced fluidity of the inner 
membrane may well serve to present a more difficult barrier for the injection of phage DNA. 
Stationary phase bacteria show reduced protein synthesis and the production of both rRNAs and 
tRNAs is decreased, a feature which is likely to impact upon phage lysis time. Similarly, aerobic 
metabolism is decreased while expression of fermentative enzymes is increased. The results reported 
here of reducing rates of expansion coinciding with entry of the bacterial population into stationary 
phase demonstrates that, for phages Felix O1 and vB_SenS-Ent1, bacteriophage genome replication 
and assembly of progeny requires that sufficient resources and synesthetic capability are available in 
the host cell to satisfy these requirements. This intuitive concept has been documented in several 
studies where it was shown that latent period, burst size and proliferation rates of bacteriophages 
are influenced by the growth conditions of the host (Hadas et al., 1997, Los et al., 2007, Corbin et al., 
2001, Webb et al., 1982, You et al., 2002, Middelboe, 2000, Kokjohn and Sayler, 1991). In general, 
bacteriophages infecting hosts with slow rates of growth due to starvation, nutrient limitation or 
sub-optimal carbon sources exhibit extended latent periods and slower formation of progeny virions 
leading to reduced burst sizes (Abedon et al., 2001, Abedon, 2011a). However, notable exceptions to 
these observations exist, for example the bacteriophage T7 results in plaques that continuously 
expand, albeit at a greatly reduced rate, in stationary phase hosts (Yin, 1993). 
Due to restrictions in mobility imposed by semi-structured environments, replicating bacteria form 
spatial arrangements termed microcolonies, which Abedon describes succinctly as a “closely 
associated collection of especially clonally related bacteria that is sufficiently small so as to be not 
readily discernible individually by the naked eye; a highly localised three-dimensional array of 
bacteria” (Abedon, 2012b). As the bacterial lawn grows to higher densities, there is a corresponding 
increase in the number of bacterial cells within a microcolony and its overall size. Such clusters of 
bacterial cells are clearly apparent within the confocal micrographs presented here. Abedon has 
considered the impact of group living, as exemplified by microcolonies, upon bacteria exposed to 
infection by lytic bacteriophages (Abedon, 2012a). It is suggested that microcolonies represent larger 
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spatial targets for phage adsorption than individual cells and secondly that, by virtue of their 
proximity and shared susceptibility, bacteria in the immediate vicinity of an infected cell are much 
more vulnerable to infection (Abedon, 2012a). Bacteriophages which infect cells present within the 
same microcolony as the parental infection can be described as settler phages, while those that 
which diffuse and infect cells in spatially separate microcolonies as scout phages (Abedon, 2011a). It 
seems intuitive to hypothesise that as microcolonies expand, the proportion of progeny phages 
which settle will increase, as there are more bacteria in the direct vicinity of the infected cell. Thus, a 
microcolony could act as a sponge, adsorbing those bacteriophages that would, at earlier times and 
with reduced microcolony size perhaps be more likely to diffuse away from the microcolony to 
become scouts. Increased microcolony size might also result in multiple infection events occurring 
for a single host cell. For the T-even phages, secondary infections can lead to lysis inhibition which, 
while resulting in extended latent periods, also results in larger burst sizes (Abedon, 1990, Paddison 
et al., 1998). Lysis inhibition also has the added advantage of preventing the release of phage when 
there are few uninfected cells. In contrast, the adsorption of many phages to a cell surface may also 
induce destabilisation of the bacterial cell envelope, leading to lysis from without, effecting either 
non-productive infection or premature lysis.  
To date, relatively few studies have employed the lux operon as a reporter within studies of 
microbial populations exposed to bacteriophages in vitro. With the exception of a microplate broth 
assay for T4 (Kim et al., 2009) and a phage-based biosorbent (Sun et al., 2001), applications of 
bacterial luciferases with bacteriophages have primarily focused upon the detection of specific 
bacterial pathogens present within mixed microbial communities in food, cosmetic, pharmaceutical 
and environmental matrices (Rees and Dodd, 2006a). Following Ulitzer and Kuhn (1987), several 
groups have reported the construction of recombinant bacteriophage encoding the luxAB genes for 
the transduction and subsequent detection of a target bacteria such as Bacillus anthracis, E. coli 
O:157, Listeria spp. and Yersinia pestis (Loessner et al., 1997, Schofield and Westwater, 2009, 
Waddell and Poppe, 2000). A number of further applications for the use of bioluminescent bacterial 
reporters within bacteriophage research may be envisioned. The use of bioluminescent reporters in 
conjunction with EMCCD imaging systems might allow temporal and spatial discrimination of the 
effects of applying bacteriophage preparations to bacteria present on surfaces as biofilms or 
colonising food or material surfaces, presenting a quantitative measurement to supplement 
traditional enumerations of plaque and colony forming units. Moreover, and perhaps more 
importantly for biocontrol applications within industry, extended longitudinal measurements of this 
kind may allow for the identification of bacterial population recovery post-exposure to 
bacteriophages. This latter point is clearly demonstrated by this study with the observation of 
colonies of resistant bacteria which form within plaque regions of clearing.  
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Chapter 8 Discussion 
The goal of this thesis was to isolate, identify, select and characterise bacteriophages specific for the 
genus Salmonella.  Three novel Siphoviridae, vB_SenS-Ent1, vB_SenS-Ent2 and vB_SenS-Ent3 were 
isolated, sequenced and annotated using bioinformatics tools. The physiological characteristics, 
including host range, rate of adsorption, burst size and latent and eclipse periods of these phages 
were determined. Using bioluminescent bacterial reporters, the effects of co-incubation of these 
phages with S. Enteritidis PT4 were investigated in batch culture, agarose matrices and foods. 
Each of the vB_SenS-Ent bacteriophages demonstrated broad host range specificity within 
Salmonella subspecies enterica. No single bacteriophage alone exhibited lysis of all Salmonella 
isolates tested when assessed using overlay spot or plaque assays. Such an observation is not 
surprising considering there are currently more than 2,500 designated serovars of Salmonella 
detailed within the LeMinor-Kauffmann-White serological typing system (Grimont and Weill, 2007). 
Analysis of those isolates lysed by these bacteriophages, and the presence of a P22-like tailspike 
protein inferred from genome sequence analysis, indicates that the vB_SenS-Ent bacteriophages 
display a host range limited to those Salmonella that display the LPS O:12 antigen. Notably, different 
isolates of the same serotype exhibited different susceptibilities which might be attributed to the 
presence of resident prophages or distinct immunity systems comprising CRISPR-Cas, restriction-
modification and abortive infection. The differences in susceptibility to bacteriophages by a 
particular bacterial isolate forms the basis of phage typing. Phage typing is used to supplement 
epidemiological data, where, after biochemical confirmation and serotyping, the isolate is infected 
via the spot plate method with a range of different bacteriophages that comprise the typing set. 
Phage types are differentiated on the basis of lysis patterns, providing additional traceability for 
those isolates recovered from different patients or environmental sources. Phage typing schemes 
have been described for S. Typhi, S. Paratyphi, S. Typhimurium (Callow, 1959, Anderson et al., 1977, 
Mitchell et al., 1989), S. Enteritidis (Ward et al., 1987), S. Heidelberg (Demczuk et al., 2003), S. 
Bareilly (Jayasheela et al., 1987) and those serovars carrying the Vi capsular antigen (Craigie and 
Felix, 1947, Felix and Callow, 1951). A short-coming of the data presented for the vB_SenS-Ent 
phages is the failure to obtain mass spectrometry data from proteins purified from 2D SDS-PAGE 
gels. Data from mass spectrometry would have provided additional evidence for inferences made 
from bioinformatics analyses and strengthened the case for the designation of structural proteins. It 
would also been of interest to investigate temporal gene expression using RT-PCR, to provide 
experimental evidence for the allocation of gene expression to early, middle or late stages of 
infection. 
In order to place the phages vB_SenS-Ent1, vB_SenS-Ent2 and vB_SenS-Ent3 within the known 
Salmonella bacteriophages with completely sequenced genomes, a comparative genomics study was 
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undertaken, representing a continuation of the approach first detailed by Lavigne et al., (Lavigne et 
al., 2008, Lavigne et al., 2009). This study, based upon the numbers of shared homologous or 
orthologous proteins between pairs of bacteriophage genomes, provided evidence for a significant 
updating of the relationships between the Salmonella bacteriophages. The vB_SenS-Ent phages are 
placed within a discrete clade of 10 members, which is proposed to constitute a novel genus within 
the Siphoviridae. However, the degree of similarity between the vB_SenS-Ent bacteriophages is 
unusual, considering the numerous and diverse bacteriophages reported to infect Salmonella in the 
literature, and is likely to be a direct result of enrichment and isolation from the same environmental 
sample. The high degree of relatedness between the vB_SenS-Ent phages, specifically that 95-100 % 
similarity is found in the majority of predicted genes, raises the question as to whether they are 
examples of separate species or merely three strains of one species. Under current ICTV definitions a 
95% nucleotide sequence identity is used to differentiate between phage species. Nevertheless, the 
differences in susceptibility to different restriction enzymes, gene ‘cargo’ and host range present an 
image of evolutionary flux in these bacteriophages. 
The control of Salmonella within the food chain and agriculture has become an increasingly 
important issue in recent years, particularly with the increasing resistance to antibiotics displayed by 
members of this genus. The use of bacteriophages for the specific recognition and eradication of this 
pathogen offers an attractive alternative approach to the use of conventional antimicrobial agents. 
Specifically, the advantages of bacteriophages include a high degree of specificity for the target host 
and the ability to increase exponentially with productive infection at the site of host infection or 
colonisation. To date, biocontrol methods involving bacteriophages have been limited to either the 
application of intact whole virions and, for Gram positive bacteria, the use of phage endolysins. 
While this thesis only considered the application of whole virions to bacterial populations in broth, 
foods and semi-structured environments (agar overlays), the efficiency by which bacteriophages 
subvert the host synthetic machinery suggests that further proteins with potential for exploitation as 
antimicrobial agents remain to be found. Indeed, a significant gap still exists between available 
sequence data and biological function; many phage proteins have no assigned function and are 
described only as ‘hypothetical proteins’. Several concerted efforts are underway to attempt to 
reduce the number of hypothetical proteins, approaches exemplified by Phamerator and ACLAME 
(Leplae et al., 2010, Cresawn et al., 2011). These approaches rely upon sequence data to generate 
clusters of orthologous proteins. Recently, an efficient system based on the recombineering of 
electroporated phage DNA has been described for directed mutagenesis of the mycobacteriophages 
was described, a process which may be extended to other phages (van Kessel et al., 2008, Marinelli 
et al., 2012). This technique allows the construction of phage mutants which can be used to assess 
the function of individual genes and their requirement within infection. It is anticipated that 
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functional characterisation of phage-encoded proteins will provide for interesting tools and 
applications in the future. 
With the exception of detection systems for the presence of specific bacteria using recombinant 
bacteriophages, bacterial luciferases are under-used as a reporter in studies of infection and lysis by 
bacteria. For in vitro assays of bacteriophage lysis, bioluminescence of the host bacterial species 
undergoes a distinct reduction in the presence of bacteriophages. However, for all combinations of 
bacteriophage and host bacteria, bioluminescence recovers after treatment with each of the 
vB_SenS-Ent bacteriophages. The growth of phage-resistant mutants is not surprising and appears 
many times within the literature (Labrie et al., 2010). In effect, the addition of lytic bacteriophage to 
bacterial cultures acts as a strong selective pressure. Predation by bacteriophages is predicted to 
help maintain microbial species diversity within the environment through a process termed ‘killing 
the winner’ (Thingstad, 2000). This model proposes that the winner population, that is a microbial 
species displaying a competitive advantage and hence high densities within a mixed population, are 
more susceptible to bacteriophages. Thus any corresponding increase in host population is 
associated with a corresponding increase in phage predation leading to increased rates of phage-
mediated killing. Phage suppression of the winner population leaves a vacuum, allowing room for 
other, potentially less competitive members of the host population to expand and fill this remaining 
niche within the prokaryotic community. The generation of resistance within the suppressed winner 
population ensures the survival of these bacteria, but it is assumed that resistance is associated with 
decreased fitness. Horizontal transfer of genes by lysogenic bacteriophage can also augment fitness 
by conferring morphological, metabolic or resistance characteristics (Weinbauer and 
Rassoulzadegan, 2004). This interaction between active virus host pairs is supported by evidence 
from marine environments where the abundance of specific phage varied in seasonal cycles while 
the overall density of bacteria and bacteriophages remained relatively stable (Wommack et al., 
1999a, Wommack et al., 1999b).   
Proof of principle studies performed on a range of foods demonstrated that the vB_SenS-Ent phages 
have the potential to control Salmonella in foods, at least for a limited number of serotypes. The 
design of phage biocontrol strategies requires careful consideration and candidate bacteriophages 
must be extensively characterised. The concentration of bacteriophages within any preparation must 
be optimised to ensure adequate coverage of the matrix to be treated and to restrict the potential 
for development of resistance in target bacterial populations. Due to the limitations imposed by host 
specificity, and the potential for selection of bacteriophage insensitive mutants, it is suggested that 
for biocontrol applications, the vB_SenS-Ent bacteriophages should be delivered in a cocktail 
containing other bacteriophages that employ distinct host receptors. The Salmonella phages show a 
great diversity of distal tail morphologies and have been demonstrated to utilise a wide variety of 
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targets for primary adsorption, including the O-antigen and core polysaccharide of LPS (Andres et al., 
2012, Bayer et al., 1980, Lindberg and Holme, 1969, Shin et al., 2012a), Vi capsular antigen (Pickard 
et al., 2010), flagella (Shin et al., 2012a) and the outer membrane proteins OmpC (Ho and Slauch, 
2001), FepA, FhuA (Casjens et al., 2005a) and BtuB (Hong et al., 2008, Kim and Ryu, 2011). During the 
initial stages of infection, bacteriophages recognise and bind to bacterial cell surface components in 
an adsorption process mediated by diverse tail fibre, tail spike and tail tip proteins. Once bound, a 
signal is transmitted by an unknown mechanism along the tail resulting in conformational changes 
and ejection of the virion nucleic acid (Tavares et al., 2012). This unidirectional process is poles apart 
from eukaryotic viruses, where the virion envelope fuses with the plasma membrane prior to release 
of the virion genome within the cell cytosol by dissociation of the proteinaceous capsid. In contrast, 
bacteriophages infecting Gram-negative bacterial hosts must overcome two hydrophobic barriers; 
the outer and inner membranes. Furthermore, the ejected genomic DNA must navigate the 
periplasmic space and the rigid peptidoglycan cell wall whilst avoiding degradative enzymes. The 
structure and properties of the proteins facilitating adsorption thus play a critical primary role in the 
determination of host specificity and initiation of infection. The identification of host receptors, 
phage adhesins and the elucidation of binding mechanisms has potential to provide insights into the 
development of phage resistance and inform the design of phage cocktails to achieve appropriate 
coverage for decontamination or biocontrol applications. Additionally, phage receptor binding 
proteins may provide alternatives to the use of antibodies as ligands within selective capture 
workflow components of assays for the detection of bacterial pathogens. In addition, whilst it is 
predicted that the Setp3likevirus are virulent phages, further studies are required to elucidate the 
mechanisms or mutations leading to host resistance before their potential as biocontrol agents can 
be fully realised. 
In addition to the use of bioluminescence alone as a quantitative measure to describe the effects of 
bacteriophage, future assays necessitate the inclusion of an additional quantitative measure, either 
by viable counts, absorbance or by titration of bacteriophages, in order to demonstrate that the 
observed decrease in light emission occurs from a reduction in viable cells, via lysis and a concurrent 
expansion of bacteriophage population, as opposed to metabolic inhibition or abortive infection. 
While an additional, automated, measure of viability might be provided by use of absorbance, the 
dynamic range of detection is limited, spanning approximately 106 to 109 cfu ml-1 and therefore 
provides no information of lysis at concentrations lower than 106 cfu ml-1. Viable counts would have 
provided a more sensitive, if time-consuming, alternative measure. However, viable counts are 
potentially subject to carry-over of bacteriophage, when performed in the absence of neutralising 
serum, which could cause an under-estimation of bacterial numbers. Bioluminescent bacterial 
reporters could potentially be used in future studies within classical one-step growth experiments to 
investigate the responses of bacterial metabolism during eclipse and latent phases of bacteriophage 
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replication. An alternative approach might be employed whereby promoter-coupled plasmid 
constructs containing the lux operon might be utilised to investigate the expression of particular sets 
of genes for host or bacteriophage upon infection.  
The application of bioluminescent Salmonella serovars and sensitive photon counting EMCCD 
cameras represents a novel and hitherto unreported technique that allowed early detection and rate 
determination for the formation of plaques in spot and overlay assays. Light output from micro-
colonies present within the plaque demonstrates the generation of metabolically viable, phage 
resistant mutants. The formation of plaques in overlay agar represents the processes of expansion 
and spread of bacteriophage populations within a semi-structured environment. Several authors 
have suggested that overlay plaque assays provide a useful model for approximating conditions 
within biofilms (Jouenne et al., 1994, Abedon and Yin, 2009). The use bioluminescent imaging could 
be extended in future work to ascertain the effects of lytic bacteriophage within steady-state biofilm 
models (Gilbert et al., 1989, Hodgson et al., 1995, Gander and Gilbert, 1997, Greenman et al., 2005, 
Thorn and Greenman, 2009). The advantages of employing a steady state biofilm system are two-
fold. First, the agarose matrix is replaced by the polysaccharide matrix produced by the bacteria, 
which is likely to represent a much more heterogeneous environment, than that represented by 
purified agarose. Second, nutrients required for bacterial growth may be controlled, allowing direct 
modulation of bacterial growth rates within the biofilm environment. Such an approach could be 
used to more accurately represent the physiological state of bacteria within the environment. 
Moreover, the use of imaging systems provides an additional layer of spatial information which could 
be used to model the expansion and spread of bacteriophage populations within the biofilm matrix. 
This thesis represents but a modest contribution to knowledge the Salmonella phages. However, 
considering the stunning morphological and genetic diversity of the bacteriophages, much still 
remains to be learned about phages infecting this genus of bacteria. The proposal that vB_SenS-Ent1, 
-Ent2 and –Ent3 belong to a distinct clade is being taken forward as part of an international 
collaboration with other phage researchers, led by Dr Hany Anany of the Canadian Research Institute 
for Food Safety at the University of Guelph.  
Since their discovery, bacteriophages have underpinned the foundations of molecular biology. Now, 
with an ever increasing volume of genetic information we are just beginning to appreciate the 
evolution of bacteriophages and their prominent roles in natural ecosystems. This truly is the third 
age of phage (Mann, 2005). 
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8.1 Supplemental Tables 
Supplemental Table 1. Functional annotation of predicted coding sequences of the vB_SenS-Ent1 genome. 
ORF Strand Co-ordinates pI 
a 
MW 
a 
Predicted Function 
b
 Best Homologue 
c
 E-value Accession 
gp01 + 88..594 5.99 18823.37 Putative phage terminase small subunit Salmonella phage SE2 2.13E-97 AEX56169.1 
gp02 + 584..1855 5.92 47669.65 Putative phage terminase large subunit Salmonella SETP7 0 ABN70691.1 
gp03 + 1868..3337 4.78 53767.14 Putative portal protein Salmonella phage SETP3 0 YP_001110831.1 
gp04 - 3367..4017 5.87 25012.55 Unknown Salmonella phage SETP3 6.25E-155 YP_001110832.1 
gp05 + 4183..5226 5.83 38627.79 Putative head morphogenesis protein Salmonella phage SETP3 0 YP_001110833.1 
gp06 + 5229..5687 4.53 16415.54 Putative head decoration protein Salmonella phage SETP3 4.16E-86 YP_001110834.1 
gp07 + 6005..6391 9.04 14320.98 Unknown Salmonella phage SETP3 5.03E-81 YP_001110835.1 
gp08
d
 + 6327..6500 4.56 6566.68 Unknown Salmonella phage MB78 1.92E-26 CAA60564.1 
gp09 + 6585..7286 5.97 25782.05 Putative scaffold protein Salmonella phage SS3e 6.31E-128 YP_005097801.1 
gp10 + 7290..8339 4.62 37812.29 Putative major coat protein Salmonella phage SS3e 0 YP_005097800.1 
gp11 + 8400..8687 9.52 9435.76 Putative head fibre Salmonella phage SE2 5.43E-42 AEX56179.1 
gp12 + 8699..9049 4.38 12198.54 Putative Wac protein Salmonella phage SE2 2.66E-77 AEX56180.1 
gp13 + 9086..9274 4.92 7139.91 Unknown Salmonella phage SETP3 3.03E-36 YP_001110840.1 
gp14 + 9278..9787 4.8 17716.82 Unknown Salmonella phage SE2 2.43E-119 AEX56182.1 
gp15 + 9790..10395 7.99 20595.52 Putative phage neck protein Salmonella phage SE2 5.27E-139 AEX56183.1 
gp16 + 10395..10754 8.86 13168.25 Putative phage neck protein Salmonella phage SETP3 2.92E-71 YP_001110843.1 
gp17 + 10751..11146 9.69 14444.35 Putative structural protein Salmonella phage SETP3 8.55E-75 YP_001110844.1 
gp18 + 11146..11565 4.56 15058.02 Unknown Salmonella phage SETP3 1.88E-98 YP_001110845.1 
gp19 + 11565..12734 4.65 41332.24 Putative major tail protein Salmonella phage SE2 0 AEX56187.1 
gp20 - 12763..13434 7.82 25635.46 Putative DNA-binding protein Salmonella phage SETP3 5.24E-161 YP_001110847.1 
gp21 - 13546..13776 6.05 8690.86 Unknown Salmonella phage SETP3 5.61E-50 YP_001110848.1 
gp22 - 13786..14286 9.85 19266.94 Putative HNH endonuclease Enterobacteria phage T1 2.03E-65 YP_003930.1 
gp23 - 14302..15456 8.58 43684 Putative recombination endonuclease subunit Salmonella phage SETP3 0 YP_001110849.1 
gp24 - 15519..15698 9.7 6603.13 Putative superinfection immunity membrane protein Salmonella phage SETP3 1.44E-33 YP_001110850.1 
gp25 + 15868..16284 5.03 15892.02 Unknown Salmonella phage SE2 1.81E-97 AEX56193.1 
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gp26 + 16290..16649 4.69 13625.27 Unknown Salmonella phage SE2 1.69E-83 AEX56194.1 
gp27 + 16642..18975 4.8 83037.7 Putative tape measure protein Salmonella phage SS3e 0 YP_005097846.1 
gp28 + 18977..19477 4.87 18638.88 Unknown Salmonella phage SS3e 2.80E-119 YP_005097845 
gp29 + 19474..19989 4.53 19266.9 Unknown Salmonella phage MB78 1.21E-123 CAB36891.1 
gp30 + 19986..20351 6.27 13865.56 Unknown Salmonella phage SE2 9.51E-84 AEX56198.1 
gp31 + 20342..22900 5.36 93938.1 Putative tail fibre protein Salmonella phage SE2 0 AEX56199.1 
gp32 + 22913..24967 5.07 72938.68 Putative tailspike protein Salmonella phage SETP13 0 ABN70698.1 
gp33 - 25086..25256 4.85 6529.48 Unknown Salmonella phage SETP3 2.79E-29 YP_001110805.1 
gp34 - 25253..27718 8.82 92422.04 Putative intein containing helicase precursor Salmonella phage SETP3 0 YP_001110806.1 
gp35 - 27715..27906 9.45 7027.22 Unknown Escherichia phage K1-dep(4) 1.92E-36 ADA82278.1 
gp36 - 27938..28225 9.6 10917.63 Putative restriction endonuclease Salmonella phage SS3e 1.75E-61 YP_005097835.1 
gp37 - 28312..31410 8.05 115917.58 Putative intein containing DNA polymerase precursor Salmonella phage SETP3 0 YP_001110810.1 
gp38 - 31468..32094 5.02 23498.22 Unknown Salmonella phage SETP3 2.42E-137 YP_001110811.1 
gp39 - 32176..32352 10.28 6991.52 Unknown No significant database matches 
gp40 - 32352..33776 7.56 52935.79 Unknown Salmonella phage SETP3 0 YP_001110812.1 
gp41 - 33819..34349 4.54 20029.55 Unknown Salmonella phage SETP3 6.55E-92 YP_001110813.1 
gp42 + 34483..34701 8.8 7920.14 Putative DNA-binding protein Salmonella phage SETP3 1.04E-46 YP_001110814.1 
gp43 - 34716..36902 4.98 80366.01 Putative phage replicative helicase primase Salmonella phage SETP3 0 YP_001110815.1 
gp44 - 36959..37192 9.56 8569.84 Putative uvsX-like protein Salmonella phage SS3e 1.34E-43 YP_005097824.1 
gp45 - 37189..37359 9.38 6637.7 Putative DNA-binding protein Salmonella phage SS3e 2.66E-33 YP_005097823.1 
gp46 + 38359..38640 4.99 10254.71 Unknown No significant database matches 
gp47 + 38637..38840 7.82 7461.58 Unknown Salmonella phage SETP3 4.16E-29 YP_001110819.1 
gp48 + 38843..39214 10.43 14160.68 Unknown Salmonella phage SE2 1.73E-69 AEX56158.1 
gp49 + 39220..39654 4.63 15380.4 Unknown Salmonella phage SS3e 1.34E-102 YP_005097818.1 
gp50 + 39734..40015 7.69 10295 Unknown Salmonella phage SETP3 3.12E-60 YP_001110821.1 
gp51 + 40017..40304 9.95 10574.75 Putative holin, class II Salmonella phage SE2 1.44E-42 AEX56160.1 
gp52 + 40285..40773 9.91 17329.74 Putative lysozyme Salmonella phage SE2 1.70E-87 AEX56161.1 
gp53 + 40958..41143 5.59 6880.89 Unknown Salmonella phage SS3e 7.54E-38 YP_005097815.1 
gp54 + 41140..41298 4.44 6092.7 Unknown Salmonella phage SETP3 9.36E-08 YP_001110825.1 
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gp55 + 41295..41450 10.29 5733.65 Unknown Salmonella phage SE2 2.97E-29 AEX56163.1 
gp56 + 41447..41803 7.02 13663.51 Putative NinH-like protein Salmonella phage SS3e 1.95E-47 YP_005097811.1 
gp57 + 41800..42099 9.89 11667.84 Unknown Salmonella phage SS3e 2.39E-52 YP_005097810.1 
gp58 + 42115..42345 5.81 8163.12 Unknown Salmonella phage SETP3 1.36E-47 YP_001110828.1 
a
Calculated from translated nucleotide sequences using Compute pI/Mw (www.web.expasy.org). 
b
Inferred from BLASTP homolog function and presence of PFAM domains. 
c
Highest scoring blastp homolog.   
d
Multiple possible translational starts (see text).  
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Supplemental Table 2. Functional annotation of predicted coding sequences of the vB_SenS-Ent2 genome. 
ORF Strand Co-ordinates pI 
a
 MW 
a
 Predicted Function 
b
 Best Homologue 
c
 E-value Accession 
gp01 + 66..572 6.00 18854.42 putative phage terminase, small subunit SETP3 3.07E-95 YP_001110829 
gp02 + 562..1833 5.92 47654.76 putative phage terminase, large subunit vB _SenS-Ent1 0 CCG55184 
gp03 + 1846..3315 4.78 53811.27 putative portal protein vB _SenS-Ent1 0 CCG55185 
gp04 - 3345..3995 5.87 24999.60 hypothetical protein vB _SenS-Ent1 2.76E-159 CCG55186 
gp05 + 4161..5204 5.83 38642.90 putative head morphogenesis protein, SPP1 gp7 family vB _SenS-Ent1 0 CCG55187 
gp06 + 5207..5665 4.53 16416.57 putative head decoration protein vB _SenS-Ent1 1.19E-85 CCG55188 
gp07 + 5983..6369 9.04 14352.04 hypothetical protein vB _SenS-Ent1 1.96E-88 CCG55189 
gp08 + 6332..6478 4.76 5581.51 hypothetical protein vB _SenS-Ent1 1.86E-128 CCG55191 
gp09 + 6563..7264 5.97 25783.10 putative scaffold protein vB _SenS-Ent1 1.86E-128 CCG55191 
gp10 + 7268..8317 4.62 37813.37 putative major coat protein vB _SenS-Ent1 0 CCG55192 
gp11 + 8377..8748 6.09 12109.65 putative head fibre protein phiEB49 1.22E-11 AEI91253 
gp12 + 8760..9110 4.47 12127.51 putative Hoc protein vB _SenS-Ent1 1.56E-74 CCG55194 
gp13 + 9147..9335 4.91 7140.93 hypothetical protein vB _SenS-Ent1 5.32E-36 CCG55195 
gp14 + 9339..9848 4.70 17817.99 hypothetical protein SE2 4.10E-118 YP_005098139 
gp15 + 9851..10456 9.05 20649.67 putative neck protein SE2 4.34E-138 YP_005098140 
gp16 + 10456..10815 8.86 13169.30 putative neck protein vB _SenS-Ent1 2.16E-79 CCG55198 
gp17 + 10812..11207 9.69 14445.38 putative structural protein vB _SenS-Ent1 3.37E-73 YP_001110844 
gp18 + 11207..11626 4.61 15059.06 hypothetical protein vB _SenS-Ent1 9.88E-97 YP_001110845 
gp19 + 11626..12795 4.62 41163.15 putative major tail protein vB _SenS-Ent1 0 CCG55201 
gp20 - 12824..13495 7.87 25485.38 putative DNA-binding protein vB _SenS-Ent1 2.44E-137 CCG55202 
gp21 - 13607..13837 6.05 8691.90 hypothetical protein vB _SenS-Ent1 1.63E-48 YP_001110848 
gp22 - 13847..14347 9.85 19268.01 putative HNH endonuclease vB _SenS-Ent1 3.39E-118 CCG55204 
gp23 - 14363..15517 8.58 43661.18 putative recombination endonuclease subunit protein SE2 0 YP_001110849 
gp24 - 15580..15759 9.70 6604.16 putative imm immunity to superinfection protein vB _SenS-Ent1 2.99E-32 YP_001110850 
gp25 + 15929..16345 5.03 15879.04 hypothetical protein vB _SenS-Ent1 1.60E-96 CCG55207 
gp26 + 16351..16710 4.69 13626.32 hypothetical protein vB _SenS-Ent1 1.41E-82 CCG55208 
gp27 + 16703..19036 4.78 83020.85 putative tape measure protein vB _SenS-Ent1 0 CCG55209 
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gp28 + 19095..19538 4.57 16502.49 hypothetical protein vB _SenS-Ent1 1.29E-105 CCG55210 
gp29 + 19535..20050 4.53 19267.96 hypothetical protein vB _SenS-Ent1 2.90E-122 CCG55211 
gp30 + 20047..20412 6.28 13866.60 hypothetical protein vB _SenS-Ent1 1.21E-85 CCG55212 
gp31 + 20403..22961 5.36 93981.35 putative tail fibre protein vB _SenS-Ent1 0 CCG55213 
gp32 + 22974..25028 5.02 73014.90 putative tailspike protein SETP13 0 ABN70698 
gp33 - 25147..25368 4.86 8652.82 hypothetical protein SS3e 1.51E-29 YP_005097839 
gp34 - 25365..27830 8.82 92294.14 putative intein containing helicase precursor vB _SenS-Ent1 0 CCG55216 
gp35 - 27827..28018 9.45 7056.29 hypothetical protein vB _SenS-Ent1 6.54E-36 CCG55217 
gp36 - 28050..28337 9.60 10877.59 putative restriction endonuclease vB _SenS-Ent1 3.04E-61 CCG55218 
gp37 - 28424..31522 7.91 115947.92 putative intein containing DNA polymerase precursor vB _SenS-Ent1 0 CCG55219 
gp38 - 31580..32206 5.04 23499.27 hypothetical protein vB _SenS-Ent1 4.15E-136 CCG55220 
gp39 - 32288..32464 10.28 6992.57 hypothetical protein vB _SenS-Ent1 3.09E-33 CCG55221 
gp40 - 32464..33888 7.56 52966.94 hypothetical protein vB _SenS-Ent1 0 CCG55222 
gp41 - 33931..34461 4.54 20030.59 hypothetical protein vB _SenS-Ent1 1.85E-94 CCG55223 
gp42 + 34595..34813 8.80 7921.18 putative DNA-binding protein SETP3 2.85E-45 YP_001110814 
gp43 - 34828..37014 4.98 80394.28 putative phage replicative helicase primase vB _SenS-Ent1 0 CCG55225 
gp44 - 37071..37304 9.47 8674.01 putative uvsX-like protein vB _SenS-Ent1 9.12E-43 CCG55226 
gp45 - 37301..37471 9.38 6638.74 putative DNA-binding protein SS3e 2.86E-33 YP_005097823 
gp46 + 38478..38681 6.71 7457.59 hypothetical protein vB _SenS-Ent1 3.11E-40 CCG55229 
gp47 + 38684..39049 10.52 13846.43 hypothetical protein SS3e 1.65E-63 YP_005097819 
gp48 + 39055..39489 4.72 15323.43 hypothetical protein vB _SenS-Ent1 1.04E-99 YP_005097818 
gp49 + 39569..39850 7.69 10296.04 hypothetical protein vB _SenS-Ent1 3.28E-60 CCG55232 
gp50 + 39852..40139 9.95 10538.76 putative holin, class II SE2 2.05E-60 YP_005098117 
gp51 + 40120..40608 9.64 17424.76 putative lysozyme SS3e 5.23E-89 YP_005097816 
gp52 + 40795..40980 7.89 6880.98 hypothetical protein vB _SenS-Ent1 4.82E-37 CCG55235 
gp53 + 40977..41132 10.29 5768.69 hypothetical protein vB _SenS-Ent1 4.73E-28 CCG55237 
gp54 + 41129..41485 7.02 13692.63 hypothetical protein vB _SenS-Ent1 9.03E-82 CCG55238 
gp55 + 41482..41781 9.89 11668.89 hypothetical protein vB _SenS-Ent1 5.00E-65 CCG55239 
gp56 + 41795..42025 5.81 8164.14 hypothetical protein vB _SenS-Ent1 7.36E-47 CCG55240 
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a
Calculated from translated nucleotide sequences using Compute pI/Mw (www.web.expasy.org). 
b
Inferred from BLASTP homolog function and presence of PFAM domains. 
c
Highest scoring blastp homolog.   
d
Multiple possible translational starts (see text).  
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Supplemental Table 3. Functional annotation of predicted coding sequences of the vB_SenS-Ent3 genome. 
ORF Strand Co-ordinates pI 
a
 MW 
a
 Predicted Function 
b
 Best Homologue 
c
 E-value Accession 
gp01 + 66..572 6.00 18854.42 putative phage terminase, small subunit SETP3 3.27E-95 YP_001110829 
gp02 + 562..1833 5.92 47670.76 putative phage terminase, large subunit vB_SenS-Ent1 0 CCG55184 
gp03 + 1846..3318 4.75 53763.26 putative portal protein vB_SenS-Ent1 0 CCG55185 
gp04 - 3349..3999 5.87 25013.63 hypothetical protein vB_SenS-Ent1 1.08E-159 CCG55186 
gp05 + 4165..5208 5.83 38628.87 putative head morphogenesis protein, SPP1 gp7 family vB_SenS-Ent1 0 CCG55187 
gp06 + 5211..5669 4.53 16416.57 putative head decoration protein vB_SenS-Ent1 1.27E-85 CCG55188 
gp07 + 5987..6373 9.04 14322.01 hypothetical protein vB_SenS-Ent1 4.47E-89 CCG55189 
gp08 + 6339..6482 4.76 5450.31 hypothetical protein vB_SenS-Ent1 1.02E-25 CCG55190 
gp09 + 6567..7268 5.97 25783.10 putative scaffold protein vB_SenS-Ent1 1.98E-128 CCG55191 
gp10 + 7272..8321 4.62 37813.37 putative major coat protein vB_SenS-Ent1 0 CCG55192 
gp11 + 8381..8752 6.09 12109.65 putative head fibre protein phiEB49 1.30E-11 AEI91253 
gp12 + 8764..9114 4.47 12127.51 putative Hoc protein vB_SenS-Ent1 1.66E-74 CCG55194 
gp13 + 9151..9339 4.91 7140.93 hypothetical protein vB_SenS-Ent1 5.67E-36 CCG55195 
gp14 + 9343..9852 4.70 17817.99 hypothetical protein SE2 4.37E-118 YP_005098139 
gp15 + 9855..10460 9.05 20649.67 putative neck protein SE2 4.62E-138 YP_005098140 
gp16 + 10460..10819 8.86 13169.30 putative neck protein vB_SenS-Ent1 2.30E-79 CCG55198 
gp17 + 10816..11211 9.69 14445.38 putative structural protein SETP3 3.59E-73 YP_001110844 
gp18 + 11211..11630 4.61 15059.06 hypothetical protein SETP3 1.05E-96 YP_001110845 
gp19 + 11630..12799 4.62 41163.15 putative major tail protein vB_SenS-Ent1 0 CCG55201 
gp20 - 12828..13499 7.87 25485.38 putative DNA-binding protein wksl3 2.28E-159 AFO12386 
gp21 - 13611..13841 6.05 8691.90 hypothetical protein SETP3 1.74E-48 YP_001110848 
gp22 - 13851..14351 9.85 19268.01 putative HNH endonuclease vB_SenS-Ent1 3.61E-118 CCG55204 
gp23 - 14367..15521 8.58 43685.16 putative recombinase endonuclease subunit protein SETP3 0 YP_001110849 
gp24 - 15584..15763 9.70 6604.16 putative imm immunity to superinfection membrane protein SETP3 3.18E-32 YP_001110850 
gp25 + 15933..16349 5.03 15879.04 hypothetical protein vB_SenS-Ent1 1.71E-96 CCG55207 
gp26 + 16355..16714 4.69 13626.32 hypothetical protein vB_SenS-Ent1 4.61E-83 CCG55208 
gp27 + 16707..19040 4.78 83020.85 putative tape measure protein vB_SenS-Ent1 0 CCG55209 
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gp28 + 19099..19542 4.57 16502.49 hypothetical protein vB_SenS-Ent1 1.38E-105 CCG55210 
gp29 + 19539..20054 4.53 19267.96 hypothetical protein vB_SenS-Ent1 3.09E-122 CCG55211 
gp30 + 20051..20416 6.28 13866.60 hypothetical protein vB_SenS-Ent1 1.28E-85 CCG55212 
gp31 + 20407..22965 5.36 93939.27 putative tail fibre protein vB_SenS-Ent1 0 CCG55213 
gp32 + 22978..25032 5.07 72939.83 putative tailspike protein vB_SenS-Ent1 0 CCG55214 
gp33 - 25151..25321 4.86 6530.49 hypothetical protein vB_SenS-Ent1 3.13E-29 CCG55215 
gp34 - 25318..27699 8.39 88954.06 putative intein containing helicase precursor vB_SenS-Ent1 0 CCG55216 
gp35 - 27780..27971 9.45 7028.24 hypothetical protein vB_SenS-Ent1 1.09E-36 CCG55217 
gp36 - 28003..28290 9.60 10918.65 putative restriction endonuclease vB_SenS-Ent1 3.21E-62 CCG55218 
gp37 - 28377..31475 8.05 115918.95 putative intein-containing DNA polymerase precursor vB_SenS-Ent1 0 CCG55219 
gp38 - 31533..32159 5.04 23499.27 hypothetical protein vB_SenS-Ent1 4.42E-136 CCG55220 
gp39 - 32241..32417 10.28 6992.57 hypothetical protein vB_SenS-Ent1 3.30E-33 CCG55221 
gp40 - 32417..33841 7.56 52936.92 hypothetical protein vB_SenS-Ent1 0 CCG55222 
gp41 - 33884..34414 4.54 20030.59 hypothetical protein vB_SenS-Ent1 4.67E-100 CCG55223 
gp42 + 34548..34766 8.80 7921.18 putative DNA-binding protein SETP3 3.04E-45 YP_001110814 
gp43 - 34781..36967 4.98 80367.28 putative phage replicative helicase primase vB_SenS-Ent1 0 CCG55225 
gp44 - 37024..37257 9.56 8570.86 putative uvsX-like protein vB_SenS-Ent1 5.83E-48 CCG55226 
gp45 - 37254..37424 9.38 6638.74 putative DNA-binding protein SS3e 3.04E-33 YP_005097823 
gp46 + 38424..38705 5.00 10255.78 hypothetical protein vB_SenS-Ent1 1.36E-61 CCG55228 
gp47 + 38702..38905 7.81 7435.54 hypothetical protein SE2 1.16E-30 YP_005098114 
gp48 + 38908..39279 10.43 14161.72 hypothetical protein vB_SenS-Ent1 1.13E-69 CCG55230 
gp49 + 39285..39719 4.62 15381.46 hypothetical protein SS3e 7.81E-101 YP_005097818 
gp50 + 39799..40080 8.49 10223.98 hypothetical protein vB_SenS-Ent1 9.12E-60 CCG55232 
gp51 + 40082..40369 9.95 10512.70 putative holin, class II vB_SenS-Ent1 2.72E-57 CCG55233 
gp52 + 40350..40838 9.61 17395.76 putative lysozyme vB_SenS-Ent1 6.85E-89 CCG55234 
gp53 + 41023..41208 7.89 6880.98 hypothetical protein ST4 1.50E-37 AFO70791 
gp54 + 41205..41363 4.28 6101.76 hypothetical protein ST4 6.90E-18 AFO70792 
gp55 + 41360..41515 10.29 5768.69 hypothetical protein vB_SenS-Ent1 5.03E-28 CCG55237 
gp56 + 41512..41745 7.68 9114.36 putative NinH-like protein wksl3 3.35E-38 AFO12346 
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gp57 + 41742..41891 5.34 6095.12 hypothetical protein SE2 3.89E-20 YP_005098122 
gp58 + 41888..42115 9.34 8600.97 putative Nin-H-like protein vB_SenS-Ent1 1.18E-45 CCG55238 
gp59 + 42133..42411 10.00 11361.44 hypothetical protein vB_SenS-Ent1 8.75E-41 CCG55239 
gp60 + 42427..42609 8.19 6776.21 hypothetical protein SE2 1.34E-29 YP_005098124 
a
Calculated from translated nucleotide sequences using Compute pI/Mw (www.web.expasy.org). 
b
Inferred from BLASTP homolog function and presence of PFAM domains. 
c
Highest scoring blastp homolog.   
d
Multiple possible translational starts (see text). 
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Supplemental Table 4. Translated sequences of vB_SenS-Ent1 ORFs with matches to domains and 
motifs in the Pfam and InterProSite databases. 
CDS IPR Accession Description Type Bit score Evalue 
gp02 IPR004921 Terminase, large subunit    
 PF03237.10 Terminase-like family (Terminase_6) Family 100.5 7.20E-29 
gp03 PF13264.1 Domain of unknown function (DUF4055) Family 146.8 3.60E-43 
gp05 IPR006528 Phage head morphogenesis domain    
 IPR017029 Bacteriophage K1H, Orf3    
 PF04233.9 Phage Mu protein F like protein (Phage_Mu_F) Family 39.6 5.40E-10 
gp06 IPR007110 Immunoglobulin-like    
gp12 IPR003599 Immunoglobulin subtype    
 IPR007110 Immunoglobulin-like    
 IPR013783 Immunoglobulin-like fold    
 PF13895.1 Immunoglobulin domain (Ig_2) Domain 29.3 6.20E-07 
gp18 PF13554.1 Domain of unknown function (DUF4128) Family 87.2 6.00E-25 
gp20 IPR005039 Bacteriophage P1, Ant1, C-terminal    
 IPR014054 Bacteriophage regulatory protein, Rha family    
 PF09669.5 Phage regulatory protein Rha (Phage_pRha)  Family 80.5 7.60E-23 
 PF03374.9 Phage antirepressor protein KilAC domain (ANT) Family 48.3 7.80E-13 
gp22 PF13392.1 HNH endonuclease (HNH_3) Domain 48.1 4.80E-13 
gp24 IPR016410 Bacteriophage T4, Imm, phage-associated 
immunity 
   
 PF14373.1 Superinfection immunity protein 
(Imm_superinfect) 
Family 65.3 2.40E-18 
gp25 IPR014859 Protein of unknown function DUF1789    
 PF08748.6 Domain of unknown function (DUF1789) Domain 32 1.00E-07 
gp29 IPR014974 Bacteriophage D3, Orf22    
 PF08875.6 Domain of unknown function (DUF1833) Family 158.4 5.90E-47 
gp32 IPR011050 Pectin lyase fold/virulence factor    
 IPR012332 P22 tailspike C-terminal domain-like    
 IPR015331 P22 tailspike C-terminal domain    
 PF09251.5 Salmonella phage P22 tail-spike (PhageP22-tail) Domain 1121.1 0 
gp34 IPR000330 SNF2-related    
 IPR004042 Intein DOD homing endonuclease    
 IPR006141 Intein splice site    
 IPR007868 Hom-end-associated Hint    
 IPR014001 DEAD-like helicase    
 PF05203.11 Hom_end-associated Hint (Hom_end_hint) Domain 99.5 2.00E-28 
 PF00176.18 SNF2 family N-terminal domain (SNF2_N) Family 36.8 1.70E-09 
 PF05203.11 Hom_end-associated Hint (Hom_end_hint) Domain 36.6 3.50E-09 
gp36 IPR014883 VRR-NUC domain    
 PF08774.6 VRR-NUC domain (VRR_NUC) Domain 47.4 1.30E-12 
gp37 IPR001098 DNA-directed DNA polymerase, family A, palm 
domain 
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 IPR006141 Intein splice site    
 IPR012337 Ribonuclease H-like domain    
 PF00476.15 DNA polymerase family A (DNA_pol_A) Family 32.4 3.30E-08 
gp38 IPR022595 Bacteriophage APSE-1, protein 50    
 PF10991.3 Domain of unknown function (DUF2815) Family 182.3 5.50E-54 
gp40 IPR021229 Protein of unknown function DUF2800    
 PF10926.3 Domain of unknown function (DUF2800) Family 336 2.60E-100 
gp42 IPR001387 Helix-turn-helix type 3    
 IPR010982 Lambda repressor-like, DNA-binding    
 PF12844.2 Helix-turn-helix domain (HTH_19) Domain 38.2 9.70E-10 
gp43 PF13481.1 AAA domain (AAA_25) Domain 95.5 2.30E-27 
gp45 PF12728.2 Helix-turn-helix domain (HTH_17) Domain 37.4 2.00E-09 
gp52 IPR002196 Glycoside hydrolase, family 24    
 IPR023346 Lysozyme-like domain    
 PF00959.14 Glycoside hydrolase family 24 (Phage_lysozyme) Domain 54 1.50E-14 
gp55 IPR020295 Protein of unknown function DUF2737    
 PF10930.3 Domain of unknown function (DUF2737) Family 84.7 2.10E-24 
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Supplemental Table 5. Translated sequences of vB_SenS-Ent2 ORFs with matches to domains and 
motifs in the Pfam and InterProSite databases. 
CDS Accession Description Type Bit score E-value 
gp02 IPR004921 Terminase, large subunit    
 PF03237.10 Terminase-like family (Terminase_6) Family 99.3 1.70E-28 
gp03 IPR025129 Domain of unknown function DUF4055    
 PF13264.1 Domain of unknown function (DUF4055) Family 146.7 4.00E-43 
gp05 IPR006528 Phage head morphogenesis domain    
 IPR017029 Putative phage head morphogenesis protein    
 PF04233.9 Phage Mu protein F like protein (Phage_Mu_F) Family 39.8 4.60E-10 
gp06 IPR007110 Immunoglobulin-like    
gp12 IPR003599 Immunoglobulin subtype    
 IPR007110 Immunoglobulin-like    
 IPR013783 Immunoglobulin-like fold    
 PF13895.1 Immunoglobulin domain (Ig_2) Domain 29.3 6.30E-07 
gp18 IPR025395 Protein of unknown function DUF4128    
 PF13554.1 Domain of unknown function (DUF4128 Family 87.2 6.00E-25 
gp20 IPR005039 Bacteriophage P1, Ant1, C-terminal    
 IPR014054 Bacteriophage regulatory protein, Rha family    
 PF09669.5 Phage regulatory protein Rha (Phage_pRha) Family 73.2 1.50E-20 
 PF03374.9 Phage antirepressor protein KilAC domain (ANT) Family 50.6 1.50E-13 
gp22 PF13392.1 HNH endonuclease (HNH_3) Domain 48.1 4.80E-13 
gp24 IPR016410 Bacteriophage-associated immunity protein    
 PF14373.1 Superinfection immunity protein (Imm_superinfect) Family 65.3 2.40E-18 
gp25 IPR014859 Protein of unknown function DUF1789    
 PF08748.6 Domain of unknown function (DUF1789) Domain 32.2 8.20E-08 
gp29 IPR014974 Bacteriophage D3, Orf22    
 PF08875.6 Domain of unknown function (DUF1833) Family 158.4 5.90E-47 
gp32 IPR011050 Pectin lyase fold/virulence factor    
 IPR012332 P22 tailspike C-terminal domain-like    
 IPR015331 P22 tailspike C-terminal domain    
 PF09251.5 Salmonella phage P22 tailspike (PhageP22-tail) Domain 1115.2 0 
gp34 IPR000330 SNF2-related    
 IPR004042 Intein DOD homing endonuclease    
 IPR006141 Intein splice site    
 IPR007868 Hom-end-associated Hint    
 IPR014001 Helicase, superfamily 1/2, ATP-binding domain    
 PF05203.11 Hom end-associated Hint (Hom_end_hint) Domain 99.5 1.90E-28 
 PF05203.11 Hom end-associated Hint (Hom_end_hint) Domain 35.9 5.30E-09 
 PF00176.18 SNF2 family N-terminal domain (SNF2_N) Family 37.8 8.80E-10 
gp36 IPR014883 VRR-NUC domain    
 PF08774.6 VRR-NUC domain (VRR_NUC) Domain 47.2 1.60E-12 
gp37 IPR001098 DNA-directed DNA polymerase, family A, palm 
domain 
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 IPR006141 Intein splice site    
 IPR012337 Ribonuclease H-like domain    
 PF00476.15 DNA polymerase Family A (DNA_pol_A) Family 32.4 3.30E-08 
gp38 IPR022595 Bacteriophage APSE-1, protein 50    
 PF10991.3 Domain of unknown function (DUF2815 Family 182.3 5.50E-54 
gp40 IPR021229 Protein of unknown function DUF2800    
 PF10926.3 Domain of unknown function (DUF2800 Family 335.6 3.30E-100 
gp42 IPR001387 Helix-turn-helix type 3    
 IPR010982 Lambda repressor-like, DNA-binding domain    
 PF12844.2 Helix-turn-helix domain (HTH_19) Domain 38.2 9.70E-10 
gp43 PF13481.1 AAA domain (AAA_25) Domain 95.3 2.60E-27 
gp45 IPR009061 DNA binding domain, putative    
 IPR011991 Winged helix-turn-helix transcription repressor 
DNA-binding 
   
gp45 PF12728.2 Helix-turn-helix domain (HTH_17) Domain 37.4 2.00E-09 
gp51 IPR002196 Glycoside hydrolase, family 24    
 IPR023346 Lysozyme-like domain    
 IPR023347 Lysozyme domain    
 PF00959.14 Glycoside hydrolase family 24 (Phage_lysozyme) Domain 57.6 1.20E-15 
gp53 IPR020295 Protein of unknown function DUF2737    
 PF10930.3 Domain of unknown function (DUF2737) Family 86.3 6.80E-25 
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Supplemental Table 6. Translated sequences of vB_SenS-Ent3 ORFs with matches to domains and 
motifs in the Pfam and InterProSite databases. 
ORF ID IPR ID Description Type Bit score E-value 
gp02 IPR004921 Terminase, large subunit    
 PF03237.10 Terminase-like family (Terminase_6) Family 100.5 7.20E-29 
gp03 IPR025129 Domain of unknown function DUF4055    
 PF13264.1 Domain of unknown function (DUF4055) Family 146.7 4.00E-43 
gp05 IPR006528 Phage head morphogenesis domain    
 IPR017029 Bacteriophage K1H, Orf3    
 PF04233.9 Phage Mu protein F like protein (Phage_Mu_F) Family 39.6 5.40E-10 
gp06 IPR007110 Immunoglobulin-like    
gp12 IPR003599 Immunoglobulin subtype    
 IPR007110 Immunoglobulin-like    
 IPR013783 Immunoglobulin-like fold    
 PF13895.1 Ig_2 Domain 29.3 6.30E-07 
gp18 IPR025395 Protein of unknown function DUF4128    
 PF13554.1 DUF4128 Family 87.2 6.00E-25 
gp20 IPR005039 Bacteriophage P1, Ant1, C-terminal    
 IPR014054 Bacteriophage regulatory protein, Rha family    
 PF09669.5 Phage regulatory protein Rha (Phage_pRha) Family 73.2 1.50E-20 
 PF03374.9 Phage antirepressor KilAC domain (ANT) Family 50.6 1.50E-13 
gp22 PF13392.1 HNH endonuclease (HNH_3) Domain 48.1 4.80E-13 
gp24 IPR016410 Bacteriophage-associated immunity protein    
 PF14373.1 Superinfection immunity protein (Imm_superinfect) Family 65.3 2.40E-18 
gp25 IPR014859 Protein of unknown function DUF1789    
 PF08748.6 Domain of unknown function (DUF1789) Domain 32.2 8.20E-08 
gp29 IPR014974 Bacteriophage D3, Orf22    
 PF08875.6 Domain of unknown function (DUF1833 Family 158.4 5.90E-47 
gp32 IPR011050 Pectin lyase fold/virulence factor    
 IPR012332 P22 tailspike C-terminal domain-like    
 IPR015331 P22 tailspike C-terminal domain    
 PF09251.5 Salmonella phage P22 tailspike (PhageP22-tail) Domain 1121.1 0 
gp34 IPR000330 SNF2-related    
 IPR004042 Intein DOD homing endonuclease    
 IPR006141 Intein splice site    
 IPR007868 Hom-end-associated Hint    
 IPR014001 Helicase, superfamily 1/2, ATP-binding domain    
 PF05203.11 Hom end-associated Hint (Hom_end_hint) Domain 99.5 1.90E-28 
 PF05203.11 Hom end-associated Hint (Hom_end_hint) Domain 36.7 3.20E-09 
 PF00176.18 SNF2 family N-terminal domain (SNF2_N) Family 36.9 1.60E-09 
gp36 IPR014883 VRR-NUC domain    
 PF08774.6 VRR-Nuc domain (VRR_NUC) Domain 47.4 1.30E-12 
gp37 IPR001098 DNA-directed DNA polymerase, family A, palm domain    
 IPR006141 Intein splice site    
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 IPR012337 Ribonuclease H-like domain    
 PF00476.15 DNA polymerase family A (DNA_pol_A) Family 32.4 3.30E-08 
gp38 IPR022595 Bacteriophage APSE-1, protein 50    
 PF10991.3 Domain of unknown function (DUF2815) Family 182.3 5.50E-54 
gp40 IPR021229 Protein of unknown function DUF2800    
 PF10926.3 Domain of unknown function (DUF2800) Family 336 2.60E-100 
gp42 IPR001387 Helix-turn-helix type 3    
 IPR010982 Lambda repressor-like, DNA-binding domain    
 PF12844.2 Helix-turn-helix domain (HTH_19) Domain 38.2 9.70E-10 
gp43 PF13481.1 AAA domain (AAA_25) Domain 95.5 2.30E-27 
gp45 IPR009061 DNA binding domain, putative    
 IPR011991 Winged helix-turn-helix transcription repressor DNA-
binding 
   
 PF12728.2 Helix-turn-helix domain (HTH_17) Domain 37.4 2.00E-09 
gp52 IPR002196 Glycoside hydrolase, family 24    
 IPR023346 Lysozyme-like domain    
 IPR023347 Lysozyme domain    
 PF00959.14 Glycoside hydrolase, family 24 (Phage_lysozyme) Domain 54.3 1.20E-14 
gp55 IPR020295 Protein of unknown function DUF2737    
 PF10930.3 Domain of unknown function (DUF2737) Family 86.3 6.80E-25 
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Supplemental Table 7. Open reading frames shared between proposed members of the Setp3likevirus. 
Putative function Ent1 Ent2 Ent3 Wksl3 SS3e SE2 SETP3 K1H K1G K1ind1 K1ind2 K1ind3 
Terminase, small subunit gp01 gp01 gp01 gp04 gp17 gp30 gp29 ORF47 ORF49 ORF48 ORF45 ORF46 
Terminase, large subunit gp02 gp02 gp02 gp03 gp16 gp31 gp30 ORF1 ORF1 ORF1 ORF1 ORF1 
Portal protein gp03 gp03 gp03 gp02 gp15 gp32 gp31 ORF2 ORF2 ORF2 ORF2 ORF2 
DNA-binding KilA-N gp04 gp04 gp04 gp01 gp14 gp33 gp32 - - - - - 
SPP1 gp7 gp05 gp05 gp05 gp64 gp13 gp34 gp33 ORF3 ORF3 ORF3 ORF3 ORF3 
Unique hypothetical protein - - - - - - - - - - - ORF4 
Putative head decoration protein gp06 gp06 gp06 gp63 gp12 gp35 gp34 ORF4 ORF4 ORF4 ORF4 ORF5 
Hypothetical protein gp07 gp07 gp07 gp62 gp11 gp36 gp35 ORF5 ORF5 ORF5 ORF5 ORF6 
Hypothetical protein gp08 gp08 gp08 - - gp37 - ORF6 ORF6 ORF6 ORF6 ORF7 
Putative scaffold protein gp09 gp09 gp09 gp61 gp10 gp38 gp36 ORF7 ORF7 ORF7 ORF7 ORF8 
Major capsid protein gp10 gp10 gp10 gp60 gp09 gp39 gp37 ORF8 ORF8 ORF8 ORF8 ORF9 
Putative head fibre protein gp11 gp11 gp11 gp59 gp08 gp40 gp38 ORF9 ORF9 ORF9 ORF9 ORF10 
Putative Hoc protein gp12 gp12 gp12 gp58 gp07 gp41 gp39 - ORF10 ORF10 ORF10 ORF11 
Hypothetical protein gp13 gp13 gp13 gp57 gp06 gp42 gp40 - ORF11 ORF11 ORF11 ORF12 
HNH endonuclease (unique) - - - - - - - - ORF12 - - - 
Hypothetical protein gp14 gp14 gp14 gp56 gp05 gp43 gp41 ORF10 ORF13 ORF12 ORF12 ORF13 
Putative neck protein gp15 gp15 gp15 gp55 gp04 gp44 gp42 ORF11 ORF15 ORF13 ORF13 ORF14 
Hypothetical (frameshift?) gp16 gp16 gp16 gp54 gp03 gp45 gp43 ORF12 ORF14 ORF14 ORF14 ORF15 
Hypothetical (frameshift?) - - - - - - - ORF13 - - - - 
Hypothetical (frameshift?) gp17 gp17 gp17 gp53 gp02 gp46 gp44 ORF13 ORF14 ORF14 ORF14 ORF15 
Hypothetical protein gp18 gp18 gp18 gp52 gp01 gp47 gp45 ORF14A ORF16 ORF15 ORF15 ORF15 
Major tail protein gp19 gp19 gp19 gp51 - gp48 gp46 ORF14B ORF17 ORF16 ORF16 ORF17 
Putative ATPase - - - - - - - ORF15 ORF18 ORF17 ORF17 ORF18 
Putative polynucleotide kinase - - - - - - - ORF16 ORF19 ORF18 ORF18 ORF19 
DNA binding protein gp20 gp20 gp20 gp50 - gp49 gp47 - - - - - 
Unique hypothetical protein - - - - - gp50 - - - - - - 
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DNA-methylase - - - - - gp51 - - - - - - 
Hypothetical protein gp21 gp21 gp21 gp49 - - gp48 - - - - - 
HNH endonuclease gp22 gp22 gp22 gp48 - - - - - - - - 
Recombination endonuclease gp23 gp23 gp23 gp47 - gp52 gp49 ORF17 ORF20 ORF19 ORF19 ORF20 
Unique hypothetical protein - - - - - - - ORF18 - - - - 
Immunity protein gp24 gp24 gp24 gp46 gp58 gp53 gp50 - ORF21 ORF20 ORF20 ORF21 
Hypothetical protein gp25 gp25 gp25 gp45 gp57 gp54 gp51 ORF19 ORF22 ORF21 ORF21 ORF22 
Hypothetical protein gp26 gp26 gp26 gp44 gp56 gp55 gp52 ORF19 ORF22 ORF21 ORF21 ORF22 
Tape measure protein gp27 gp27 gp27 gp43 gp55 gp56 gp53 ORF20 ORF23 ORF22 ORF22 ORF23 
Hypothetical protein gp28 gp28 gp28 gp42 gp54 gp57 gp54 ORF21 ORF24 ORF23 ORF23 ORF24 
Hypothetical protein gp29 gp29 gp29 gp41 gp53 gp58 gp01 ORF22 ORF25 ORF24 ORF24 ORF25 
Hypothetical protein gp30 gp30 gp30 gp40 gp52 gp59 - ? ? ? ? ? 
Tail fiber or baseplate 
gp31 gp31 gp31 gp39 gp50 gp60 gp02 ORF23 ORF26 ORF25 ORF25 ORF26 
- - - - gp51 - gp03 - - - - - 
Tailspike: P22-like gp32 gp32 gp32 gp38 gp52 gp61 gp04 - - - - - 
Tailspike - K1F and HK620-like - - - - - - - ORF24 ORF27 ORF26 ORF26 ORF27 
Hypothetical protein Gp33 Gp33 Gp33 Gp37 gp48 - gp05 ORF25 - - - - 
Hypothetical protein - - - - - - - ORF26 ORF28 - - - 
Helicase Gp34 Gp34 Gp34 Gp36 Gp47 Gp01 Gp06 ORF27 ORF29 ORF27 ORF27 ORF28 
MTE-like protein - - - - - - - ORF28 ORF30 ORF28 ORF28 ORF29 
C-specific methylase - - - - - - - ORF29 ORF31 ORF29 ORF29 ORF30 
HNH Homing endonuclease (pdb:1u3e) - - - - Gp46 Gp02 Gp09 - - - - - 
Hypothetical protein Gp35 Gp35 Gp35 Gp35 Gp45 Gp03 Gp07 ORF30 ORF32 - - - 
Holliday-junction resolvase (pdb:1hh1) Gp36 Gp36 Gp36 Gp34 Gp44 Gp04 Gp08 ORF31 ORF33 - - - 
Hypothetical protein - - - Gp33 - - - - - - - - 
DNA polymerase 
Gp37 Gp37 Gp37 Gp32 Gp41  Gp05 Gp10 ORF32 ORF34 ORF30 ORF30 ORF31 
    
Gp43 Gp06 
     
  
Gp2.5-like protein (pdb:1je5) 
Gp38 Gp38 Gp38 Gp31 Gp40 Gp07 Gp11 ORF33 ORF35 - ORF31 ORF32 
    
Gp39 
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Hypothetical protein Gp39 Gp39 Gp39 - - - - - - - - - 
Helicase subunit (pbd:3u4q) Gp40 Gp40 Gp40 Gp30 Gp38 Gp08 Gp12 ORF34 ORF36 ORF31 ORF32 ORF33 
Hypothetical protein - - - - Gp37 - - - - ORF32 - - 
Hypothetical protein - - - Gp29 - Gp09 - ORF35 ORF37 ORF33 
 
  
Hypothetical protein - - - Gp28 - Gp10 - - - - - - 
Hypothetical protein Gp41 Gp41 Gp41 Gp27 Gp36 Gp11 Gp13 ORF36 ORF38 ORF34 ORF33 ORF34 
Transcriptional regulator (pdb:3bs3) Gp42 Gp42 Gp42 Gp26 Gp35 Gp12 Gp14 - - - - - 
Hypothetical protein - - - - - - - - ORF39 - - - 
Helicase-primase Gp43 Gp43 Gp43 Gp25 Gp34 Gp13 Gp15 ORF38 ORF40 ORF35 ORF34 ORF35 
Uvsx-like (not evidence from hhpred) Gp44 Gp44 Gp44 Gp24 Gp33 Gp14 - ORF37 - ORF36 - - 
DNA-binding (pdb:1z4h) Gp45 gp45 gp45 Gp23 Gp32 Gp15 GP16 - - ORF37 - - 
Hypothetical protein - - - - - - - ORF39 ORF41 - ORF35 ORF36 
Hypothetical protein gp46 - Gp46 - - - - ORF40 ORF42 ORF38 ORF36 ORF37 
Hypothetical protein gp47 gp46 gp47 gp19 gp29 gp18 gp19 - - - - - 
Hypothetical protein gp48 gp47 gp48 gp18 gp28 gp19 gp20 ORF41 ORF43 ORF39 ORF37 ORF38 
Hypothetical protein gp49 gp48 gp49 gp17 gp27 gp20 - - - - - - 
Hypothetical protein gp50 gp49 gp50 gp16 - - gp21 ORF42 ORF44 ORF40 ORF38 ORF39 
Holin class II gp51 gp50 gp51 gp15 gp26 gp21 gp22 ORF43 ORF45 ORF41 ORF39 ORF40 
Lysozyme gp52 gp51 gp52 gp14 gp25 gp22 gp23 ORF44 ORF46 ORF42 ORF40 ORF41 
Holin class I 
     
gp27 
 
ORF45 ORF47 ORF44 ORF42 ORF43 
Hypothetical protein - - - - - - - - - ORF45 ORF43 ORF44 
Unique hypothetical protein  - - - - - - - - - ORF46 - - 
Hypothetical protein gp53 gp52 gp53 gp13 gp24 gp23 gp24 - - - - - 
Hypothetical protein gp54 
 
gp54 gp12 - - gp25 - - - - - 
Hypothetical protein gp55 gp53 gp55 gp11 gp23 gp24 - - - - - - 
Hypothetical protein 
gp56 gp54 gp58 gp08 gp20 gp25 gp26 ORF46 ORF48 ORF47 ORF44 ORF45 
    
gp22 
    
gp43? 
 
gp42? 
Hypothetical protein - gp57 - gp09 - gp26 gp27 - - - - - 
Hypothetical protein gp57 gp55 gp59 gp07 gp19 - - - - - - - 
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Hypothetical protein gp58 gp56 - - - - gp28 - - - - - 
Hypothetical protein - - gp60 gp06 gp18 gp28 - - - - - - 
Hypothetical protein - - - gp05 - gp29 - - - - - - 
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